Yadda za a yi amfani da wadannan magani?
da kowane ƙaunar ƙaunar ƙaunar ƙaunar ƙaunar ƙaunar ƙaunar ƙaunar ƙaunar ƙaunar ƙaunar ƙaunar ƙaunar ƙaunar ƙaunar ƙaunar ƙaunar ƙaunar
Kuma tare da matsa lamba
da kuma ya kamata ka duba cholesterol damuwa
Yadda za ka samu magani a yanzu?
Shin kana da wannan ƙaunar ƙaunar ƙaunar?
har ila yau, za ka iya haifar da hankali
Shin, za ka iya magana da abin da sauran maganin da za ku yi tare da wannan?
Yadda za a yi magani
kuma ina da cough
kuma ina da wani tsanani da tsanani
kuma ina yi da wani bad chest pain yau
Kuma wannan shi ne mafi kyau lokaci domin your hay fever
Kuma yana da matsa lamba matsa
kuma na san cewa ina da wani bit na fever
kuma na so ka ce wuri a kan wuri ne
Kuma su da wasu fever kuma
kuma tare da hadin gwiwa na diabetes
kuma ka san cewa yana da matsala kamar yadda za a gane crush
kuma ka san mutane cough a kan ni a kowace lokaci
kuma kana da ƙaunar ƙauna
kuma ka ce wannan shi ne matsa lamba a cikin ƙaunarka
kowace mutum a gaban da matsaloli matsaloli matsaloli matsaloli matsaloli matsaloli matsaloli matsaloli matsaloli
kowace wasu matsaloli ko matsaloli da za ku zo tare da muscular pain?
Kuna da wasu mutane da aka jima'i kamar yadda ka a cikin gida tare da samfurori?
Shin kana da wasu magani?
Shin kana da wani matsa lamba?
Yadda za ka samu ƙauna a cikin ƙauna
Saboda haka, wannan shi ne influenza season
but also we shouldn't be put aside for the heart heart origin chest pain
amma mafi muhimmanci matsaloli yanzu ne wannan matsaloli
Kuma ina da matsaloli
but I know a lot of people cough on me
but we need to treat every chest pain with the utmost seriousness
but you're breathing all right right right now?
'cause of this chest pain i completely forgotten
Yadda za a yiwuwa kamar yadda mutum ya shigar da ƙaunarka
Yadda za a yiwuwa kamar shortness of breath
Shin, ba za su ji su yi magana da matsaloli?
Shin kana da wani wasu jima'i kamar high blood pressure ko abin da yaushe?
Shin kana da wani wasu magani da matsaloli matsaloli matsaloli kamar diabetes?
Kuna da wani matsa lamba tare da wannan matsa lamba?
Kuna da high blood pressure?
Kuna da wani shortness na halitta ya yi tare da wannan?
Shin, za ka san abin da yake da matsaloli?
Shin kana neman image?
Ƙararrawa Ƙararrawa Ƙararrawa Ƙararrawa
Yadda za a yi gwaje-gwaje ga diabetes
har ila yau, yana da matsaloli kamar yadda na
Yadda za a yi magani?
Yadda za a yi damuwa?
Idan kana da high fever
idan kana da karfin ruwa na hundred da biyu ko fiye da
idan ka san cewa matsaloli ko matsaloli dace da kyau
Yau ina da magani
Ina da karamin ƙafafi kuma
Yau ina haɓaka
Ina da matsa lamba a cikin ƙarfi
Ina da matsaloli da matsaloli
Ina saita ku da hotuna
I'm having some chest pain yau
I am just having a few headaches and some fever yau
Ina daidai da shi ne influenza
a nan, wannan shi ne wani m flu
Shin, shi ne kamar yadda wani matsa lamba matsa lamba a kan ƙasa?
Duk da haka, duk da haka, duk da haka, duk da haka, duk da haka, duk da haka, duk da haka.
Yana da matsa lamba a cikin tsakiya
shi ne wani matsa lamba kamar matsa lamba
Yana a cikin ƙaunarku
shi ne a cikin tsakiyar na'urarku
Yana a cikin cibiyoyin ƙarfi
I've got pain in my chest
I am very worried about this ƙwayar ƙwayar ƙwayar
I want you to say to me in describing wannan ƙaunar ƙaunar
kamar high blood pressure ko diabetes
kamar yadda a tsakiya a cikin tsakiya
yanzu ga matsa lamba za ka iya samun tachipirina mai kyau
yanzu mary da yawa daga da za ku da matsaloli
yanzu ka ce ku da ƙaunar ƙauna
Kowace lokacin da na da wani ƙaunar ƙaunar
Okay, za ka da wani wasu magani tare da wannan ba tare da hanya magani
Ko da wani mutum ya yi a kan ƙaunarka?
game da wannan tare da matsa lamba da matsa lamba da matsa lamba
Yanzu a cikin tsakiya
ya nuna ni a cikin wannan hotuna, a cikin abin da kammala
Ta yaya ka da magani
so ka san cewa wasu daga wadannan magani za a iya daidaita tare da zuba jari?
kowace abin da suka yi da wasu samfurori?
Yadda za ka ce game da ƙarfi na ƙarfi
Ƙararrawa Ƙararrawa Ƙararrawa Ƙararrawa
The fever na ya dace da shekaru biyu
Ƙananan ƙaunar ƙaunar ƙaunar ƙaunar ƙaunar ƙaunar ƙaunar
Wannan shi ne Doctor Porter a cikin Emergency Room Triage Center
Shin, za ka iya magana da wani matsala game da ƙaunarku?
well I feel a pain in the front of my body here in my chest
well I've been having a strong pain in my chest
well when I have that pain in my chest
Yadda za a yi magana a cikin ƙaunarku?
Yadda za a fara wannan matsa lamba?
Yadda za ka samu da matsa lamba a cikin ƙarfi?
where you feel this chest pain eel wannan chest t
Yadda za a yiwuwa a kan ƙaunarku
You know i got diabetes da kuma abubuwa
ya ce ka samu wannan ƙaunar ƙauna
Ƙararrawa da ƙararrawa na coronavirus disease (COVID-19) a Turai/European Economic Area da Birtaniya, 1 Janairu zuwa 15 Maris 2020
The cumulative incidence of coronavirus disease (COVID-19) cases is showing similar trends in European Union/European Economic Area countries and the United Kingdom confirming that, yayin a wani daban-daban mataki da kasa, COVID-19 pandemic is progressing rapidly in all countries.
Tare da kwarewa daga Italiya, kasashe, magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magunguna.
Tare da 31 Disamba 2019, a cikin Wuhan, Hubei Province, China, an ra'ayi na pneumonia mataki da aka sani.
Nuwamba 9, 2020, China Center for Disease Control da Prevention ya gabatar da matsa lantarki a matsayin wani sabon coronavirus wanda a yanzu aka sani da matsa lantarki na acute respiratory syndrome coronavirus 2 (SARS-CoV-2).
Tare da haka, magani wanda ya sami daga SARS-CoV-2 infection an sani da coronavirus magani (COVID-19).
Saboda haka, 80% na mutane tare da COVID-19 yana da magani, wanda ya hada da magani da ko ba tare da pneumonia.
A game da 14% na matsala, COVID-19 yana ci gaba a cikin matsala da ake bukata, yayin da 6% na matsala yana da matsala da ake bukata da ake bukata.
Ƙararrawa na matsaloli a cikin magunguna saboda COVID-19 ne fiye da 4%.
A cikin wannan bincike, mu daidaito a cikin daidaitacce na COVID-19 a kowane Turai/European Economic Area (EU/EEA) kasashe da Birtaniya (UK) da kuma haɗa su tare da Hubei Province, China.
Za mu karanta da yawan yanzu na COVID-19 a cikin EU / EEA kasashe da Birtaniya da wanda a Italiya tsakanin 31 Janairu da 15 Maris 2020.
COVID-19 mataki a cikin EU / EEA kasashe da UK
Bayan kasar Sin, COVID-19 ya ci gaba da ƙarƙashin yanayi, da kuma dinamici na COVID-19 pandemic a cikin sauran duniya a yanzu ya ci gaba da wannan kasar.
Maris 11, 2020, Director-General na World Health Organization (WHO) ya sanar da COVID-19 a matsayin pandemic.
A 5 Maris na Eurosurveillance 2020, Spiteri et al. ya gabatar da farko na Turai da aka gabatar da matsala na COVID-19 a kan WHO case definition.
A cikin EU / EEA, na farko da uku kwarewa da kwarewa da aka gabatar da Faransa a Janairu 24, 2020 a cikin mutane da suka zo daga Wuhan, Hubei Province, China.
A kan 15 Maris 2020, matakan COVID-19 da aka kwatanta a duk 30 kasashe na EU / EEA da Birtaniya (UK), wanda, tsakanin 31 Disamba 2019 da wannan bayan, 39,768 matakan da 1,727 matakan da aka kwatanta, tare da 17,750 matakan da 1,441 matakan daga Italiya kawai.
Ƙara yawan da kuma ƙara yawan COVID-19 cases
The European Centre for Disease Prevention and Control (ECDC) na gabatarwa COVID-19 kasuwa a kowane kasashe a duniya, da aka samu daga kawai asali kayayyakin kamar da kasashe na Health Ministry, kasa da kasa da yankin health authorities da WHO, suna updated kowane rana a 8:00 a.m.
Wannan bayanai da aka amfani da ci gaba da COVID-19 a cikin EU / EEA da UK, da kuma daidaita su tare da Italiya.
Kamar yadda proxy na ƙaddamar da mataimakin COVID-19 ajiya, mu sayar da ƙaddamar da matakan COVID-19 a cikin 14 kwanaki, tare da haka da karkashin tsari na COVID-19 a kowane EU / EEA kasashe da Birtaniya, a lokacin 1 Janairu - 15 Maris 2020.
Tare da ƙaddamar da ƙaddamar da yawan kwarewa na kowane kasa a kan 15 Maris 2020 a 8:00 a kan kwarewa da Italiya a kan lokaci na 31 Janairu zuwa 15 Maris 2020.
Trends na COVID-19 a cikin EU / EEA kasashe da UK
Tuntubewa a cikin 14 na yau da kullum tsari na COVID-19 a kasar EU / EEA da Birtaniya a karkashin Hubei Province (China) (Figure 1).
Ga EU/EEA da Birtaniya a cikakken, matsaloli na COVID-19 ya fara ci gaba a kan 21 watan Fabrairu da kuma ya ci gaba da ƙarfi a kan 28 watan Fabrairu 2020 (Supplementary material).
Wannan shi ne mafi girma a kan ƙaddamar da yawa da yawa daga Italiya, amma duk sauran EU / EEA kasashe da Birtaniya ya nuna daidaici ƙaddamar da ƙaddamarwa na COVID-19 (Supplementary Material).
Sabuwar 2 yana nuna da yawan kwarewa na COVID-19 a cikin EU / EEA kasashe da Birtaniya da kuma a Italiya a cikin lokaci na 31 Janairu - 15 Maris 2020.
Yana nuna cewa, a kan 8:00 a rana na 15 Maris, 15 sauran EU / EEA kasashe da Birtaniya ya gabatar da yawan kwarewa da ke daidaita da Italiya kawai 3 makonni da suka wuce.
Our bayanai sun nuna cewa yawan kwarewa na COVID-19 a cikin EU / EEA da Birtaniya yana ci gaba da sauƙi.
Tattalin COVID-19 ta ƙaddamar da ƙaddamar da ƙaddamar da ƙaddamar da ƙaddamar da ƙaddamar da ƙaddamar da ƙaddamar da ƙaddamar da ƙaddamar da ƙaddamar da ƙaddamar da ƙaddamar.
Wannan shi ne ba tare da kasashe da aka a daban-daban mataki, daban-daban a cikin kasashe na jima'i na jima'i, da zai iya daban-daban mataki na kasashe da daban-daban protocols don zabi maganin da za a yi gwaji don karanta COVID-19, ciki har da gwaji-gwaje.
Maris 2020, magungunan magungunan magungunan magungunan magungunan Magungunan Magungunan Magungunan Magungunan Magungunan Magungunan Magungunan Magungunan Magungunan Magungunan Magungunan Magungunan Magungunan Magungunan Magungunan Magungunan Magungunan Magungunan Magungunan Magungunan Magungunan Magungunan Magungunan Magungunan Magungunan Magungunan Magungunan Magungunan Magungunan Magungunan Magungunan Magungunan Magungunan Magungunan Magungunan Magungunan Magungunan Magungunan Magungunan Magungunan Magungunan Magungunan Magungunan Magungunan Magungunan Magungunan Magungunan Magungunan Magungunan Magungunan Magungunan Magungunan Magungunan Magungunan Magungunan Magungunan Magungunan Magungunan Magungunan Magungunan Magungunan Magungunan Magungunan Magungunan Magungunan Magungunan Magungunan Magungunan Magungunan.
Takaddun shaida game da kwarewa na COVID-19 a cikin magunguna da / ko kwarewa na jiki ne yanzu samuwa a tasiri na EU / EEA don kawai 6% da kuma 1% kwarewa, da dai sauransu (takaddun shaida ba).
Duk da haka, su za a daidaita a cikin wani tsarin, don buga bayanai na jima'i na jima'i da ke daidaito a kan yawan kwarewa da yawan jima'i.
A bincike da aka yi a 2010-11 ya nuna ƙarfi mai girma a cikin samfurori na kwarewa da kwarewa a Turai, daga 29,2 a Jamus zuwa 4,2 kwarewa ga 100,000 jama'a a Portugal.
Wannan yana daidai da ƙasƙanci za su iya samun fiye da ko fiye da kayayyakin da Italiya (12,5 na'ura mai aiki da karfin jiki da na'ura mai aiki da karfin jiki a kan 100,000 mutane a 2010-11).
Modeling scenarios related to healthcare capacity saturation, tare da ra'ayi ga kowane EU/EEA kasashen da kuma Birtaniya na tsakiya na matsaloli COVID-19 matsaloli da aka kwatanta da &gt; 90% ra'ayi na fiye da matsaloli kwararrun, suna samar da a cikin sixth update na ECDC Quick Risk Assessment on COVID-19.
Saboda cewa matsaloli suna ƙunshi a wasu yankin a cikin EU/EEA kasashe da Birtaniya, da kuma magungunan jiki da jiki na jiki da suka yi amfani da yawancin jiki na yankin, bayanai game da matsaloli da matsaloli na jiki na jiki za a yiwuwa a tasiri na Nomenclature of Territorial Units for Statistics 2 (NUTS-2).
Tare da kwarewa na Italiya da kuma kwarewa a wasu kasashe yana nuna cewa COVID-19 pandemic yana ci gaba da sauƙi a cikin EU / EEA da UK.
Kasuwanci, magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan.
Kamar yadda ya ce a cikin sabon ECDC Fast Risk Assessment, wani sauri, m da kuma cikakken yanayin ne mai ban sha'awa don rarraba da SARS-COV-2, tare da wani canji daga ajiya da ajiya, kamar yadda dacewa da ci gaba da yawan matsala za a iya ba da yawa lokaci don ƙirƙirar takaddun sha'awa da magungunan magunguna don sani, shigar da kuma mayar da sha'awar su, idan ba a yi aiki a karkashin lokaci.
The Fast Risk Assessment yana ƙirƙirar ƙirƙirar tsarkakewar tsarkakewar tsarkakewar tsarkakewar tsarkakewar tsarkakewar.
Yana da ƙananan lokaci a lokacin da ƙasashe yana da damar ƙirƙirar ƙarƙirar ƙarƙirar ƙarƙirar ƙarƙirar SARS-CoV-2 ƙarƙirar ƙarƙirar ƙarƙirar ƙarƙirar ƙarƙirar ƙarƙirar ƙarƙirar ƙarƙirar.
Idan wannan ba, za a yiwuwa da cewa shirye-shirye-shirye na magani na sauran kasashe na EU / EEA za su karantawa tare da wani ƙarfi na magani da ake bukata a cikin gaba da kwanakin ko kwanakin.
Mataki na Coronavirus na 2019 (COVID-19), wanda aka haifar da mataki mataki na acute respiratory syndrome (SARS) coronavirus 2 (SARS-CoV-2), ya wuce fiye da 3,000 mutane da kuma rage fiye da 80,000 a kasar Sin da sauran ƙasashe a duniya, wanda ya zama tsuntsaye ga mutane.
Similar to da homologous virus, SARS-CoV, wanda ya ƙara SARS a cikin ma'aikace-aikace a 2003, SARS-CoV-2 za a iya dauke daga bututu da kuma ya ƙirƙirar samfurori kamar yadda za a yi amfani da wani samfurori.
Duk da haka, COVID-19 yana da ƙarshe da matsaloli fiye da SARS, amma yana da ƙarfafafafa da kuma ƙarfafafa fiye da mata fiye da mata.
Saboda da yawa da yawa na makamashi game da magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magunguna.
Za mu ƙunshi asali game da epidemiology, etiology, virology, diagnosis, magani, prognosis, da ci gaba da magani.
Duk da yawa tambayoyin da suka bukatar shawarar, mu so cewa wannan review zai taimakawa a cikin fahimci da gyara da magana da magana.
The Spring Festival a kan Janairu 25, 2020 ya zama mai ban sha'awa da kuma mai ban sha'awar ga dukan Kinesis wanda aka ba da sha'awar don zama a cikin gida don dukan kowane kudi da kuma da yawa kwanan nan bayan tsari na sabon magani.
Virus ne mafi homologous da coronavirus (CoV) wanda ya ci gaba da matsa lamba na matsa lamba na acute respiratory syndrome (SARS) a 2003; Saboda haka, shi aka ba da sunan SARS-CoV-2 ta World Health Organization (WHO) a watan Fabrairu 11, 2020, da kuma jiki da aka ba da sunan CoV Disease-19 (COVID-19).
Epidemic ya fara a Wuhan, kasar Sin, da kuma sauƙi buga a kowace kasar da kuma a gudu 50 wasu a duniya.
Tare da 2 Maris 2020, virus ya sa fiye da 80,000 kwarewa na COVID-19, tare da fiye da 40,000 dalibai da kuma fiye da 3,000 dalibai da aka gyara.
WHO ya gabatar da cewa COVID-19 ne "tallace-tallace Number 1" da kuma za a iya zama mafi girma fiye da ra'ayi.
Saboda PubMed (https://www.ncbi.nlm.nih.gov/pubmed/), a fiye da wata biyu, fiye da 200 kayayyakin da aka buga a kan COVID-19 ciki har da virology, epidemiology, etiology, diagnosis, da matsa lissafi tun da farko rabo a kan Janairu 7, 2020 wanda ya ƙunshi matsa lissafi na virus da aka rarraba daga matsa lissafi.
Wannan bincike na ci gaba da saukar da ci gaba da bincike a cikin sabon da kuma sauƙi ci gaba da yanki.
Kamar yadda za a iya, za mu yi ci gaba da ƙara COVID-19 tare da SARS da wani magani na CoV, Middle East respiratory syndrome (MERS, wani matsa lamba a 2012).
Za mu tambaya da abin da aka koyi don haka game da tsarewa da prognosis na magani, da kuma wasu mahimmanci.
CoVs suna da al'amala da aka kira nonlethal patogenes ga mutane, mafi girma tsari game da 15% na matsaloli 4.
Duk da haka, a cikin wannan karni, mu kasance da biyu matsala tare da manyan patogenic human CoVs, da shi ne, SARS-CoV da MERS-CoV, wanda ya ƙirƙirar matsala a kasar Sin a 2003 da kuma Saudi Arabia a 2012, da yaushe a cikin yawa sauran kasashe tare da matsaloli da matsaloli.
Saboda haka, yanzu COVID-19 ne na uku CoV fadi a cikin tarihi na al'umma na mutane.
Kamar yadda ya nuna a Fig.1.1, clusters na pneumonia da ke da al'ada ba za a gabatarwa daga Wuhan a ranar Disamba 31, 2019 zuwa China National Health Commission.
Sabuwar kwanaki da suka wuce da tsari na CoV aka saita.
Yuni 15, 2020, na farko matsalolin matsaloli daga Wuhan aka kwatanta.
Tare da haka, jima'i da aka sauri zuwa kasashen jiragen kasa, provinces, da kasashe.
Yau, 20 Janairu, lissafi na masana'antun magani da aka gabatar da cewa lissafi daga mutum zuwa mutum za a iya zama.
23 Janairu, birni Wuhan aka shigarwa tare da duk ta jama'a ta jirgin kasa.
Janairu 24, na farko na ilimi bincike game da magani ya gabatar da cewa, daga 41 ma'aikata tare da matsala da aka gabatarwa, kawai 21 ya dace tsari tare da Wuhan masana'antu masana'antu masana'antu wanda aka sani da yanki na farko na magani daga mai ban sha'awa.
Yau 30 Janairu, WHO ya gabatar da tsuntsaye tsuntsaye a duniya.
A lokacin da wannan bayanin, magani ya sa a cikin kasar Sin da kuma fiye da 50 sauran kasashe a duniya (Fig. (Fig. 2).2).
Kamar yadda hali yana ci gaba da sauƙi, ƙarin ƙarfi da ƙarfin ƙarfin ƙarfin ƙarfin ƙarfin ƙarfin ƙarfin ƙarfin ƙarfin ƙarfin.
On February 11, 2020, wani multicenter bincike a kan 8,866 dalibai, ciki har da 4,021 ya gabatar da COVID-19 dalibai, ya gabatar da wani mai update illustration na epidemic kamar wannan (https://mp.weixin.qq.com/s/UlBi-HX_rHPXa1qHA2bhdA).
SARS-CoV-2 ya rage mutane a kowane al'amari, amma mafi girma a cikin shekaru 30-65.
Karkashin yarda (47.7%) na ra'ayoyi suna fiye da shekaru 50, fiye da shekaru 20, kuma kawai 14 na ra'ayoyi suna fiye da shekaru 10.
SARS-CoV-2 ya sa da yawa mutane (0,31/100,000) fiye da mata (0,27/100,000).
COVID-19 ya ci gaba a cikin clusters musamman a cikin da kuma kusa da Hubei.
COVID-19 ya dace a karkashin 5 (2-9) kwanakin daga matsaloli zuwa magani.
A karshe inkubation lokaci ne 4.8 (3.0-7.2) kwanaki.
Ma'aikatan lokaci daga matsaloli zuwa matsaloli ne 9.5 (4.8-13) kwanaki.
Basic ƙirƙirar lambar (R0) ne 3.77 (95% CI: 3.51-4.05), kuma daidaito R0 ne 2.23-4.82.
Ƙararrawa da yawan mutane da aka fitarwa a karkashin 23 Janairu 2020, daidai da lokaci na masana'antu a karkashin Spring Festival a kasar Sin.
Ƙididdiga na magani na magani tare da matsaloli da aka gabatar da matsaloli ne 1.44% (95% CI: 1.10-1.86%), kuma matsaloli na duk maganin da aka gabatar da 3.06% (95% CI: 2.02-4.59%).
Tare da matsakaici na COVID-19 suna jima'i (maskulin), umurni (≥60), da kuma m pneumonia.
CoVs ne wani subfamily na manyan da ƙarfin jima'i na jima'i wanda ke ƙunshi wani tsari na jima'i RNA.
Za su iya ƙirƙirar a cikin hudu jini, daidai, alpha, beta, gamma, da delta, wanda alpha- da beta-CoVs suna sani da zauna mutane.
Glycoprotein (S) mai ƙarfi mai ƙarfi mai ƙarfi mai ƙarfi mai ƙarfi mai ƙarfi mai ƙarfi mai ƙarfi mai ƙarfi mai ƙarfi mai ƙarfi mai ƙarfi mai ƙarfi mai ƙarfi mai ƙarfi mai ƙarfi mai ƙarfi mai ƙarfi mai ƙarfi mai ƙarfi mai ƙarfi mai ƙarfi mai ƙarfi mai ƙarfi mai ƙarfi.
The viral RNA genome da aka ba a cikin cytoplasm; bayan replication na viral genome, genomic RNA tare da shirye-shirye glycoproteins da nucleocapsid proteins yana samar da virion-tallace-tallace vesicles, wanda sa'an nan fuse tare da plasma membrane don haifar da virus.
The farko genomic sequence na SARS-CoV-2 aka sanar a kan 10 Janairu 2020.
SARS-CoV-2 ya zama wani nau'i na beta-CoV tare da fiye da 99.98% na jima'i daga cikin 10 jima'i samfurori da aka saita daga yanki na fitarwa, Huanan Seafood Market a Wuhan.
SARS-CoV-2 ne genetically karfi tare da SARS-CoV fiye da MERS-CoV.
Ta hanyar lantarki electron microscopy, SARS-CoV-2 particles aka samu a cikin ultrathin sassa na m epithelium.
Human ACE2 ya zama wani receptor ga SARS-CoV-2 da kuma SARS-CoV.
Duk da haka, S-protein na SARS-CoV-2 yana haɗari tare da ACE2 a cikin mutane fiye da SARS-CoV, wanda aka kwatanta tare da cewa SARS-CoV-2 yana haifar da lissafi a cikin matsala fiye da SARS-CoV.
SARS-CoV-2 za a iya samar da wani sabon short protein coded da orf3b da wani secreted protein coded da orf8.
The orf3b na SARS-CoV-2 za a yi aiki a cikin viral pathogenicity da inhibits da fassara IFNβ; duk da haka, orf8 ba da wani sanannun aiki yankin ko motif.
On February 18, 2020, Zhou, et al., ya sanar da cryo-EM halitta na full-length human ACE2 a 2.9 Å ƙarfi tare da amino acid transporter B0AT1.
Yawancin da aka samu cewa tsarin, wanda ya dace da kuma shigarwa, aka gabatar a matsayin dimer da ACE2-B0AT1 tsarin yana iya ƙirƙirar biyu S-proteins, wanda ya samar da kayayyakin ga CoV recognition da lissafi.
B0AT1 za a iya zama wani therapeutic sashi don magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magunguna.
The asali da kuma mid-host
Yana da aka sani cewa duk SARS-CoV da MERS-CoV aka fara daga bututu da aka buga zuwa mutane ta hanyar civet cats da camels, da dai sauransu.
Ƙungiyar phylogenetic na SARS-CoV-2 tare da sauran CoVs, butterflies aka sani da na'ura mai ban sha'awa na SARS-CoV-2 kamar yadda sabon virus ne 96% identical da biyu SARS-kayan CoVs daga butterflies da aka sani bat-SL-CoVZX45 da bat-SL-CoVZX21.
Duk da haka, abin da aka taimakawa don taimakawa virus ta fitarwa lantarki don rage mutane, ba za a sani, da kuma lalace-tallace-tallace-tallace-tallace-tallace-tallace.
Ji, da dai sauransu, ya ce gyara a matsayin mai amfani da virus daga bututu zuwa mutane wanda ya hada da homologous recombination a cikin S protein.
Bisa ga wani bincike, masu bincike a Guangzhou, China, ya nuna cewa pangolins - long-snoted, mita-maza mamaki da aka yi amfani da a cikin halitta na kasar Sin - ne daidaitacce gabatarwa na SARS-CoV-2 a kan 99% lantarki homology a CoV samu a cikin pangolins da SARS-CoV-2.
Duk da haka, 1% daban-daban tsaye a duk biyu genomes ne ko da wani babban daban-daban; haka, daidaici results ga kyakkyawan bukatun ne dacewa (Fig. 33).
The physicochemical halitta na SARS-CoV-2 ne mafi girma a yanzu ba ya sani.
SARS-CoV da MERS-CoV za su iya haifar in vitro don 48 hours a cikin yanayi da kuma fiye da 5 kwanaki a cikin 20 ° C da 40%-50% ruwa.
SARS-CoV-2 za a iya ƙirƙirar samuwa.
Yana gabatar da cewa SARS-CoV-2 shi ne m ga ultraviolet rai da karfi a 56 ° C don 30 minti; ether, 75% ethanol, chlorine-namfani disinfectant, peracetic acid, chloroform, da sauran mafita solvents, amma ba da chlorhexidine, za a iya inganta virus.
Ƙungiyoyi na kowace jiki na kowace jiki na SARS-CoV-2 da haka suna m ga sabon virus.
Yanzu, ba da ƙarin bincike a kan immunological yanayin SARS-CoV-2.
Saboda haka, za mu iya kai kawai da gabatarwar bincike game da sauran CoVs, musamman SARS-CoV da MERS-CoV (Fig. (Fig.4).4).
Yawancin, bayan wani virus ya zo a cikin shirye-shirye, shi ne na farko sani da shirye-shirye na al'umma na al'umma ta hanyar pattern recognition receptors (PRRs) ciki har da C-type lectin-like receptors, Toll-like receptor (TLR), NOD-like receptor (NLR), da RIG-I-like receptor (RLR).
Ta hanyar daban-daban lalata, virus induces expressions of inflammatory factors, matsa lambar dendritic, da kuma synthesis na type I interferons (IFNs) wanda kammala sabis na virus da kuma sauri macrophage phagocytosis na virus antigenes.
Duk da haka, N-protein na SARS-CoV zai taimaka wa virus ba tare da matsaloli.
Haka, daidaitacce immunity yanar gizo a cikin magana da virus.
T lymphocytes ciki har da CD4+ da CD8+ T cell yana da muhimmanci jiki a cikin haɓaka.
CD4 + T cells stimule B cells don samar da virus-specific antibodies, kuma CD8 + T cells tafi tsaye virus-infected cells.
T helper cells samar da proinflammatory cytokines don taimakawar cells.
Duk da haka, CoV za a iya ƙirƙirar T cell function by inducing apoptosis na T cell.
Humoral immunity ciki har da ƙaddamarwa kamar C3a da C5a da antibodies ne kuma muhimmanci a ci gaban virus jikin.
Saboda haka, antibodies da aka ƙirƙirar daga wani matsa lamba ya ƙirƙirar MERS-CoV.
Sa'an nan, wani overreaction na tsarin sha'awa yana samar da wani yawan free radicals a yanki da za a iya ƙirƙirƙirar matsala a cikin lamba da sauran jiki, da, a mafi kyau yanki, multi-organ failure da kuma har maza.
The SARS-CoV-2 magani, wanda yafi da matsaloli matsa lissafi, yana da matsa lissafi da matsa lissafi da matsa lissafi da matsa lissafi.
Yana da yaushe cewa ga mutane da aka kwatanta da yawancin viruses ko waɗannan immunity aiki suna rage, suka da mafi yawancin da aka rage fitarwa fitarwa.
Tsarin ƙwayar tsari na SARS-CoV-2 ne 1-14 kwanaki, mafi yawanci 3-7 kwanaki a kan wani bincike na farko 425 mataki a Wuhan.
Duk da haka, wani bincike a kan 1,099 matakan yana nuna cewa tsawon tsari ne 3 kwanaki a karkashin 0 zuwa 24 kwanaki.
A karshe bincike, kamar yadda ya rubuta a karkashin, ya nuna cewa tsawon sha'awa ne 4.8 (3.0-7.2) kwanaki a kan demographics na 8,866 matakan.
Yana da muhimmanci ga masana'antun magani don ƙirƙirar karantina lokaci da aka kafa a kan ƙarin ƙarƙirar lokaci, tare da haka za a iya haɓaka mutane da aka ƙirƙirar amma ba tare da magani daga ƙirƙirar virus zuwa sauran.
Kamar yadda wani al'ada, mutane da aka kwatanta, ko rage da, da virus an ƙaddamar da 14 kwanaki.
Yadda za a ƙirƙirar karantin lokaci zuwa 24 kwanaki?
Fever yana da yawa mafi girma da kuma farko matsaloli na COVID-19, wanda za a iya haɗa da wani matsaloli ko sauran matsaloli kamar cika, matsaloli, matsaloli, matsaloli, matsaloli, matsaloli, matsaloli, rhinorrhea, matsaloli, matsaloli, matsaloli, da matsaloli.
Wadannan maganin da aka kwarewa da dyspnea da / ko hypoxemia a cikin makonni bayan ci gaba da magani.
A matsalolin matsaloli, ma'aikata da sauri ci gaba zuwa ci gaba da acute respiratory syndrome, septic shock, metabolic acidosis, da coagulopathy.
Patients tare da matsa lamba da / ko matsa lamba matsa lamba da matsa lamba, ko da ba tare da lamba image abnormalities, za su daidaita ga viruses don daidaitacce.
A demographical bincike a karkashin Disamba 2019 ya nuna cewa mataki na mataki ne 98% don mataki, 76% don mataki, 55% don mataki, da 3% don mataki; 8% na mataki da aka bukatar ventilation support.
Similar gaban da aka kwatanta a cikin biyu kwarewar bincike na wani family cluster da wani cluster da aka ƙirƙirar ta ƙirƙirar daga wani asymptomatic mutum.
Saboda haka, wani bincike na lissafi a 2012 ya nuna cewa MERS-CoV dalibai yana da karfi (98%), cika (47%), da matsaloli (55%) a matsayin matsaloli.
Duk da haka, 80% na su bukatar ventilation taimako, da yawa fiye da COVID-19 mutane da kuma daidaita tare da fatality na MERS fiye da COVID-19.
Diarrhea (26%) da ra'ayoyi (21%) da aka samu tare da MERS magani.
A cikin SARS dalibai, an nuna cewa matsa lantarki (99%-100%), matsa lantarki (29%-75%), matsa lantarki (40%-42%), matsa lantarki (20-25%), da matsa lantarki (13-25%) suna babban matsa lantarki da kuma ventilation taimako da aka bukatar game da game da 14%-20% na dalibai.
Tare da 14 Fabrairu, matsala na COVID-19 ne 2% a duniya, yayin da matsala da aka gabatar da 66,576 a duniya.
Saboda haka, matsaloli na SARS a watan Nuwamba 2002 ne 10% na 8,096 matsaloli da aka gabatar da.
Ga MERS, bisa ga bincike na demographics a watan Yuni 2012, matsaloli ya kasance 37% daga 2.494 matsaloli da aka gabatarwa.
A karshe bincike ya gabatar da cewa R0 na SARS-CoV-2 ya zama kamar 6.47 tare da 95% jiki (CI) na 5.71-7.23, yayin da R0 na SARS-CoV ya rufe kawai daga 2 zuwa 4.
Shawarar SARS-CoV-2 tare da MERS-CoV da SARA-CoV game da matsaloli, matsaloli, da R0 suna nuna a Tabla1.1.
Tsarin bayanai sun nuna cewa SARS-CoV-2 yana da ƙarfi mai girma da MERS-CoV da SARS-CoV, amma yana da ƙarfi fatal fiye da biyu biyu.
Saboda haka, shi ne mafi kyau don ƙirƙirar jiki na SARS-CoV-2 fiye da jiki na MERS-CoV da SARS-CoV.
Clustered mataki da yawa ya zama a cikin sama gundumar ko daga sama gundumar ko kayan aiki, kamar cruise boat.
Ma'aikata da yawa na zamani na tafiya ko ajiya a Wuhan ko sauran ƙasashe da aka kwatanta tare da matsaloli ko matsaloli a cikin shekaru biyu da suka wuce da matsaloli.
Duk da haka, an ƙirƙirar da cewa mutane za su iya ƙirƙirar virus ba tare da matsaloli fiye da wata biyu da kuma matsaloli da aka rufe daga kasuwa za su iya ƙirƙirar virus, wanda ya ba da alama don ƙirƙirar lokaci don karantina.
Ma'aikata yana da yawan jiki na halitta na halitta na halitta (karkashin lymphocytes) a cikin matsaloli.
Saboda haka, lymphopenia tare da white blood cell count &lt; 4x109/L ciki har da lymphocyte count &lt; 1x109/L, da kuma rage aspartate aminotransferase tasiri da viremia aka samu a cikin 1,099 COVID-19 mata.
Tsarin karfin jiki da kuma muscular enzymes da myoglobin aka ƙara a kan wasu maganin, kuma C-reactive protein da erythrocytes sedimentation aka ƙara a cikin damuwa na mafi yawan maganin.
Daga cikin matakan matakan matakan matakan matakan matakan matakan matakan matakan matakan matakan matakan matakan matakan matakan matakan matakan matakan matakan matakan matakan matakan matakan matakan matakan matakan matakan matakan matakan matakan matakan matakan matakan matakan matakan matakan matakan matakan matakan matakan matakan matakan matakan matakan matakan matakan matakan matakan matakan matakan matakan matakan matakan matakan matakan matakan matakan matakan matakan matakan matakan matakan matakan matakan matakan matakan matakan matakan matakan matakan matakan matakan matakan matakan matakan matakan matakan matakan matakan matakan matakan matakan matakan matakan matakan.
Abnormalities a karkashin X-ray suna samu a cikin mafi COVID-19 ma'aikata da kuma yafi da bilateral patchy shadows ko ground glass opacity a cikin lamba.
Patients da yawa ci gaba da atypical pneumonia, acute lung injury, da acute respiratory distress syndrome (ARDS).
Kada ARDS ya zama, ƙwayar ƙwaƙwalwar ƙwaƙwalwar ƙwaƙwalwar ƙwaƙwalwar ƙwaƙwalwar ƙwaƙwalwar ƙwaƙwalwar ƙwaƙwalwar ƙwaƙwalwar ƙwaƙwalwar ƙwaƙwalwar ƙwaƙwalwar.
Disfunction na Type-I da Type-II pneumocytes rage surfaceactant tasiri da kuma ƙirƙirar surface tension, da haka rage iya aiki na lamba don ƙirƙirar da kuma ƙirƙirar rage na lung collapse.
Saboda haka, mafi girma chest x-ray bayanai da yawa parallel tare da mafi matsakaici matsakaici.
On February 18, 2020, na farko patological analysis na COVID-19 ya nuna desquamation na pneumocytes, hyaline membrane formation, da interstitial lymphocyte infiltration, da multinucleated syncytial cells a cikin lamba na mutum wanda ya rage daga magani, daidai da patology na viral infection da ARDS da kuma kamar yadda na SARS da MERS matsala.
The detection of SARS-CoV-2 RNA via reverse-transcriptase polymerase chain reaction (RT-PCR) aka amfani da matsayin manyan criteria ga magani na COVID-19.
Saboda haka, saboda high false-negative farashin, wanda zai iya haɓaka jiki, lissafin lissafi da aka fara amfani da gyara don magani ( wanda ba ya ba kawai riga RT-PCR) a kasar Sin a kan 13 Fabrairu 2020.
Tare da wannan matsaloli tare da magani na SARS.
Saboda haka, wani gabatarwa na fasaha, lissafin lissafi, gwaje-gwaje gwaje-gwaje, da kuma radiological foundations ne muhimmanci da muhimmanci don samar da mai kyau magani.
On February 14, 2020, Feng Zhang Group ya bayyana wani protocole na amfani da CRISPR-based SHERLOCK tekniya don gane SARS-CoV-2, wanda ya gane synthetic SARS-CoV-2 RNA fragments a 20 × 10-18 mol/L to 200 × 10-18 mol/L (10-100 copies per microliter na saukewa) ta amfani da dipstick a kowace sa'o'i ba tare da bukatun kayan aiki.
Shin, za mu yiwuwa, sabon fasaha za a iya ci gaba da kwarewa da sauki idan ya gabatar da a cikin hankali samfurori.
Saboda ba da kwarewa da sabon CoV, magani za su iya samar da taimakon taimako ga COVID-19 ma'aikata, yayin da za su yi amfani da daban-daban magani da aka amfani da ko gabatarwa a gaban sauran CoVs kamar SARS-CoV da MERS-CoV da sauran magani (Table2).
Wadannan tsari sun hada da tsari da antiviral magani, immunosuppressants, steroids, plasma daga magani, Chinese medicine, da kuma psychological support.
Ko da plasma daga matsaloli da aka gabatarwa don amfani da matsaloli.
Pharmaceutical masana'antu suna rage don samar da antibodies da vaccines ga virus.
SARS-CoV-2 fitar da hanyoyi a farkon, kuma za a iya dauke, a ƙarin ƙarfi, sauran jikin da ke nuna ACE2, kamar magungunan magungunan jiki da ƙarfin jiki.
Duk da haka, matsa lamba da matsa lamba ne mai ban sha'awa ga matsa lamba da kuma mafi girma matsa lamba.
Saboda haka, haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin.
Patients tare da matsaloli da matsaloli da matsaloli na matsaloli za su daidaita tare da extracorporeal membrane oxygenation (ECMO), wani modified cardiopulmonary bypass technique da aka yi amfani da matsaloli na matsaloli na matsaloli ko matsaloli.
Har ila yau, daidaitaccen elektrolyte kudin, ci gaba da ci gaba da tsari na secondary infection da septic shock, da kuma ci gaba da ci gaba da ayyuka na ma'aikata suna da muhimmanci ga SARS-CoV-2 matsala.
Yana da aka sani cewa tsitokin tsunduma yana da matsaloli na tsarin immunity a cikin SARS da MERS matsaloli.
Cytokine Storm ne wani nau'i na tsarin ƙarfin jiki da yafi da samarwa na wani jerin cytokines ciki har da TNFα, IL-1β, IL-2, IL-6, IFNα, IFNβ, IFNγ, da MCP-1.
Wadannan cytokines ƙirƙirar ƙirƙirar ƙirƙirar ƙirƙirar ƙirƙirar ƙirƙirar ƙirƙirar ƙirƙirar ƙirƙirar ƙirƙirar ƙirƙirar ƙirƙirar ƙirƙirar ƙirƙirar ƙirƙirar ƙirƙirar.
Immunosuppression ne da muhimmanci a cikin magani na cytokine storms, musamman a cikin matsakaici.
Corticosteroids da tocilizumab, wani anti-IL6 monoclonal antibody, da aka amfani da tsari cytokine storm.
Other immunosuppression treatments for cytokine storm include modulation of T cell-directed immune response; blockade of IFN-γ, IL-1, da TNF; JAK inhibition; blinatumomab; suppressor of cytokine signaling 4; da HDAC inhibitors.
Steroids, kamar immunosuppressants, suna amfani da yawa a cikin magungunan SARS don rage jiki na jiki na jiki.
Duk da haka, steroids a high doses ba da kyau ga matsa lamba matsa lamba a cikin SARS da COVID-19 matsa lamba.
Yanzu, za su iya ƙirƙirar matsaloli, musamman avascular osteonecrosis, da ke haɗari a kan prognosis.
Duk da haka, short koda na corticosteroids a low to moderate doses da aka tsara don amfani da tsare-tsare COVID-19 mataimakin.
A lokacin da ya rubuta, ba tare da kyakkyawan antiviral therapy.
Duk da haka, daidaitacce da remdesivir, wani nucleotide analogue, ya zama daidaitacce a cikin Americans da COVID-19.
Remdesivir ne wani sabon antiviral magani da aka ci gaba da Gilead farko don magani na magani da Ebola da Marlburg viruses.
Bayan haka, remdesivir kuma ya nuna damar inhibition na sauran single-stranged RNA viruses ciki har da MERS da SARS viruses.
Bisa ga wadannan, Gilead ya samar da gwiwa a kasar Sin don yi biyu gwaje-gwaje a kan SARS-CoV-2 infected mutane, kuma matsaloli suna da yaushe.
Bugu da haka, baricitinb, interferon-α, lopinavir / ritonavir, da kuma ribavirin da aka ce a matsayin m magani ga mata da acute respiratory magani.
Diarrhea, naushe, ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar.
Ƙararrawa na wadannan Ƙararrawa tare da sauran Ƙararrawa da aka yi amfani da magani.
Plasma daga matsaloli da kuma antibody generation
Ƙididdiga na damuwa daga magani da aka saita daga magani na magani don magani da sauran magani da suka faru da magani ko don ƙirƙirƙirar magani daga magani na magani yana da tsawon tarihin.
Yanzu, daidaitacce ma'aikata da yawa yana da ƙarfi mai girma na antibodies ga patogen a kansa.
Antibodies ne wani immunoglobulin (Ig) samar da B lymphocytes don ƙirƙirar maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin.
Bisa ga wannan, plasma aka kammala daga damuwa na ƙungiyoyi da aka saita daga COVID-19 da aka ajiya a cikin 10 mafarki mafarki.
Ma'aikata suna inganta a cikin 24 sa'o'i, tare da rage ƙarfin jiki da ƙarfin jiki, da inganta ƙarfin oxygen a kansa.
Duk da haka, daidaitaccen da ingantaji suna da muhimmanci don ƙirƙirar magani don amfani da magungunan magungunan magungunan magungunan magungunan magungunan magungunan.
Bugu da amfani da magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magunguna.
Misali, antibodies za a iya overstimulate immunity yanayin da kuma sa cytokine release syndrome, wanda shi ne mai ban sha'awa jiki na jiki.
Ƙararrawa na antibodies a cikin damuwa ne yawanci low, da kuma bukatun na plasma ne mai girma don magance masu kwarewa.
Yadda za a ci gaba da samar da antibodies daidai sauri da za a ci gaba da ci gaba da ci gaba da ci gaba da ci gaba da ci gaba.
Saboda haka, shi ne mafi muhimmanci da kuma m don ƙirƙirar B cell daga matsaloli da aka rarraba da kuma tabbatar da hanyoyin jini da ke daidaitacce antibodies ko screen ga daidaitacce antibodies ga esential protein na virus.
Saboda haka, za mu iya daidaita samar da antibodies.
TCM da aka amfani da tsari na daban-daban magani a kasar Sin da miliyoyin shekaru.
Duk da haka, haɗin da aka yi amfani da ƙananan ƙananan kayayyakin a cikin ƙananan da ke daidaita a karkashin magani na magani a kan magani a kan maganin TCM.
Mafi yawancin daidaitaccen da aka ba da gaskiya ko suna m saboda yana da matsala don ƙirƙirƙirar da tabbatar da waɗannan kayan aiki ko ƙirƙirƙirƙirƙirƙirƙirƙira.
Yanzu, saboda ba da inganci da kuma musamman therapy ga COVID-19, TCM ya zama daya daga cikin manyan hanyoyin yanayi ga matsaloli tare da matsaloli zuwa matsaloli matsaloli, ko ga waɗanda suka rãya daga matsaloli matsaloli.
Saboda haka, Shu Feng Jie Du capsules da Lian Hua Qing Wen capsules aka samu a yi amfani da COVID-19.
Top cure rates a tsari COVID-19 dalibai da aka kwatanta a cikin wasu kasashe a kasar Sin da amfani da TCM a cikin 87% na su dalibai, ciki har da Gansu (63.7%), Ningxia (50%), da Hunan (50%), yayin Hubei province, wanda amfani da TCM a cikin kawai game da 30% na COVID-19 dalibai, yana da low cure rates (13%).
Duk da haka, wannan shi ne mai ban sha'awa, kamar yadda yawa sauran matsakaici, kamar yawan da matsakaici na ma'aikata, za a hada a cikin bincike.
On February 18, 2020, Boli Zhang da abokan ciniki ya gabatar da bincike don ƙara Western Medicine (WM) magani kawai tare da magani na WM da TCM.
Ya samu cewa tsawon lokaci da ake bukata don jiki na jiki na jiki, magani, da jiki na jiki ya zama karfi a cikin WM+TCM jiki fiye da a cikin WM kawai jiki.
Mafi m, daidaici ga matsalolin matsalolin (tallace zuwa matsalolin) ya zama karfi don WM+TCM gundumar da kuma domin WM kawai gundumar (7,4% to 46,2%) da kuma matsalolin shi ne karfi a cikin WM+TCM gundumar da WM kawai gundumar (8,8% to 39%).
Duk da haka, da ingancin da kayan aiki na TCM, yana da faruwa da bincike mai kyau a mafi girma da kuma a mafi yawan cibiyoyin.
Za su kuma zama mai ban sha'awa don karanta tsarin ayyuka da kuma sauke da ingancin sassa na TCM magani ko da hanyoyin su, idan iya.
Patients tare da COVID-19 da aka kwatanta ko kwatanta ne mafi girma baƙi na high-gaba da kuma fatal jima'i, kuma mutane da aka kwatanta suna kuma kwatanta m, jima'i, da kuma haske.
Bugu da haka, magani da jiki kamar magani, hypoxia, da cough, da kuma haɗari na tsari kamar magani da korticosteroids za a iya ƙirƙirar ƙarƙirar ƙarƙirar ƙarƙirar da matsaloli.
A cikin farko na tsari na SARS, wani jerin psychiatric matsaloli ciki har da matsaloli matsaloli, matsaloli, panic attacks, psychomotor jiki, psychotic matsaloli, delirium, da kuma har ila yau da kullum.
Tsarin sadarwa da kwarantena, a matsayin sassa na jama'a da jima'i da jima'i na COVID-19, za a iya sa mutane da ƙananan sha'awa da sha'awa game da matsaloli, kwarantena, da sha'awa game da ma'aikata da abokan ciniki.
Saboda haka, jima'i na jima'i na jima'i na jima'i na jima'i na jima'i na COVID-19, mutane da mutane da suka haifar da su, da kuma jama'a da ke daidaito.
Ƙararrawa na jima'i na jima'i ya hada da kafa na multidisciplinary jima'i na jima'i na jima'i na jima'i na jima'i na jima'i na jima'i na jima'i na jima'i na jima'i na jima'i na jima'i na jima'i na jima'i na jima'i na jima'i na jima'i na jima'i na jima'i na jima'i na jima'i na jima'i na jima'i na jima'i na jima'i.
Ƙananan magani suna da muhimmanci don ƙirƙirar ƙirƙirar ƙirƙirar ƙirƙirar daga ƙirƙirar ƙirƙirar ƙirƙirar ƙirƙirar ƙirƙirar ƙirƙirar ƙirƙirar ƙirƙirar ƙirƙirar ƙirƙirar ƙirƙirar ƙirƙirar ƙirƙirar ƙirƙirar ƙirƙirar ƙirƙiri.
Yana da sha'awa don ci gaba S-protein-based vaccines don samar da tsawon lokaci da kuma m neutralizing antibodies da / ko protective immunity ga SARS-CoV.
Live-tallace-tallace-tallace-tallace-tallace-tallace-tallace-tallace-tallace-tallace-tallace-tallace-tallace-tallace-tallace-tallace-tallace-tallace-tallace-tallace-tallace-tallace-tallace
Duk da haka, da ingancin in vivo na wadannan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magunguna.
Wannan ya zama saboda SARS ya wuce 17 shekaru da suka wuce, kuma ba da wani nau'i da aka gabatar da bayan.
Saboda haka, matsaloli da matsaloli na MERS yana da faruwa a cikin Middle East da kuma ƙirƙirar zuwa sauran yanki saboda daidaito na zoonotic kayayyakin a cikin yanki.
Takaddun shaida suna ci gaba ga MERS ta amfani da inactivated viruses, DNA plasmids, viral vectors, nanoparticles, virus-kayan sassa, da kuma recombinant protein subunits da wasu da aka gyara a cikin haihuwa model.
Tsarin da kuma ingantacin vaccine ga SARS-CoV-2 ga non-immunous mutane ne mai ban sha'awa da kuma muhimmanci aiki don ƙirƙirar da tsari na tsari.
Duk da haka, shi ne mai ban sha'awa don ƙirƙirar ƙananan tsawon lokaci (kimanin 18 watanni) da ake bukata don ciwon daji da kuma ciwon daji na CoVs.
Kamar yadda wani nau'in magani, COVID-19 yana da farawa ta cikakken lissafi a cikin ma'aikatan ma'aikatan.
Mafi yawancin matakan, matakan za a iya samun sauƙi ba tare da sequelae.
Duk da haka, kamar SARS da MERS, COVID-19 yana haƙĩƙa tare da high morbidity da matsaloli a cikin matsaloli tare da matsaloli.
Saboda haka, ci gaba da model prognosis ga magani ne mai ban sha'awa don masana'antu masana'antu ya ƙirƙirƙirar sabis, musamman a cikin kayayyakin rage.
Bisa ga bincike na lissafi da aka kwatanta har yanzu, wasu matsakaici za a iya haɓaka ko daidaita tare da lissafi na COVID-19 (Table33):
Yara: Yara ya zama mafi muhimmanci matsakaici a kan prognosis na SARS, wanda aka daidaita da COVID-19.
COVID-19 yafi a cikin shekaru 30-65 tare da 47.7% na waɗannan matakan da aka fiye da 50 a cikin bincike na 8,866 matakan kamar yadda ya rubuta.
Ma'aikata da ake bukata haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin.
Jima'i: SARS-CoV-2 ya rage mutane fiye da mata (0.31/100,000 to 0.27/100,000), kamar yadda ya rubuta a karkashin.
Komorbidities da matsaloli: Patients tare da COVID-19 wanda ke bukata matsa lamba ne fiye da matsa lamba daga acute heart injury da arithmia.
Tsarin matsaloli da aka zama babban matsaloli a cikin SARS matsaloli.
Yana ƙaddamar da cewa SARS-CoV-2 za a iya ƙaddamar da ACE2 positive cholangiocytes, wanda za a iya ƙirƙirar matsaloli na lamba a cikin COVID-19 mata.
Yana da muhimmanci cewa matakan da kuma magani na jiki suna daidaitawa da kuma za a iya canza tare da wani.
An abnormal gwaje-gwaje: Tsarin C-reactive protein (CRP) a cikin damuwa ya nuna matsa lantarki na lantarki ko ƙwayar daidaitacce da aka gabatar da cewa shi ne mai amfani da matsa lantarki ga magani, matsa lissafi, da ƙwayar sauƙi.
Tsarin CRP tasiri da matsa lamba da prognosis na COVID-19 da kuma aka gabatarwa.
Bugu da ƙaddamar da lactate dehydrogenase (LDH), aspartate aminotransferase (AST), alanine aminotransferase (ALT), da creatine kinase (CK) za su iya taimakawa da matsaloli.
Wadannan enzymes suna al'amala a cikin masu yawa organ, musamman a cikin ƙarfi da ƙarfin jiki, da kuma suna buga a lokacin ƙwayar ƙwayar ƙwayar.
Saboda haka, su ne masana'antun kwarewa na kardiya ko liver dysfunctions.
Major lissafin lissafi: X-ray na thorax da tsawon lokaci na lissafin lissafi za a kira tare da sauran matsaloli don zabi matsaloli na matsaloli da matsaloli na COVID-19.
amfani da steroids: Kamar yadda ya rubuta a kan, steroids ne immunosuppressant da aka amfani a matsayin adjunctive therapy ga magungunan magani don rage jiki na magani.
Saboda wani high dosage na corticosteroids aka amfani da yawa a cikin matsaloli SARS, mutane da yawa ya ci gaba su ci gaba da avascular osteonecrosis tare da rayuwa-tallace-tallace da kuma low quality na rayuwa.
Saboda haka, idan ake bukata, steroids za a yi amfani a low dosage da kuma a lokacin da lokaci a COVID-19 mutane.
Psychic stress: Kamar yadda ya rubuta a karkashin, a lokacin da COVID-19 tsuntsaye, mutane da yawa da yawa da suka wuce da ban sha'awa, kamar yadda su sauƙi tsawon lokaci na kwarantena da ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan.
Yana da muhimmanci don samar da sabis na kimiyya da kuma taimakawa a tsawon lokaci don taimakawa wadannan magani don taimakawa daga ƙarfi da kuma fara a cikin rayuwa.
Bisa ga bincike na demographics har yanzu, COVID-19 yana nuna daban-daban epidemiological sassa daga SARS.
Ƙaddamarwa a cikin ƙaddamarwa na ƙaddamarwa, SARS-CoV-2 za a iya ƙaddamar da ƙaddamarwa a cikin ƙaddamarwa na ƙaddamarwa da za a iya ƙaddamar da matsaloli ko ba tare da matsaloli a cikin matsaloli na farko, kamar yadda sauran CoVs wanda ke ƙaddamar da matsaloli.
Saboda haka, maganin jima'i a farkon matakan ko ƙwayar lokaci za a iya samar da yawancin jiki a lokacin da aiki na yau da kullum, wanda ya ƙirƙirƙirar babban matakan domin kudin jima'i.
Duk da haka, ƙirƙirar SARS-CoV ya zama a lokacin da ma'aikata suna m, yayin da yawancin ƙirƙirar ba ya zama a cikin matsaloli.
Saboda haka, halin yanzu tsari na COVID-19 ne mafi ƙarfi da kuma ƙarfi don sarrafa fiye da tsari na SARS.
Manyan aiki da aka yi a cikin kasar Sin, ciki har da ƙirƙirar Wuhan da ƙungiyar jirgin sama da kuma daidaitaccen kwarantena na fiye da yawancin mutane a gaban da za su haɓaka tsari na SARS-CoV-2.
Duk da waɗanda suka yi aiki sun haƙĩƙa ƙarya a cikin masana'antu da sauran masana'antu na kasar, yawan sabon magani da aka rufe, wanda ya nuna ƙarya na tsarkakewa.
Ma'aikata mafi kyau ne cewa matsa lissafi za a fara a watan Maris da matsa lissafi za a ci gaba da 3-4 watanni.
Duk da haka, wasu masana'antu ba su ne mafi kyau.
Paul Hunter, et al., ya ƙara cewa COVID-19, wanda yana daidai mai ban sha'awa da SARS, ba zauna a 2020.
Ira Longini, da dai sauransu, ya kafa wani model don fassara matsaloli na epidemic da ya nuna cewa SARS-CoV-2 za a iya rage biyu uku na duniya mutane.
The Canadian group ya sanar da cewa SARS-CoV-2 ya samu a cikin biyu-turbinate da farin ciki a cikin magungunan ƙarfin jiki da suka rãyawa da kuma haifar da magungunan jiki 2 makonni kafin, wanda ya nuna cewa nau'i da aka samu virus za a iya zama wani cyclic episode similar to influenza.
Duk da haka, ban mamaki dalilin da aka kwatanta a kasar Sin a kan ƙara yawan nau'i, wanda ya nuna cewa yanayin yanzu za su iya aiki.
Sabon Ebola ya wuce su yi amfani da fiye da miliyan matsala da yarda miliyan matsala.
Saboda haka, ta hanyar kyakkyawan kwarantena da ƙirƙirƙirar, magani ya zama a karkashin kudin.
Yana iya, kamar SARS-CoV, cewa SARS-CoV-2 za a iya zama karfi a kan jima'i da kuma sa'an nan zauna ko zama mai karfi jima'i mai karfi tare da mutane.
Ƙarawar COVID-19 tare da SARS da MERS ne a karkashin (Fig. (Fig. 55).
SARS-CoV-2 yana da ƙarfi mai ƙarfi ta hanyar coughing ko ajiya, da kuma zai iya dace ta hanyar tsari tare da kayayyakin da aka ƙaddamar da virus.
The virus da aka samu a cikin halitta, wanda ya ƙirƙirar wani sabon damar na halitta-to-mouth transmission.
Kyakkyawan bincike na 138 matsaloli ya gabatar da cewa 41% na matsaloli suna iya haƙƙoƙi na nosocomial matsaloli, ciki har da 17 matsaloli da sauran matsaloli da kuma 40 masana'antu.
Saboda haka, za a yi amfani da babban tsare-tsare don sarrafa mutane, musamman masu sana'a, ma'aikata, ma'aikata, ma'aikata, ma'aikata, da kuma ko dai sauransu a cikin haɗari tare da magani ko ma'aikata.
The farko line of defence cewa za a iya amfani da su rage jiki na jima'i ne ta hanyar haɓaka masks; duk da amfani da na'urorin masks da kuma N95 respirator masks (series # 1860s) taimaka wa daidaitacce na viruses.
Surgical face masks haƙƙoƙoƙoƙoƙoƙoƙoƙoƙoƙoƙoƙoƙoƙoƙoƙoƙoƙoƙoƙoƙoƙoƙoƙoƙoƙoƙoƙoƙoƙoƙoƙoƙoƙoƙoƙoƙoƙoƙoƙoƙoƙoƙoƙoƙoƙoƙoƙoƙoƙoƙoƙoƙoƙoƙoƙoƙoƙoƙoƙoƙoƙoƙoƙoƙoƙoƙoƙoƙoƙoƙoƙoƙoƙoƙoƙoƙoƙoƙoƙoƙoƙoƙoƙoƙoƙoƙi.
Duk da haka, kawai N95 (series # 1860s) masks za su iya haɓaka da haɓaka na virions kamar 10 zuwa 80 nm, tare da kawai 5% na virions za su iya shigar da cikakken; SARS-CoV-2 ne sama da SARS-CoV a girma da kuma biyu ne game da 85 nm.
Saboda ƙananan za a iya shigar ko da fiye da hira masks da aka sauke tare da, masu sana'a masu sana'a a tsakiya tare da matsala za su yi amfani da N95 (series # 1860s) masks amma ba tare da hira masks.
Bugu da masks, masu sana'a masu sana'a ya kamata a yi amfani da haɓaka gwiwa don ƙarfafafawa ƙarfafafawa tare da viruses.
Viruses za a iya rage wani mutum ta hanyar mata.
On January 22, 2020, wani daktara aka rage SARS-CoV-2 ba tare da wani N95 maski; virus zai zama a cikin jiki ta hanyar mata.
Saboda haka, masu sana'a masu sana'a za su kuma yi amfani da shigarwa na jiki ko shigarwa a lokacin aiki tare da magani.
Domin jama'a a cikin yanayin da aka rarraba ko dacewa, shi ne mai ban sha'awar cewa kowane mutum ya rufe ma'aikata da sabis mai sauƙi fiye da yaushe, ci gaba da zama a cikin gida don karantina, da kuma rage haɓaka tare da mutane da aka rarraba.
Tare da mataki na uku ne daidai da mataki don mutane da aka dogara daga magani.
Wadannan ayyuka ne mai kyau hanyoyin don rage matsa lamba da kuma taimakawa da fitarwa na virus.
Duk da SARS-CoV-2 ya zo a matsayin wani sabon virus a cikin duniya, da high homology zuwa SARS-CoV kamar yadda ya rubuta a kan 7 Janairu 2020, ya kamata a ƙirƙirar high alamar a kasar Sin a karkashin ƙaunar ƙaunarsa na SARS a 2003.
Duk da haka, ko da 19 Janairu 2020, mai kwarewa na Wuhan Centers for Disease Control ya sa abokan ciniki da ya ce cewa sabon virus yana da ƙwayar ƙwayar ƙwayar ƙwayar da ƙwayar ƙwayar daga mutum zuwa mutum, kuma cewa ba shi ne wani matsaloli don ƙirƙirar da ƙirƙirar jiki.
Wannan rahoton ya ƙarfi alama na jama'a, musamman a lokacin da kowace ƙasa ya shirya don Spring Festival, kuma lokaci da muhimmanci da aka ba da gaskiya don ƙirƙirar magani a Wuhan.
Kasuwancin magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magunguna.
Misali, wadannan shirye-shiryen za su zama (1) mafi tsare a lokacin da ya yi jama'a sabis, kamar yadda kowane al'amuran yana daidaita ga ra'ayoyi da za a iya canza hanyoyinsa da kyakkyawansa; (2) mafi m da kuma reactivous ga ban mamaki bayanai daga gine-gine ko ba za a yi wawar da kwarewa daga magungunan magunguna ko ma'aikata; (3) mafi kyakkyawanci don haɓaka wani m epidemic a karshe fiye da ci gaba da taimakawa na jama'a; da (4) fiye da yawa don samar da cibiyoyin da kuma inganta gwaje-gwaje na jama'a game da magunguna da magunguna da magunguna.
Tsarin COVID-19 wanda aka haifar da sabon SARS-CoV-2 virus ya fara a karkashin Disamba 2019.
A kowace biyu watanni, shi ya fitar da dukan kasar Sin da kuma fiye da 50 sauran kasashe a duniya a lokacin da wannan rubutu.
Saboda cewa magungunan COVID-19 da SARS yana da matsala tare da SARS-CoV, matsala na COVID-19 da SARS, matsala na COVID-19 ya ƙirƙirar wani matsala na SARS.
Duk da haka, akwai wasu ban mamaki daban-daban tsakanin COVID-19 da SARS, wanda ke da muhimmanci don ƙirƙirar tsari da matsaloli.
COVID-19 ya ƙaddamar da mutane da yawa fiye da mutane da mutane da yawa fiye da mutane, da kuma matsaloli da matsaloli ne mafi girma a cikin mutane da yawa fiye da mutane da yawa.
SARS yana da mafi girma matsaloli da COVID-19 (10.91% to 1.44%).
COVID-19 masu amfani da magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magunguna.
Wannan ya ƙarfi saboda SARS-CoV-2 ya ƙirƙirar fiye da fiye da SARS-CoV.
Tsarin RNA gwajin ga SARS-CoV-2 za a iya daidaitacce a cikin wasu COVID-19 dalibai.
Saboda haka, waɗanda suka yi amfani da magani za su iya yi amfani da magani.
Wannan samfurori ya ƙirƙirar tsanani na jima'i na viruses.
Tare da wannan sauƙin ci gaba a cikin bincike a kan COVID-19, wasu matsaloli da aka ba da kammala, kamar wannan:
Ta yaya SARS-CoV-2 ya zo?
Duk da 96% na lantarki homologue aka samu tsakanin SARS-CoV-2 da biyu batsa SARS-kayan CoVs, ba mu iya ba da kwarewa cewa SARS-CoV-2 ne daga batsa.
Yadda haihuwa ya zama sassa don ƙirƙirar virus daga asali gaskiya, ya ce bututu, zuwa mutane?
Kamar yadda ba za mu sanwa ga # 1 da # 2, ba za mu iya haɓaka da lantarki, kuma matsa lamba za a iya fara a kowane lokaci.
Duk da modeling molecular da kuma biochemical gwaje-gwaje da ya nuna cewa SARS-CoV-2 daidaita da ACE2, yadda ya dace da virus ya zo a cikin halitta na halitta da kuma ƙirƙirar ƙananan magani?
Shin viruses da ACE2-expressing cells a wasu jiki?
Kuma ba tare da sha'awa, ba tare da sha'awa, ba za mu iya samun sauri da sauki magani da tsari.
Yadda za a ci gaba da epidemic?
Ta yaya virus ne genetically ci gaba a lokacin da ya ƙirƙirar tsakanin mutane?
Za a zama wani pandemic a duniya, za a rage a matsayin SARS, ko za a rarraba a lokacin da za a rarraba a matsayin magunguna?
Yana da muhimmanci, amma za a iya samun lokacin da za ku zo da shawara ga matsaloli da sauran matsaloli.
Duk da haka, ba tare da kowane kudin da za mu iya bukatar, ba mu ba da wani yanki amma za mu haɓaka jima'i har yanzu da za mu tafi da rayuwa.
Zoonotic asali na manyan coronavirus
Mutation da adjustment sun haɓaka co-evolution na coronaviruses (CoVs) da masana'antu, ciki har da mutane, da miliyoyin shekaru.
Tare da 2003, biyu mutum CoVs (HCoVs) aka sani da ke sa da magana, kamar tsarkakewa.
Tsarin tsuntsaye na karfi acute respiratory syndrome (SARS) da Middle Eastern respiratory syndrome (MERS) suna ƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙiri.
Shawarar SARS-CoV-2 a tsakiya na China a karkashin 2019 ya haɓaka CoVs a cikin mataki da ya sauke mu tare da ƙarfi mai kyau, amma rage patogenicity karkashin ƙasar SARS-CoV.
HCoV jima'i ne zoonosis da kuma sani da zoonotic asali na HCoVs za mu yi amfani da kyau.
Mafi yawan HCoVs aka fara daga bututu, inda su ne ba patogenic.
The mid-reservoir masana'antu na wasu HCoVs da aka sani.
Ƙwararrun haihuwar da haihuwa yana da haɗari a kan ƙirƙirar magani na mutane.
Tsarin CoV-host interactions a cikin dabbobi za a iya samun muhimmanci dubawa game da CoV pathogenesis a cikin mutane.
A cikin wannan review, mu ba da kwatanta game da mahimmanci game da HCoVs saba, tare da hankali game da tarihi na binciken su, kazalika da zoonotic asali da transmissions interspecies.
Mafi muhimmanci, mu daidaita da kuma daidaita daban-daban HCoVs daga wani matsakaici na virus ci gaba da kuma genom recombination.
The halin yanzu CoV disease 2019 (COVID-19) epidemic an kira a cikin wannan yanki.
Bugu da ƙara, bukatun ga ma'aikata switches da kuma matsaloli na virus ci gaba a kan jiki na jiki suna kuma highlighted.
Coronaviruses (CoVs) suna da al'umma na Coronaviridae, wanda ya hada da wani jerin, positive-sensed, single-stranded RNA viruses.
Wadannan viruses da kewaye mafi girma na genome na 26 zuwa 32 kilobases tsakanin RNA viruses aka sani da "CoVs" saboda dace-karshen morphology a karkashin electron microscope.
Structurally, CoVs yana da non-segmented genomes da ke ƙirƙirar sama shirye-shirye.
Game da biyu thirties na genome yana ƙunshi biyu manyan haɗin yanar gizo (ORF1a da ORF1b), wanda aka ƙirƙirar zuwa pp1a da pp1ab replicase polyproteins.
The polyproteins suna ƙirƙirar ƙarfi don samar da 16 non-structural protein, da aka sani da nsp1~16.
The rest of the genome yana da ORFs ga tsarin protein, ciki har da spike (S), envelope (E), membrane (M) da nucleoprotein (N).
Manyan lineage-specific accessory protein ne kuma coded da daban-daban lineages na CoVs.
Dangane da daban-daban a cikin protein jerin, CoVs suna ƙirƙirar a cikin hoto (alpha-CoV, beta-CoV, gamma-CoV da delta-CoV), tsakanin cewa beta-CoV jerin yana da mafi yawan HCoVs da aka ƙirƙirar a cikin hoto na hoto (A, B, C da D).
Phylogenetic nau'i ya nuna cewa dabbobi da dabbobi sun yi amfani da alpha-CoVs da beta-CoVs, yayin da birds ne babban tsakiya na gamma-CoVs da delta-CoVs.
Tare da miliyoyin shekaru, CoVs da aka ci gaba da ƙarfi na species, kuma wasu da aka buga a matsayin muhimmanci ma'aikata na mutane.
Yanzu, 7 mutum CoVs (HCoVs) suna sani.
Daga cikin su HCoV-229E da HCoV-NL63 ne alpha-CoVs.
Mafi biyu beta-CoV sun hada da HCoV-OC43, HCoV-HKU1, m acute respiratory syndrome coronavirus (SARS-CoV), Middle East respiratory syndrome coronavirus (MERS-CoV) da SARS-CoV-2.
HCoV-229E, HCoV-OC43, HCoV-HKU1 da HCoV-NL63 an ƙaddamar da matsa lamba, kamar tsarkakewa da / ko haskewa.
Saboda haka, SARS-CoV, MERS-CoV da SARS-CoV-2 da aka samu ne mai karfi patogenic, ƙirƙirar matsakaici na ƙasƙanci na ƙasƙanci na ƙasƙanci a kan ƙasƙanci mai girma a ci gaba da acute respiratory distress syndrome (ARDS) da kuma extrapulmonary matsakaici.
The farko HCoV-229E sassa, B814, an ƙirƙirƙirar daga ƙirƙirar nasal na ma'aikata tare da tsarkakewa a karkashin 1960s.
Tare da haka, fiye da kwarewa da aka gyara ta hanyar ƙarin bincike a kan HCoV-229E da HCoV-OC43, duk da suka haifar da matsaloli.
Yanzu, da al'amuran da aka fitar da cewa lantarki da HCoVs ne a karkashin sarari fiye da sarari na SARS.
Tsarin SARS da aka kwatanta a 2003 ne daya daga cikin mafi ƙarfi a cikin tarihin yanzu, ya ƙirƙirar fiye da 8,000 mutane tare da matsaloli na matsalolin matsaloli na fiye da 10%.
Kwanan shekaru da suka wuce, matsaloli na Middle East respiratory syndrome (MERS) ya ƙaddamar da matsaloli a Arabian Peninsula tare da ƙaddamarwa a duniya.
The 2019 novel HCoV (2019-nCoV), wanda aka sauƙi suna SARS-CoV-2, ne mai ban sha'awa na daidaitacce na daidaitacce na coronavirus na 2019 (COVID-19), wanda ya ƙara fiye da 3,120 mutane da kuma rage fiye da 91,000 mutane a kan Maris 3, 2020.
Tsarin ƙarfi da aka riga da kuma duniya yana da shirye-shirye don daidaitaccen SARS-CoV-2.
Kowane saba HCoVs suna zoonotic asali daga bututu, mouse, ko gine-gine.
Multiple line of evidence supports an evolutionary asali na duk HCoVs daga bututu, inda viruses suna da kyau canza da kuma ba patogenic amma nuna babban genetic farantin.
Tsarin COVID-19 ya nuna ban mamaki magani, kimiyya, jima'i da kuma al'ada ga kasar Sin da kuma duniya.
Tattaunawa na zoonotic asali na HCoVs yana samar da ramummuka don sani da asali tarihin, ƙirƙirar ƙarfi da kuma ƙirƙirar ƙirƙirar da species jumping.
Wannan zai iya ƙirƙirar ko inganta bincike ga reservoir, intermediate da amplifying haihuwa (s) na SARS-CoV-2, tare da muhimmanci matsaloli a cikin lantarki na gaba.
A cikin wannan review, mu ba mu samfurori na zoonotic asali, interspecies transmission da pathogenesis na HCoVs.
Saboda haka, mu daidaita da kuma tattauna da matsaloli cewa mataimakin viruses na HCoVs ne musamman ba patogenic a cikin halitta reservoir masana'antu, amma zama patogenic bayan interspecies fitarwa zuwa wani sabon masana'antu.
Za mu tambaya trend na HCoV ci gaba, a cikin cewa daidaita a transmisibility da yawa ya zo tare da ƙara a patogenicity.
Tsarin tsari na tsari SARS-CoV-2 a cikin wannan yanayin da aka magana.
Animal CoVs da aka sani tun karshe 1930s.
Tare da farko da HCoV-229E sassa B814 daga nasal ƙirƙirar daga magani da suka ci gaba da tsarkakewa, daban-daban CoVs da aka ƙirƙirar a cikin daban-daban sassa, ciki har da turkey, mouse, cow, pig, cat da dog.
A cikin shekaru da suka wuce, 7 HCoVs da aka sani.
Kyakkyawan tsari na tarihi na HCoV gaban a tsari (Table 1) zai zama bayani da kuma ilimi.
The farko HCoV-229E sassa aka ƙirƙirar daga ƙarfi na ƙarfi na ƙarfi na ƙarfi na ƙarfi na ƙarfi na ƙarfi a shekara na 1966, kuma aka sauƙi daidaita don ci gaba a cikin WI-38 ƙarfi na ƙarfi.
Patients rage da HCoV-229E ya gabatar da matsaloli na tsari, ciki har da matsaloli, tsari, matsaloli da matsaloli, tare da matsaloli da tsari a cikin 10~20% na matsaloli.
Tare da 1967, HCoV-OC43 an ƙirƙirar daga jikin jiki da kuma karshe tsari a cikin jiki na sucking mace.
Tsarin lissafi na HCoV-OC43 lissafi suna daidai da waɗannan da aka haifar da HCoV-229E, wanda za a iya haifar da magana daga lissafi tare da sauran magungunan lissafi, kamar influenza A viruses da rhinoviruses.
Duk da HCoV-229E da HCoV-OC43 suna rarraba a duniya, kuma suka yi domin a lokacin da zafin jiki a cikin m iklim.
Yawancin lokaci na haihuwa na biyu wadannan viruses ne fiye da wani makonni, da suka wuce a kan 2 makonni na magani.
Bisa ga wani bincike na mutane masu ban sha'awa, masu sana'a masu ban sha'awa da HCoV-229E ya ci gaba da m tsari.
kawai wasu maganin immunocompromised ya nuna matsalolin matsalolin ƙarfi na ƙarfin jiki.
SARS, wanda aka sani da "atypical pneumonia", shi ne na farko da kyau dokokin HCoV-caused pandemic a cikin al'umma, kuma da etiological mita ne SARS-CoV, na uku HCoV samu.
Tsarin SARS na farko za a iya daidaita zuwa karshe 2002 a Guangdong Province na kasar Sin.
Tsarin SARS ya ƙaddamar da 8,096 matsala da 774 matsala, ƙirƙirar da yawa kasashen da ƙasƙanci.
Bugu da super-spreaders, an sayar da cewa kowane kasuwa za a iya samar da kira biyu kasuwa, tare da lokaci na haihuwa na 4 zuwa 7 kwanaki da ƙarfi na viral karfin jiki a cikin 10th rana na magani.
Patients da aka rage da SARS-CoV na farko suna tare da myalgia, headache, fever, malaria da rage, da suka wuce da matsaloli, cough da matsa lamba a matsayin matsa lamba.
Lymphopenia, matsalolin jiki aiki gwaje-gwaje, da kuma rage creatine kinase ne matsalolin laboratory abnormalities na SARS.
Diffuse alveolar daidaitacce, epithelial cell proliferation da kuma daidaitacce na macrophages suna samuwa a cikin SARS mutane.
Yawancin 20-30% na dalibai da ya kamata a ci gaba da matsaloli da na'ura mai aiki da karfin ruwa.
Bugu da ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar.
Virus na farko da aka ƙirƙirƙirar daga biopsy na halitta na ban sha'awa na wani al'umma na index da aka tafi zuwa Hong Kong daga Guangzhou.
Tare da haka, ban mamaki ci gaba da HCoV bincike.
HCoV-NL63 an ƙirƙirƙirar daga cikin mutum na 7 watanni daga Netherlands a karkashin 2004.
Yanzu ya samu a yi amfani da su a cikin ma'aikata, ma'aikata da kuma immunocompromised dalibai tare da matsaloli.
Presentation na coryza, conjunctivitis, fever, da kuma bronchiolitis ne da yawa a cikin magani da aka haifar da HCoV-NL63.
Wani m bincike ya rubuta da ƙirƙirar samfurin sama daga nasal samfurin daga 8 watanni-ta'aikace-aikacen ma'aikata a Netherlands.
Duk da aka samu a Netherlands, shi ne a duniya.
Yawancin cewa HCoV-NL63 ya kira 4.7% na matsaloli na matsaloli, kuma matsaloli ya zama a cikin karshen gudu, spring da yamma.
HCoV-NL63 yana haɓaka tare da laryngitis obstructive, wanda aka sani da croup.
A cikin wannan shekara, HCoV-HKU1 an ƙaddamarwa daga wani 71-year-old mutum wanda aka shigarwa tare da pneumonia da bronchiolitis a Hong Kong.
Bugu da pneumonia da bronchiolitis, HCoV-HKU1 da aka kwatanta a kan acute asthma exacerbation.
Similar to HCoV-NL63, HCoV-229E da HCoV-OC43, HCoV-HKU1 da aka samu a duniya, wanda ya ƙirƙirƙirar lantarki magani.
Wadannan four HCoVs da aka samu ta jama'a suna da kyau canzawa ga mutane da kuma suna har ila yau da kullum ba za a mayar da su yi amfani da magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magunguna a China.
General, a lokacin da wadannan HCoVs samu damar da za a yi aiki da kuma tabbatar da shi a cikin mutane, su kuma zama fassara virulent ko pathogenic.
MERS-CoV ya zama na farko a 2012 daga ƙarfi na 60 shekaru da suka ci gaba da acute pneumonia da ƙwayar ƙwaƙwalwar ƙwaƙwalwar a Saudi Arabia.
Saboda cewa mafi yawan kasuwa da aka gabatarwa ta labaru suna daga Middle East, kasuwa da aka gabatar da kasuwa tare da kadai-kasuwanci zuwa haɗari da aka kwatanta a daban-daban kasashen Turai da Tunisia.
Wani tsari na tsarkakewa ya zama a South Korea a 2015 tare da 186 matsala da aka gabatarwa.
Littafin lissafi na MERS suna sama da SARS, wanda aka halitta da ci gaba da acute pneumonia.
Kamar yadda SARS, mutane da yawa tare da MERS kuma ci gaba da acute ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar HCoV.
Har ila yau, fiye da 30% na masu amfani da magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magunguna.
Tare da Fabrairu 14, 2020, fiye da 2,500 kasuwa da aka gabatarwa a laboratory tare da matsalolin matsalolin matsalolin 34,4%, yin MERS-CoV daya daga cikin matsalolin matsalolin matsalolin da aka sani ga mutane.
A karkashin watan Disamba zuwa karkashin Disamba 2019, mataki na pneumonia da aka sani da aka daidaita tare da SARS-CoV-2 infection aka samu a Wuhan, Hubei Province, China.
The World Health Organization ya gabatar da matsaloli na ƙaunar ƙaunar ƙaunar ƙaunar ƙaunar ƙaunar ƙaunar ƙaunar ƙaunar ƙaunar ƙaunar ƙaunar ƙaunar ƙaunar ƙaunar ƙaunar ƙaunar ƙaunar ƙaunar ƙaunar ƙaunar ƙaunar ƙaunar ƙaunar ƙaunar ƙaunar ƙaunar ƙaunar ƙaunar ƙaunar ƙaunar ƙaunar ƙaunar ƙaunar ƙaunar ƙaunar ƙaunar ƙaunar ƙaunar ƙaunar ƙaunar ƙaunar ƙaunar ƙaunar.
Tare da 3 Maris 2020, 90.053 mataki da aka gabatar da duniya, tare da mataki na mataki na mataki na 3.4%.
Saboda haka, matsaloli a Hubei, China ne 4.2%, yayin da wanda a waje shi ne 1.2%.
SARS-CoV-2 yana haifar da matsakaici tsarkakewa kamar SARS-CoV da MERS-CoV, wanda aka nuna a matsayin matsa lamba, cika da matsa lamba.
Diarrhea da aka samu a cikin wasu dalibai.
Pneumonia ne daya daga cikin mafi matsakaici matsakaici da za a iya ci gaba da sauƙi zuwa acute respiratory distress syndrome.
Duk da SARS-CoV da SARS-CoV-2 suna sosai sama saboda high nucleotide sequence homology na 82%, su cluster a daban-daban sassa a cikin phylogenetic tree.
SARS-CoV-2 yana da ƙananan patogenic, amma fitarwa fiye da SARS-CoV da MERS-CoV.
Asymptomatic subjects da aka rabi da SARS-CoV-2 kuma za su iya taimaka wa sauri sauri a duniya.
Shiryawa da kuma daidaita SARS-CoV-2 tare da sauran hCoVs saduwa daban-daban da daban-daban ne mai ban sha'awa.
Na farko, lokaci na incubation da tsawon tsari na HCoV magani ne sosai sama.
Saboda wannan, SARS-CoV-2 yana da al'ada da al'ada na sauran hCoVs.
Sabuwar, matsakaici na COVID-19 ne tsakanin SARS-CoV da kuma hCoV-NL63, HCoV-229E, HCoV-OC43, HCoV-HKU1 da HCoV-NL63.
Kamar yadda wani, SARS-CoV-2 magani ya nuna siffofin da aka karfafafi a lokacin magani tare da HCoV da aka samu ta jama'a, ciki har da ƙirƙirar da non-specific, m ko ko ba da dalibai.
Sa'an nan, wani m subset na matsakaici COVID-19 za a iya samun kamar yadda a kan SARS-CoV lissafi, ba tare da ratio ne dace.
Har ila yau, SARS-CoV-2 ta ƙirƙirar ƙirƙirar ƙirƙirar ƙirƙirar ƙirƙirar ƙirƙirar ƙirƙirar ƙirƙirar ƙirƙirar ƙirƙirar ƙirƙirar ƙirƙirar ƙirƙirar ƙirƙirar ƙirƙirar ƙirƙirar.
Kamar yadda ya dace da SARS-CoV-2 ya zama mafi girma kamar yadda ya dace da HCoV a cikin jama'a.
Saboda haka, ba za a tabbatar da cewa sars-CoV-2 tsari ba tare da tsari a cikin mutane, kamar yadda a cikin SARS-CoV da MERS-CoV.
Yanzu, kamar yadda sauran HCoVs, SARS-CoV-2 za a iya samu a cikin fecal samfurori.
Yadda fecal-oral transmission na SARS-CoV-2 yana da wani muhimmanci jiki kamar yadda a kan SARS-CoV a kowace lokaci, ba za a ƙara da ci gaba da bincike.
Yana da mahimmanci mai ban sha'awa don ganin idan SARS-CoV-2 za a iya nuna seasonality kamar yadda a cikin mataki na gundumar HCoVs.
Duk da haka, sassa na SARS-CoV-2, ciki har da ƙaddamarwa, pathogenicity, da kuma daidaitacce bayan passages a cikin mutane, za su iya haɓaka game da kammala na daidaitacce na daidaitacce na COVID-19.
Dukan HCoVs da aka samu ta jama'a wanda ya haifar da matsaloli da matsa lamba suna da kyau a cikin mutane.
Saboda wani mataki, za a iya daidai cewa mutane suna da kyau canza ga wadannan hCoVs.
Saboda haka, dukkan za su iya zama mataimakin na zamani HCoV pandemics.
HCoVs da ke ƙirƙirar matsaloli a cikin mutane da mutane da suka ci gaba da matsaloli na HCoV suna ƙirƙirar.
Domin wannan ya zama, HCoVs ya kamata a ƙirƙirar a cikin mutane a cikakken ƙarfi don ƙirƙirar ƙirƙirar m mutations da ke ƙirƙirar ƙirƙirar ƙirƙirar abokan ciniki.
Saboda haka, fiye da lokacin da sarin SARS-CoV-2 tsuntsaye, da yawa mutane da ya sa, mafi kyau za a yi amfani da mutane.
If it adapts well, ta ƙirƙirar a cikin mutane zai zama m don karantawa ko sauran ƙirƙirar ƙirƙirar jiki.
Yau da shekaru da yawa, hudu CoVs da aka samu a cikin jama'a, ƙirƙirar tsari a cikin mataimakin immunocompetent.
Wadannan viruses ba da bukatun haihuwa.
Saboda haka, high-patogenic SARS-CoV da MERS-CoV ba da kyau canza ga mutane da kuma su canza a cikin mutane ba za a iya daidaita.
Ya kamata a ƙirƙirar da ƙirƙirar a cikin zoonotic kayan aiki da kuma za su zo a kan wani damar don ƙirƙirar zuwa m al'umma, zai iya amfani da daya ko da yawa tsari da kuma ƙirƙirar abokan ciniki.
SARS-CoV-2 yana da siffofin da aka daidaita da SARS-CoV / MERS-CoV da kuma hCoV da aka samu ta jama'a.
Yana da muhimmanci ƙirƙirar kamar yadda HCoVs da aka samu ta jama'a, ko da haka a yanzu.
Duk da haka, shi ne mafi patogenic fiye da HCoVs da aka samu ta jama'a da kuma fiye da patogenic fiye da SARS-CoV ko MERS-CoV.
Yadda za a yiwuwa idan za a yi daidaita cikakken ga mutane da za a tsirara a cikin mutane ba tare da wani shigarwa ko m haihuwa.
Kafin tattauna haihuwa asali na HCoVs, za mu iya amfani da kyau don tattauna asali da siffofin na evolutionary, natural, reservoir, intermediate da amplifying masana'antu na HCoVs.
Anfani ya yi amfani da wani HCoV ta ci gaba-gwaje a matsayin wani HCoV idan yana haifar da wani matsakaici wanda ya hada high homology a tasiri na nucleotide sequence.
The ancestral virus yana da yawa da kyau da kuma ba patogenic a cikin wannan gaskiya.
Saboda haka, wani shuka mai ban sha'awa HCoV daidai da tsawon lokaci.
Duk da haka, masana'antu suna tsare-tsare da kuma suna masana'antu na HCoV ko yaushe virus.
Saboda haka, idan HCoV da aka sabon a cikin wani na'ura mai aiki da karfin jiki kafin ko game da shi a cikin mutane, shi ba da kyau canza da sabon mai aiki da karfin jiki da yawa ne patogenic.
Wannan gabatarwa mai ban sha'awa za a iya aiki a matsayin zoonotic kayan na jikin jikin jikin jikin jikin jikin jikin jikin jikin jikin jikin jikin jikin jikin jikin jikin jikin jikin jikin jikin jikin jikin jikin jikin jikin jikin jikin jiki.
HCoV za a iya samun dead-end lissafi idan shi ba zai iya ci gaba da ƙirƙirar a cikin mid-host.
Yanzu, HCoVs za su iya daidaita tare da na'ura mai tsanani da kuma ko daidaita endemicity a tsawon lokaci.
A wannan hali, na'ura mai tsaye ya zama na'ura mai tsaye na'ura mai tsaye.
Epidemiological data ya nuna retrospectively cewa index case na SARS yana da hadin gwiwa da dabbobi.
Kyakkyawan bincike na seroprevalence ya nuna cewa dabbobi mai girma na anti-SARS-CoV IgG fitarwa fitarwa fitarwa fitarwa fitarwa fitarwa fitarwa fitarwa fitarwa fitarwa.
Masked palm civets (Paguma larvata) da wani racoon dog a cikin haihuwa masana'antu da aka farko da aka sani don ƙirƙirar SARS-CoV-kayan viruses wanda aka karkashin sama da SARS-CoV.
Wannan aka haƙƙoƙi da cewa ba mai sarin SARS aka kwatanta bayan ƙirƙirar dukan civets a cikin kasuwar.
Duk da haka, ya rubuta cewa masked palm civets daga cikin halitta ko masana'antu ba tare da ƙaddamar da haihuwa masana'antu suna mafi girma ga SARS-CoV, ƙaddamar da cewa masked palm civets za su yi amfani da kawai a matsayin gabatarwa amplifying abokin ciniki, amma ba da asali reservoir na SARS-CoV.
Saboda haka, saboda 80% na daban-daban dabbobi a cikin masana'antu a Guangzhou yana da anti-SARS-CoV antibodies, ba za a iya ƙirƙirƙirar da cewa daban-daban m mamaki za a iya dace a matsayin gabatarwa amplifying masana'antu na SARS-CoV.
Duk da haka, duk da haka, sun yi amfani da SARS-CoV.
Ƙaddamar da haihuwa mai ban sha'awa na SARS-CoV ya bayyana wani m bat CoV, da aka sani da SARS-rabi Rhinolophus bat CoV HKU3 (SARSr-Rh-BatCoV HKU3), wanda aka zama a cikin Chinese horseshoe bates.
Wadannan bates ne na anti-SARS-CoV antibodies da kuma jima'i jima'i na SARSr-Rh-BatCoV HKU3.
Wannan da sauran bat CoVs share 88-92% nucleotide jerin homology tare da SARS-CoV.
Wadannan binciken da aka ƙirƙirar asali ga sabon ra'ayi cewa bututun shirye-shirye na emerging human patogens.
Manyan SARS-kayan CoVs (SL-CoVs) da aka samu daga bats, amma ba tare da wani WIV1 da aka ƙirƙirar za a iya ƙirƙirar a matsayin live virus.
Human angiotensin-converting enzyme 2 (ACE2) an san cewa shi ne receptor na SARS-CoV.
WIV1 samarwa daga fecal samfurin na bututu ya nuna amfani da bututu, civet da kuma mutum ACE2 a matsayin receptor ga cell entry.
Tsarin sha'awa, serum na SARS ma'aikata suna iya gyara WIV1.
Tare da haka, WIV1 ya nuna mafi ƙarfafafa al'umma na SARS-CoV a cikin bututu, ƙirƙirar 95% nukleotid sequence homology.
Duk da high homology tsakanin wadannan biyu viruses, shi ne a gane da cewa WIV1 ba ne na tsaye dadin viruses na SARS-CoV da bututu ba na tsaye reservoir gashi na SARS-CoV.
Phylogenetic bincike clusters MERS-CoV zuwa sama grup da bat CoV-HKU4 da bat CoV-HKU5.
Bat CoV-HKU4 da MERS-CoV yi amfani da wannan abokin ciniki receptor, dipeptidyl peptidase 4 (DPP4), don cika virus.
RNA-dangane RNA polymerase tsari na MERS-CoV ne phylogenetically karkashin kwarewa a cikin bat beta-CoVs da aka samu daga Turai da Afrika.
Yanzu, duk wani live MERS-CoV za a iya samun a cikin hutu.
MERS-CoV da ƙaddamarwa mai daidaitacce CoV-HKU25 yana da kawai 87% na nucleotide jerin homology.
Saboda haka, rubutun ba za a iya zama m reservoir abokin ciniki na MERS-CoV.
Sa'an nan, bincike a Middle East ya nuna cewa dromedary camels ne seropositive ga MERS-CoV-specific neutralizing antibodies, kamar yadda camels na Middle East asali a da yawa kasashen Afrika.
Live MERS-CoV identical to viruses found in humans da aka ƙaddamarwa daga nasal sassa na dromedary camels, ƙarin nuna cewa camels yi a matsayin bona fide reservoir abokin ciniki na MERS-CoV.
Yana da muhimmanci da cewa yawanci sauƙi, amma masu girma viruses shigar da aka kwatanta a cikin camels gwaje-gwaje da MERS-CoV.
Saboda haka, ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar.
Duk da haka, tambayoyi da aka zama, tun da yawa da aka gabatar da matsaloli na MERS ba da hadin gwiwa tare da camels kafin matsaloli, wanda ya yiwuwa a cikin matsaloli daga mutum zuwa mutum, ko ban sha'awa matsaloli yanayin ciki har da haifar da haifar da haifar da haifar MERS-CoV.
SARS-CoV-2 yana da 96.2% nucleotide homology tare da wani bat CoV RaTG13 da aka ba daga Rhinolophus affinis batsa.
Kamar yadda a cikin mataki na SARS-CoV da MERS-CoV, mataki na tsari tsakanin SARS-CoV-2 da RaTG13 ne mafi girma don ƙirƙirar mataki.
Yana da ya ce, bates za a iya ba tare da tsaye reservoir hosts (s) na SARS-CoV-2 idan fiye da identical bat CoVs suna samu a nan gaba.
Tsarin haihuwa na SARS-CoV-2 za su zama a cikin sassan halitta da aka sayarwa a Huanan Seafood Wholesale Market, tare da abin da yawa na farko matsala na COVID-19 aka kwatanta, wanda ya nuna matsala na matsala na haihuwa zuwa mutum.
Manyan kwarewa da aka kafa a kan metagenomic sequencing ya nuna cewa wani jerin ƙaunar ƙauna da aka sani da pangolins (Manis javanica) za a iya har ma'aikatan beta-CoV related to SARS-CoV-2.
Wadannan sabon pangolin CoV genomes share 85-92% nucleotide sequence homology tare da SARS-CoV-2.
Duk da haka, su ne daidai da aka gane da RaTG13 tare da game da 90% identity a tasiri na nucleotide sequence.
Yana ƙirƙirar a cikin biyu sub-lineages na SARS-CoV-2-kayan viruses a cikin phylogenetic tree, wanda daya daga cikin wanda ya ƙirƙirar wani karfi receptor binding domain (RBD) tare da SARS-CoV-2, tare da 97.4% amino acid sequence identity.
Saboda haka, RBDs na SARS-CoV-2 da RaTG13 ne mafi girma, ba tare da wani mafi girma na sequence homology a kan genome.
A karshe bincike a kan magani pangolins kuma ya gabatar da detection na viral contigs daga lung samfurori, wanda ya zama da aka hada da SARS-CoV-2.
Wannan bincike ya ƙirƙirar daban-daban assembly methods da kuma manual curation don ƙirƙirar wani sassa na genome hadawa game da 86.3% na full-length viral genome.
Za mu iya ƙirƙirar cewa pangolin ne daya daga cikin haihuwa masu haihuwa na SARS-CoV-2.
Duk da haka, a yanzu, akwai ba da bukatun don taimakawa wani tsaye pangolin asali na SARS-CoV-2 saboda jaddada jaddada tsakanin SARS-CoV-2 da pangolin SARS-CoV-2-related beta-CoVs.
Bugu da haka, tsawon tsakanin SARS-CoV-2 da RaTG13 ne ko dai sauransu da tsawon tsakanin SARS-CoV-2 da pangolin SARS-CoV-2-related beta-CoVs.
Tsarin ci gaba na SARS-CoV-2 a cikin rubutun, pangolins da sauran mamaki da zauna don kafa.
Kamar yadda mafi girma sequence homology aka samu a cikin RBDs tsakanin SARS-CoV-2 da pangolin, SARS-CoV-2-related beta-CoVs, SARS-CoV-2 da RaTG13 share mafi girma genome-wide sequence homology.
Yana da muhimmanci ra'ayoyi cewa mataki na mataki tsakanin RBDs na pangolin SARS-CoV-2-related beta-CoVs da SARS-CoV-2 ne dace da selectivity-mediated convergent evolution.
Tallace-tallace ne a karkashin ƙirƙirar tsakanin pangolin SARS-CoV-2-karkashin beta-CoV da RaTG13 a cikin karkashin halitta na halitta.
Kamar yadda wani motsa jiki a ci gaba, recombination ne m tsakanin beta-CoVs.
Juri ne ko da yaushe a kan tsananin zoonotic asali na SARS-CoV-2.
Kamar yadda high-patogenic HCoVs, zoonotic asali na HCoV-229E, HCoV-OC43, HCoV-NL63 da HCoV-HKU1 da aka binciken.
Phylogenetic nau'i ya nuna cewa biyu HCoV-NL63 da HCoV-229E za su iya yi daga bat CoVs, yayin da mataimakin viruses na HCoV-OC43 da HCoV-HKU1 da aka samu a cikin roba.
Yana da cewa wani bat CoV da aka sani da ARCoV.2 (Appalachian Ridge CoV) da aka samu a cikin North American tri-colored bat ya nuna tsakiya tare da HCoV-NL63.
Sa'an nan, HCoV-229E ya daidaita a kan wani bat CoV, da aka sani da Hipposideros / GhanaKwam/19/2008, wanda aka kammala a Ghana, yayin da camelids da aka kwatanta a matsayin mahimmanci.
Ƙararrawa, yanzu da kwarewa game da haihuwa asali na HCoVs da aka sani a cikin Lambar 1 da Tabbatar 2.
Phylogenetic bincike ya samar da alama ga interspecies transmission events na HCoVs a cikin tarihi.
Kada HCoV-OC43 ya ƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙira.
HCoV-229E ta hadin gwiwa tsakanin al'ummai ne ƙarshe.
Bat alpha-CoVs da aka kwatanta da HCoV-229E.
Daga cikin su akwai wani alpaca alpha-CoV.
Manyan nau'i na bukatun ƙirƙirar ƙirƙirar ƙirƙirar virus daga bututu zuwa mutane.
Na farko, mutane, amma ba tare da alpacas, za su iya samun haɓaka tare da bututu a cikin ƙwayar ecological niche.
Yanzu, mutane suna da haɗari tare da alpacas.
Second, HCoV-229E-related bat alpha-CoVs ne daban-daban da kuma ba patogenic a batsa, yayin da alpaca alpha-CoV ya ƙirƙirƙirar matsa lamba a cikin matsa lamba.
Yanzu, alpaca alpha-CoV ba ya samu a cikin dabbobi.
Saboda haka, ba za a iya ba da damar cewa alpacas samu HCoV-229E-related alpha-CoV daga mutane.
Kyakkyawan, butterflies ne tsaye kayayyakin na mutane na patogenic viruses ciki har da rabies viruses, Ebola viruses, Nipah viruses da Hendra viruses.
Saboda haka, ba shi ne mai ban mamaki cewa rubutun za a iya ƙirƙirar HCoV-229E zuwa mutane.
Yanzu, yayin da bat alpha-CoVs yi aiki a matsayin gen pool na HCoV-229E, alpacas da dromedary camels za a yi aiki a matsayin gabatarwa mai ban sha'awa da ke ƙirƙirar viruses zuwa mutane, kamar yadda a kan MERS-CoV.
MERS-CoV ne mai kyau samfurori na interspecies transmision daga bututu zuwa dromedary camels da kuma daga dromedary camels zuwa mutane.
MERS-CoV ta ci gaba da asali daga bututun yana sani a lokacin da aka kafa asali, kuma an ƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙiri.
Yana da yaushe cewa butterflies samar da wani m pool na virus species don interspecies canji na jima'i na jima'i da interspecies canji.
Longevity, ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar.
Sa'an nan, MERS-CoV da aka kafa a cikin dromedary camels don shekaru.
Yana da kyau canza ga wadannan camels da aka canza daga wani gabatarwa gaskiya zuwa wani daidaito da kuma dabara gaskiya gaskiya.
MERS-CoV yana ƙirƙirar ƙananan magani da kuma yana ƙirƙirar ƙananan mutations a cikin waɗanda.
Its sporadic buga zuwa mutane ne a gaskiya da kuma mutane suna wani dead-end abokin ciniki na MERS-CoV kamar yadda ta buga ba za a iya ci gaba.
Yanzu da jiki na camels a cikin ƙirƙirar MERS-CoV, jiki na pangolins, idan akwai, a cikin ƙirƙirar SARS-CoV-2 ne daban-daban.
Saboda haka, pangolin beta-CoVs ne sosai patogenic a pangolins.
Za su iya zama wani dead-end shirye-shirye ga SARS-CoV-2-related beta-CoVs, kamar yadda civets a kan SARS-CoV.
Manyan damar da SARS-CoV-2 tsari daga dabbobi zuwa mutane za a yi amfani da ko yaushe a cikin bincike a gaba.
Na farko, butterflies za a iya zama reservoir gaskiya na wani SARS-CoV-2-related viruses a karkashin identical da SARS-CoV-2.
Ma'aikata za su iya ƙirƙirar da yanayi tare da butterflies ta hanyar masana'antu ko masana'antu.
Duk da haka, pangolins za a iya zama daya daga cikin gabatarwa amplifying shirye-shirye da wani SARS-CoV-2-related virus da aka dace.
Ma'aikatan da aka ƙirƙirar virus ta hanyar ƙirƙirar da kuma kula da masana'antu.
Yana iya cewa da yawa mamaki, ciki har da dabbobi, suna sosai ga SARS-CoV-2.
Ƙararrawa na dabbobi da dabbobi na dabbobi don antibodies ne mahimmanci.
Tare, kamar yadda ya rubuta a karkashin, recombination da adaptation na SARS-CoV-2 za a iya zama a cikin wani karshe species wanda ya daidaita da biyu bututu da pangolins.
Sabuntawa a kan haihuwa na SARS-CoV-2 yana faruwa.
Bugu da daban-daban nau'i na dabbobi na dabbobi, uku manyan abubuwa a kan yanar gizo suna da muhimmanci a taimakawa CoVs don ƙirƙirar nau'i na dabbobi.
Na farko, da yawancin mutations da yawa a cikin RNA replication.
Kamar yadda aka kwatanta da sauran single-stranded RNA viruses, da aka sayar da mutation rates na CoVs za a iya kira a matsayin "moderate" to "high" tare da a kananan replacement rate ne ~10-4 replacement a kowace shekara a kowace site 2, bisa ga mataki na CoV adaptation ga sabon masana'antu.
CoVs yana da proof-reading exoribonuclease, wanda canza ya sa a mafi girma mutability da attenuation ko kawai inviability.
Saboda haka, na nucleotide analogue Remdesivir aka sani don ƙirƙirƙirar CoV ta hanyar ƙirƙirar wannan exoribonuclease da RNA-dangane RNA polymerase.
Remdesivir ne daya daga cikin mafi m anti-SARS-CoV-2 kayayyakin da za a yi gwaje-gwaje a cikin gwaje-gwaje.
Duk da haka, rates na mutations na CoVs ne game da wani miliyan karfi fiye da waɗannan na masana'antu.
Bugu da haka, yawancin mutation farashin ne mafi girma a lokacin da CoVs suna ba da kyau canzawa ga abokin ciniki.
Karkashin SARS-CoV tare da high mutation rate, mutation rate na SARS-CoV-2 ne yafi low, nuna wani karfi mataki na adaptation ga mutane.
Yadda za a yiwuwa, ya dace a cikin wani abokin cin abokin ciniki kusa da mutane.
Bugu da SARS-CoV-2, wannan ya dace da MERS-CoV, wanda yana da kyau don dromedary camels.
Theoretically, shi ne ba za a yiwuwa cewa genetic drift zai sa vaccines da antivirals ga SARS-CoV-2 sauri.
Second, babban RNA genome a CoVs yi amfani da ƙarin plasticity a genom modification ga mutations da recombination, da haka ci gaba da damar ga interspecies co-evolution, wanda shi ne mai kyau ga matsaloli na sabon CoVs a lokacin da matsaloli zama m.
Wannan shi ne taimakawa da ban mamaki na musamman open read frames da protein ayyuka da aka coded ga 3′ ƙarshe na genome.
Tare, CoVs rarraba da kuma sauƙi canza templates a lokacin RNA replication ta hanyar wani musamman "copy-choice" mechanism.
A cikin mai ban sha'awa da ke aiki a matsayin mai aiki da karfin ruwa, sha'awar sha'awar da aka kwatanta a lokacin CoV RNA transcription.
Highly homologous full-length da subgenomic RNAs za a iya recombine don samar da sabon CoVs.
Phylogenetic albarkatun na halitta recombination da aka samu a cikin HCoV-HKU1 da HCoV-OC43, kazalika da haihuwa CoVs kamar bat SL-CoV da batCoV-HKU9.
Virus-host daidaitacce a kan transmissions
Bugu da uku viral mataki da aka ce a kan, viral mita tare da abokan ciniki ne wani mataki mai muhimmanci da ke daidaito a kan interspecies transmision.
A cikin wannan, recombination na SARS-CoV an samu a matsayin tipical samfurin, wanda kuma ya nuna alama na kyau selection a lokacin interspecies transmission events.
Based on the comparative analysis between isolates of human and civet SARS-CoVs, SARS-CoV ne ya yiwuwa a cikin sauri adjustment a cikin daban-daban masana'antu, musamman tare da mutations a RBD na S protein.
Generally, RBD a cikin S protein na CoV yana daidaita da cellular receptor da aka daidaita tare da gaskiya na antibody tsari.
A SARS-CoV, RBD ne a cikin 318th to 510th amino acid a kan S1 fitarwa, wanda ya sa tare da mutum ACE2 da kuma da koreceptors ga viral shiga.
RBD na SARS-CoV yana iya sani ACE2 receptors na daban-daban dabbobi, ciki har da batsa, civet, mouse da raccoon dog, wanda zai iya lissafi tsakanin jiki na virus.
Yanzu, kawai 6 amino acid ƙarfi da aka kwatanta su zama daban-daban daga manyan da civet viral isolat a cikin RBD da kuma 4 daga gare su a cikin receptor-binding motif don haɓaka tare da ACE2 receptor.
Civet SARS-CoV yana da K479N da S487T mutations a cikin RBD, wanda zai iya ƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙira.
Saboda haka, wadannan biyu amino acid ƙirƙirar za a iya zama mai ban sha'awa ga viral ƙirƙirar a cikin mutane.
Yana da muhimmanci cewa SARS-CoV-2 yana ƙirƙirar sama na cellular receptor tare da SARS-CoV.
Tsarin 30% daban-daban tsakanin SARS-CoV-2 da SARS-CoV a cikin S1 na protein S yana nuna cewa matsa lantarki na S protein tare da ACE2 na mutum za a iya canza.
Yanzu, wani cryo-EM bincike ya nuna 10 zuwa 20 fiye da matsaloli na wannan matsaloli fiye da wannan tsakanin mutum ACE2 da SARS-CoV S protein.
Za su zama mahimmanci don tabbatar da idan wani wasu coreceptor za a iya bukatar ga SARS-CoV-2 transmission.
Fasaha, HCoV-NL63 yana haɗa tare da ACE2 amma tare da wani daban-daban S.
Kuna da yawa sauran HCoV receptors, kamar aminopeptidase N ga HCoV-229E, da 9-O-acetylated sialic acid ga HCoV-OC43.
Za su iya ƙaddamar da ci gaba da ƙaddamar da wadannan CoVs a cikin mutane bayan interspecies fitarwa daga masana'antun su.
Bugu da cellular receptors, matsaloli na interspecies transmission na HCoVs ne kuma daidaita da sauran abokan ciniki da kuma ƙirƙirar matsaloli.
Tare da wadannan hoto protein tsakanin mutane da dabara reservoir hoto na HCoVs kamar batsa, Dromedary camels da kuma rubutun za a iya zama wani ƙarfi ga interspecies fitarwa.
HCoVs za su usurpate masana'antu dependency factors da kuma gyara masana'antu restriction factors don m interspecies transmision.
Saboda wannan, daidaitaccen molecular a cikin wannan muhimmanci yanki na virus-host interaction yana da yaushe da kuma karanta.
Ƙungiyoyi a kan genome-tallace-tallace na abokan ciniki da kuma rage factors ga SARS-CoV-2 ta amfani da fasaha-of-the-art fasaha na CRISPR za a iya zama m.
Tsarin HCoVs: Back to Ground Zero
Sabis na bat CoVs yana samar da kyau damar ga matsaloli na sabon HCoVs.
Saboda wannan, bat CoVs yi aiki a matsayin gen pool na HCoVs.
Bugu da haka, fasaha mutation da kuma genetic recombination da aka ƙirƙirar HCoV ci gaba da kuma rufe a matsayin biyu muhimmanci mataki a cikin wannan tsari.
Misali, samfurin ko ƙirƙirar sabon protein-coding genes yana da ƙananan ƙirƙirar ƙirƙirar virus phenotypes.
Daga cikin SARS-CoV accessory protein, ORF8 ya zama muhimmanci a cikin canzawa ga mutane, kamar yadda SARS-CoV-related bat viruses aka daidaitacce amma aka koda divergent ORF8 protein.
A 29-nucleotide deletion yanayi na SARS-CoVs da aka samu a cikin sojoji da aka ba a faruwa a farkon jima'i.
Wannan ƙirƙirar ƙirƙirar ORF8 a cikin ORF8a da ORF8b, kuma an san cewa shi ne wani ƙirƙirar ƙirƙirar ƙirƙirar wanda ke taimakawa ƙirƙirar ƙirƙirar.
Bugu da haka, SARS-CoV yana da damar yin yin yin yin yin yin yin yin yin yin yin yin yin yin yin yin yin yin yin yin yin yin yin yin yin yin yin yin yin yin yin yin yin yin yin yin yin yin yin yin yin yin yin yin yin yin yin yin yin yin yin yin yin yin yin yin yin yin yin yin yin yin yin yin yin yin yin yin yin yin yin yin.
Recombination wurare da aka samu a cikin nsp9, mafi yawan nsp10, da kuma sassa na nsp14.
Har ila yau, an nuna cewa m MERS-CoV ya gabatar da matsaloli tsakanin daban-daban matsaloli, wanda aka kwatanta a cikin dromedary camels a Saudi Arabia.
Bugu da SARS-CoV da MERS-CoV, matsaloli na ƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙira.
Yana da ya kamata a karanta da cewa masana'antun jiki za a iya taimakawa ga matsaloli a cikin viral genomes, mafi za a yi amfani da matsaloli na viruses daga matsalolin matsaloli matsa lamba, kamar da shirye-shirye na jiki.
A misali na wadannan daidaitaccen ne rage na full-length ORF4 a cikin HCoV-229E prototype shuka, saboda biyu-nucleotide riga.
Kamar yadda intact ORF4 za a iya zama a cikin batsa da camel viruses related to HCoV-229E, alpaca alpha-CoV ya nuna wani nau'i nukleotid insert, wanda ya sa a frameshift.
Last but not least, da ci gaba da sabon HCoVs ne kuma ƙirƙirar da ƙirƙirar ƙirƙirar a cikin masana'antu masana'antu.
Asymptomatic ko kawai matsa lamba matsa lamba da aka rufe da CoVs, wanda ya nuna mutualization tsakanin CoVs da matsa lamba.
Ya nuna cewa rubutun suna da kyau adapted to CoVs anatomically da kuma physiologically.
Misali, gyara a cikin ƙirƙirar ƙirƙirar ƙirƙirar ƙirƙirar ƙirƙirar ƙirƙirar ƙirƙirar ƙirƙirar ƙirƙirar ƙirƙirar ƙirƙirar ƙirƙirar ƙirƙirar.
Bugu da haka, daidaitaccen daidaitaccen daidaitaccen daidaitaccen daidaitaccen daidaitaccen daidaitaccen daidaitaccen daidaitaccen daidaitaccen daidaitaccen daidaitaccen daidaitaccen daidaitaccen daidaitaccen daidaitaccen daidaitaccen daidaitaccen daidaitaccen daidaitaccen daidaitaccen daidaitaccen daidaitaccen.
Bugu da haka, da yawa na reactive oxygen species (ROS) da aka yi daga high metabolic aiki na bututu za a iya duk da haɓaka CoV replication da kuma haɓaka proofreading by exoribonuclease, da haka samar da ƙirƙirar ƙirƙirar domin samar da mata patogenic virus sassa a cikin wani sabon gaskiya.
More patogenic CoV tsari za a iya ci gaba da recombination, wanda ke ta ci gaba da sabon protein ko protein sassa don shiryawa.
Saboda haka, ba shi ne a gaskiya cewa uku sabon HCoVs da aka buga a cikin shekaru biyu da suka wuce.
CoVs ne non-patogenic ko ƙirƙirar matsala a cikin abokin cin abokin cin abokin cin abokin cin abokin cin abokin cin abokin cin abokin cin abokin cin abokin cin abokin cin abokin cin abokin cin abokin cin abokin cin abinci.
Za su ƙirƙirar daidai ba tare da ƙirƙirar ƙirƙirar ƙirƙirar mai kyau.
Wannan yana da ra'ayoyi don haka da abin da suka yiwuwa da abokan cin abinci da kuma abin da ke ba da matsaloli a cikin matsaloli a cikin mutane.
Ƙararrawa ƙararrawa sun daidai da ƙararrawa na ƙararrawa na ƙararrawa da tsitokin ƙararrawa, a cikin abin da ƙararrawa ƙararrawa mai ƙararrawa, ƙararrawa ƙararrawa mai ƙararrawa.
Saboda haka, a cikin asymptomatic na'ura mai aiki da karfin ruwa, na'ura mai aiki da karfin ruwa mai aiki da karfin ruwa mai aiki da karfin ruwa mai aiki da karfin ruwa mai aiki da karfin ruwa mai aiki da karfin ruwa mai aiki da karfin ruwa mai aiki da karfin ruwa.
Samun takardun ƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙiri.
Interferon tsari ne musamman m a cikin bututu.
Saboda haka, amfani da type I interferon, ko da yaushe a cikin farko na SARS-CoV-2 infection a cikin mutane, za a yi amfani da.
Bugu da haka, NLRP3 inflammasome ƙirƙirar a cikin bututun ne defective.
Saboda wannan ra'ayi, inhibition na NLRP3 inflammasome tare da MCC950 za a iya amfani da a cikin magani na COVID-19.
Tsarin SARS-CoV-2 yana da al'ada da al'ada da SARS-CoV da MERS-CoV.
Kamar yadda wani bat beta-CoV daidaita 95% nucleotide homology tare da SARS-CoV an samu, akwai kuma wani bat-CoV daidaita 96% nucleotide homology tare da SARS-CoV-2.
Kamar yadda civets da sauran dabbobi a cikin masana'antun da aka samu don haɓaka viruses identical to SARS-CoV, tsananin mid-hosts ga SARS-CoV-2 ba daidai.
Pangolin beta-CoVs da ake bukata homologous to SARS-CoV-2 da aka samu, nuna cewa pangolins za a iya aiki a matsayin daya daga gabatarwa gaskiya, ko pangolin beta-CoVs za a iya taimakawa jima'i fragments to final version na SARS-CoV-2.
Har ila yau, duk da cewa SARS-CoV-2 ne mai ban sha'awa, ko mai ban sha'awa.
CoVs da aka fara a cikin ƙarfi a karkashin karshe tsari na SARS-CoV-2.
The bincike na CoVs a cikin bututun da sauran dabbobi da ke canza mu al'amala da muhimmanci na zoonotic asali da haihuwa kayayyakin na HCoVs a cikin lamba.
Ƙungiyoyi suna nuna cewa SARS-CoV, MERS-CoV da SARS-CoV-2 yana da asali na batsa da aka ƙirƙirar zuwa mutane ta hanyar masana'antu.
Saboda cewa SARS-CoV infection yana da asali daga tsari tsakanin mutane da civets a cikin masana'antu, ƙirƙirar masana'antu da kuma ƙirƙirar civets a cikin su za su iya yi amfani da sarrafa SARS epidemic.
Saboda wannan ra'ayoyi, pangolins za su daidaita daga masana'antun ruwa don canza zoonotic ƙirƙirar, a kan gaban da yawa lineages na pangolin beta-CoVs da aka kwatanta tare da SARS-CoV-2.
Ko da kuma yadda SARS-CoV-2 an ƙirƙirar mutane ta hanyar pangolins da sauran mamaki, ba za a gane a cikin bincike a gaba.
Sa'an nan, MERS-CoV ya zama a cikin dromedary camels a tsawon lokaci.
Wadannan camels suna da muhimmanci kayan aiki don jirgin kasa da kuma babban kayayyakin masana'antu, ma'aikata, ƙarfi da kuma kayayyakin waya ga mutane.
Yana da yaushe a cikin Middle East da Africa.
Saboda haka, ba za a iya ƙirƙirar kammala don ƙirƙirar MERS, kamar yadda abin da aka yi a cikin masana'antu a kasar Sin don ƙirƙirar SARS-CoV da SARS-CoV-2.
Za a haɓaka matsaloli na MERS, za a yi amfani da wani kyakkyawan yanayin don ci gaba da karfi magungunan magungunan MERS-CoV ga camels, a gabatar da sauran magungunan magungunan magungunan.
Saboda cewa ba mu iya gyara wadannan viruses, sabon genotypes za a iya buga don haɗari.
A daban-daban zoonotic CoVs suna zuba jari a cikin halitta.
Kasuwanci, bat CoVs tare da zoonotic damar suna da yawa.
Yana da yawa damar cewa wadannan zoonotic CoVs ci gaba da kuma ƙirƙirar, tare da ƙaddamar da sabon CoVs da ke daidaito da kuma / ko matsaloli a cikin mutane a cikin gaba.
Ƙungiyoyi na kula da dabbobi a wasu wurare na kasar Sin za a ba da gaskiya don rage mahimmanci tsakanin mutane da dabbobi.
Tare da matsaloli na SARS, MERS da COVID-19, mai kyau matsaloli da matsaloli mai kyau za a yi a kan.
Kyakkyawan, da yawa viruses suna a cikin duniya a tsawon lokaci.
Za su zama a cikin halitta kayan haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin.
Har ila yau, ba tare da yawa siffofin da ke taimakawa da fitarwa na viruses, za a iya rage shigar da mutane da bututu da sauran halitta na halitta da za a iya rage idan mutane suna koyar da su riga daga su.
Ƙididdigawa a cikin mamaki da ake bukata don mafi kyau sani da ecology na CoVs da kuma har ma'aikata, wanda za su yi amfani da su taimakawa da ƙirƙirar daga dabbobi zuwa dabbobi da kuma gaba da matsaloli.
Saboda haka, mafi kyau abin da za a canza virus zoonosis shi ne don mutane zama daga cikin ecological niches na halitta na zoonotic viruses.
Manyan abubuwa a cikin matsaloli na zoonotic asali na SARS-CoV-2 suna ba.
Na farko, idan rubutun ƙirƙirar wani ancestral virus na SARS-CoV-2 zuwa pangolins, za su zama mahimmanci don ganin abin da yanayi rubutun da pangolins za su iya ƙirƙirar da sama ecological niche.
Duk da haka, idan bututun da aka yi amfani da wani mai ban sha'awa a cikin jima'i, kamar yadda mutane za su samu a kan bututun, za su daidaita.
Tare da haka, idan wani karami na karami na karami na karami ya yi aiki a matsayin m girmamawa, da yadda ya dace da daban-daban, ciki har da mutane, rubutun da pangolins, da ya kamata a kammala.
Saboda haka, tun da yawa mamaki, ciki har da dabbobi, za a iya zama m ga SARS-CoV-2, duk da shawarar da gwaji na jima'i za a yi.
Idan shi ne batsa, pangolin, ko wani mamaki, za a rage cewa SARS-CoV-2 ko daidaitaccen virus da aka daidaitaccen suna samu a cikin mahimmanci a cikin gaba.
Ma'aikata bincike a cikin wannan yanki za su saukar da ci gaba-gwaje na SARS-CoV-2 a cikin dabbobi, tare da muhimmanci matsaloli a kan ƙirƙirar da ƙirƙirar COVID-19 a mutane.
Yana da mahimmanci na tsari na COVID-19 "mashara" da "confirmed case"
A 6 Fabrairu 2020, tawagar mu ya gabatar da wani gyara-gyare-gyare-gyare-gyare-gyare-gyare-gyare-gyare-gyare-gyare-gyare-gyare-gyare-gyare-gyare-gyare-gyare-gyare-gyare-gyare-gyare-gyare-gyare-gyare-gyare-gyare-gyare-gyare-gyare-gyare-gyare-gyare-gyare-gyare-gyare-gyare-gyare-gyare-gyare-gyare-gyare-gyare-gyare-gyare-gyare-gyare-gyare-gyare-gyare-gyare-gyare-gyare-gyare.
Duk da haka, Coronavirus Disease 2019 (COVID-19) ne wani sabon magani, mu al'amala da kwarewa suna ci gaba da ci gaba da hanyoyin bincike da kwarewa na lissafi. Saboda haka, zane-zane na jima'i da jima'i suna da aka ci gaba da ci gaba.
A wannan barka, mu gabatar da wani alama a kan alama da aka samar da mafi kyau gwaje-gwaje kayayyakin na "masharwa kasuwa" da "masharwa kasuwa" a karkashin mafi kyau COVID-19 Diagnosis and Treatment Guidelines (Seventh Version) da aka gabatar da National Health Committee na People's Republic of China.
A watan Disamba 2019, 2019 novel coronavirus (2019-nCoV) ya ƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙira.
11 Maris 2020, WHO ya ƙirƙirar COVID-19 a matsayin pandemic.
Saboda yawar da SARS-CoV-2 magani, tawagar mu ya ci gaba da wani tsari mai sauƙi da kuma da aka buga online a cikin Military Medical Research a 06 Fabrairu 2020.
Yana haƙƙoƙi babban matsa lamba daga lokacin da aka buga.
Saboda haka, COVID-19 ne wani sabon magani, mu al'amala da ilimi yana ci gaba da ci gaba da hankali a kan bincike da ilimi na lissafi. Saboda haka, zane-zane na magani da matsa lissafi da kuma jima'i da aka ci gaba da ci gaba.
Saboda haka, da Guidelines for Diagnosis and Treatment for COVID-19 da aka ba da National Health Committee of the People's Republic of China (http://www.nhc.gov.cn/), tsakanin 16 Janairu 2020 to 3 Maris 2020, ya gabatar da saba editions tare da wasu hadin gwiwa da aka canza.
Yanzu mu takardun shaida da shaida na Zhou et al., suka gabatar da tsari mai tsanani mai tsanani a kan kwarewa da kwarewa.
Their aiki ya ƙirƙirar nau'in nau'in mu takardar kebantawa da kuma kuma yi da muhimmanci reference ga wannan pandemic a duniya.
Tuntube mu m aiki da kuma sayen mu shakka.
Duk da haka, ayyukansa yana da bukatar update bisa ga latest Diagnosis da Tsaro Guidelines for COVID-19 (Trial saduwa version) da kuma karshe bincike.
Saboda na saba edition (3 Maris 2020), don gabatar da sakamako kasuwa ya kamata ka kombine wani mataki na epidemiological hadin gwiwa da biyu mataki na lissafi don samar da cikakken bincike, ko kamata ka samu uku mataki na lissafi idan ba tare da m epidemiological hadin gwiwa:
Epidemiological hadin gwiwa: (1) wani hadin gwiwa ko ajiya a Wuhan birnin da yanki, ko sauran jama'a inda COVID-19 matakan da aka gabatar a cikin wata 14 kwanaki kafin matakan matakan; (2) wani hadin gwiwa tare da SARS-CoV-2 matakan matakan (dangane na nucleic acid test); (3) wani hadin gwiwa tare da matakan da matakan da kowa da matakan jiki daga Wuhan birnin da yanki, ko sauran jama'a inda COVID-19 da aka gabatar a cikin wata 14 kwanaki kafin matakan matakan matakan; (4) wani hadin gwiwa da matakan da matakan da aka gabatar da matakan (≥ 2 matakan da matakan da matakan da kuma / ko matakan matakan matakan da aka kwatanta a cikin 2 makonni, kamar gida, ofishin, dalibi, da dai sauransu).
Clinical manifestations: (1) fever da / ko matsa lamba matsa lamba; (2) tare da imagery matsa lamba na COVID-19 lamba; (3) total white blood cell count showing normal, lowed, ko lowed lymphocyte count a farkon matsa lamba.
Diagnosis da sakamako ya kamata a fara a kan sakamako da wani mataki na patogenic ko serological kayayyakin kamar yadda ya ce: (1) real-time PCR test positive for SARS-CoV-2; (2) viral cikakken genom sequencing nuna high homogenity to da aka sani da sabon coronaviruses; (3) positive for specific IgM antibody and IgG antibody to SARS-CoV-2 in serum test; ko wani canji na SARS-CoV-2-specific IgG antibody daga negative to positive, ko titers ci gaba ≥4 times a cikin tsarkakewa fasin fiye da cewa a cikin acute fasin.
Za mu iya ganin cewa real-time PCR gwajin ga nucleic acid a cikin matsa lantarki ko damu samfurori aka ƙaddamar da na biyu (18 Janairu 2020) da na uku (22 Janairu 2020) editions.
The patogenic detection of blood sample aka ƙaddamar da na farko (27 Janairu 2020) da na farko (8 Fabrairu 2020) editions; kuma bayan da serological evidence aka ƙaddamar da na farko edition.
Wadannan canje-canje-canje-canje-canje-canje-canje-cante-cante-cante-cante-cante-cante-cante-cante-cante-cante-cante-cante-cante-cante-cante-cante-cante-cante-cante-cante-cante-cante-cante-cante-cante-cante-cante-cante-cante-cante-cante-cante-cante-cante-cante-cante-cante-cante-cante-cante-cante-cante-cante-cante-cante-cante-cante-cante-cante-cante-cante-cante-cante-cante-cante-cante-cante-cante-cante-cante-cante-cante-cante-cante-cante-cante-cante-cante-cante-cante-cante-cante-cante-cante-cante-cante-cante-cante-cante-cante-cante-cante-cante-cante-cante-cante-cante-cante-cante-cante-cante-cante-cante-cante-cante-cante-cante-cante-cante-cante-cante-cante-cante-cante-cante-cante-cante-cante-cante-cante-cante-cante-cante-cante-cante-cante-cante-cante-cante-cante-cante-cante-cante-cante-cante-cante-cante-cante-cante-cante-cante-cante-cante-cante-cante-cante-cante-cante-cante-cante-cante-cante-cante-cante-cante-cante-cante-cante-cante-cante-cante-cante-cante-cante-cante-cante-cante-cante-c
Bugu da haka, akwai fiye da yawa alama da ya gane mu da alama tare da atypical symptomatic da asymptomatic dalibai.
Saboda haka, zane-zane-zane na Zhou et al. za su zama updated, kamar yadda suka rarraba da mutum ba tare da lissafin lissafi a matsayin "low risk".
Tsarin tsarin da ake bukata a cikin ƙarin lissafi da bincike.
Saboda haka, mu yiwuwa da ƙarfi mai ban sha'awar da aka ba da sha'awa don samar da comments.
Kamar yadda za a magana da "masharar kwarewa" da "masharar kwarewa", mu shawarar da cewa za su karanta da kuma karanta da mafi kyau hanyoyi na gida.
Our tawagar za mu daidaito update mu takardun shaida don samar da taimako.
Bangladesh ya gabatar da fiye da fiye da matsala daga COVID-19, mai girma a rana
Yau, Bangladesh ya gabatar da 5 sabon matsaloli daga COVID-19 a cikin wannan rana.
Wannan shi ne mafi girma yawan matsaloli a kowace rana saboda virus.
Kamar yadda ya wuce, Bangladesh ta Institute of Epidemiology, Disease Control and Research (IEDCR) ya gabatar da yawan da aka rubuta matakan da aka hada da 114 matakan da aka haifar da 33 matakan da aka haifar a cikin gida.
A karkashin 17 matsaloli da aka rubuta.
A online news briefing, director na IEDCR, Dr Meerjady Sabrina Flora, ya ce da 'yan ma'aikata sun hada da 'yan maza da wani maza.
Bayan Dr. Meerjady, biyu matakan da aka zama fiye da 60, biyu tsakanin 51 da 60, kuma daya daga 41-50 shekaru.
Yana kuma ya ce da cewa biyu daga cikin ma'aikata suna daga Dhaka.
The World Health Organization (WHO) ya sanar da COVID-19 a matsayin pandemic a watan Maris 11.
Jami'ar magani ya ce Anadolu Agency, wani yanar gizo na yanar gizo, cewa daya daga cikin ma'aikata shi ne Jalal Saifur Rahman, mai kwarewa na Bengali Anti-Corruption Commission, wanda aka kammala a Kuwait Maitree Hospital.
Yuni, a kan online video announcement, Bangladesh Road Transport and Bridges Ministan Obaidul Quader ya ce cewa jama'a ta jiragen kasa za a shigar da tsawon lokaci fiye da aka kafa, har zuwa wannan gaba sabis.
Wannan shutdown na jirgin kasa ta farko ya fara a kan 26 Maris da aka kafa a ranar Sabis, 4 Aprili.
Ƙididdiga na musamman kayayyakin - magani, karfi da kayayyakin - aka dace.
Ma'aikatan farko da aka kwatanta na COVID-19 a Bangladesh suna a watan Maris 8, a cikin biyu mutane da suka zo daga Italiya da kuma ma'aikata na daya daga su.
Daga 19 Maris, wadannan hudu suna da yaushe.
SARS-CoV-2 ya zama fiye da miliyan a duniya
Yuni, total yawan mataimakin SARS-CoV-2 coronavirus jima'i karkashin miliyan a duniya, data na Johns Hopkins University ya nuna.
Har ila yau, fiye da 52,000 mata suna daidaita a kan COVID-19, magani wanda ya haifar da coronavirus.
Ma'aikace-aikace ya zo a cikin wannan rana da Malawi ya gabatar da farko coronavirus jikin da kuma Zambia ya zama ta farko coronavirus-karkashin jiki.
North Korea ya ce, a ranar Alhamis, shi ne daya daga cikin wasu kasashe da aka zama free daga coronavirus zartarwa.
Yau, World Health Organization ya gabatar da 1,051,635 matsaloli, ciki har da 79,332 matsaloli a cikin 24 hours kafin 10 am Central European Time (0800 UTC) a watan Afrilu 4.
A Amurka, fiye da 244 thousand cases of coronavirus da aka rubuta, wanda ya haɗu da fiye da 5,900 dalibai.
CBS News ya gabatar da bayanai daga Jami'ar Johns Hopkins, akwai fiye da 1,000 mata a Amurka a ranar Alhamis da aka haifar da magungunan coronavirus.
A kowace duniya, masana'antu da aka gabatar da ƙarfi don ƙirƙirar magani na magani.
Yuni, Sergei Sobyanin, mai girma na Moscow, ya ƙirƙirƙirar gundumar zuwa 1 May.
Kasuwanci Vladimir Putin ya gabatar da cewa Russians za su ci gaba da bayar ba tare da aiki fiye da Apr. 30.
Portugal ta ƙirƙirar ƙirƙirar ƙarƙirar ƙarƙirar ƙarƙirar ƙarƙirar ƙarƙirar ƙarƙirar ƙarƙirar ƙarƙirar ƙarƙirar ƙarƙirar ƙarƙirar ƙarƙirar ƙarƙirar ƙarƙirar ƙarƙirar ƙarƙirar ƙarƙirar ƙarƙirar ƙarƙirar ƙarƙirar ƙarƙirar ƙarƙirar ƙarƙirar ƙarƙirar ƙarƙirar ƙarƙirar ƙarƙirar ƙarƙirar ƙarƙirar ƙarƙirar ƙarƙirar ƙarƙirar ƙarƙirar ƙarƙirar ƙarƙirar ƙarƙirar ƙarƙirar ƙarƙirar ƙarƙirar ƙarƙirar ƙarƙirar.
Saudi Arabia ya ƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙira.
Thailand ya shirya da shiryawa a tsakanin 10 am da 4 am.
Governor of Ohio, Mike DeWine, ya sanar da bangaskiya ya ƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙiri.
Ma'aikata a Australia ƙirƙirar lissafi na Toilet Paper per transaction
Sabis da Sabis, Australian masana'antu chains Woolworths da Coles haƙƙoƙoƙoƙoƙoƙoƙoƙoƙoƙoƙoƙoƙoƙoƙoƙoƙoƙoƙoƙoƙoƙoƙoƙoƙoƙoƙoƙoƙoƙoƙoƙoƙoƙoƙoƙoƙoƙoƙoƙoƙoƙoƙoƙoƙoƙoƙoƙoƙoƙoƙoƙoƙoƙoƙoƙoƙoƙoƙoƙoƙoƙoƙoƙoƙoƙoƙoƙoƙoƙoƙoƙoƙoƙoƙoƙo.
ALDI ya ƙirƙirar wani kudi na kudi, a ranar Alhamis.
Wadannan kudi da aka rubuta a matsayin bayanai a kan kudi, da kuma a kan Facebook sayarwa na chains.
Ma'aikatan ciniki ya ce ya zo a kan rage daga COVID-19 a gundumar da mutane suna bukatar su riga.
Satumba, Woolworths ya ƙarya samfurori na toalet paper don ƙirƙirƙirar gida zuwa wani shirye-shirye a kowace ba.
Wadannan canje-canjewa suka wuce da ƙaddamarwa na four-pack per transaction da aka kafa da Woolworths da Coles a watan Maris 4 da 5.
"Coles, a cikin wasanni 8 Maris, ya gabatar da cewa tare da ƙirƙirar four-pack a kan layi, "manyan masana'antu suna yanzu sayarwa a cikin sa'o'i na samfurin", kuma ya kira da bukatun "tallace-tallace", yayin da ALDI, a cikin Facebook post a ranar Maris, ya kira shi "tallace-tallace". "
"Sale ya fara a cikin "" sharp daidaitacce"" a cikin makonni, a kan Woolworths kamfanoni. "
Costco's store a Canberra kuma ya ƙara da yawan da aka ba da karfi zuwa biyu shiryawa a karshe.
Za ka iya ƙara rage, Coles ya ba da ƙarfi mai girma daga masana'antu da kuma ƙarfi mai tsawo, Woolworths ya ba da ƙarin kayayyakin, yayin da ALDI ya sa kayayyakin don shirye-shirye sabis na musamman.
Russell Zimmerman, CEO na Australian Retailers Association, ya ce da cewa masana'antun masana'antun masana'antun masana'antun masana'antun masana'antun masana'antun masana'antun masana'antun masana'antun masana'antun masana'antun masana'antun masana'antun masana'antun masana'antun.
Ya ƙaddamar da kudin samarwa, kamar yadda masana'antun ma'aikatan ci gaba da cika, da kuma fiye da kayayyakin.
Yuni, ALDI ya gabatar da cewa bayan da ya fi dacewa na stock, wasu masana'antu ba za a iya rarraba Wednesday Special.
A News.com.au sabis, Dr. Gary Mortimer, masana'antu masana'antu daga Queensland University of Technology, ya ce da masana'antu sun ƙunshi kayayyakin kowace rana.
Ya ce da toilet paper ne mai girma kayayyakin, wanda ke tafi da yawan yawan kayayyakin a yawan, kuma, a lokacin da aka sayarwa, ya ba da ƙarƙwalwar ƙasa na shigarwa, ƙarƙwalwar jiki na cika.
" "" Coles da Woolworths yana da matsala [da] idan akwai yawa abubuwa a kan shigarwa, idan kayayyakin kamar toalet rolls da sanitary za a iya [sale] da kuma akwai a kan yawanci, za ka iya rage panic," Russell Zimmerman ya ce ga ABC News. "
Recycled Toilet Paper masana'antu Who Gives a Crap ya ce a ranar Alhamis da suka wuce su zauna a cikin kayayyakin.
Kimberly-Clark, wanda ya samar da Kleenex Toilet Tissue, da Solaris Paper wanda ya samar da Sorbent, ya ce su aiki 24/7 don ƙirƙirar samfurin, bayan News.com.au sabis.
Domain.com, wani yanar gizo website, ya sanar da wasu masu sayar da yanar gizo bayar da free toalet papers ga farko bidiyo a cikin sayarwa a Melbourne, a lokacin da fiye da sayarwa da aka yi a kan abokan ciniki da zauna lokaci a cikin m Weekend na Labour Day.
The Thursday edition na NT News, a yau da kullum da aka buga a Darwin, ya hada da ƙarfi na ƙarfi na ƙarfi na ƙarfi da za a yi amfani da su a matsayin toalet papers.
The masana'antu na farko da aka ba da sha'awar don ƙirƙirar kudi, a kan wani gabatarwa daga ABC Australia a watan Maris 3, wanda ya ce cewa su ba da aikace-aikace don ƙirƙirar kudi.
Russell Zimmerman ya gabatar da cewa sauran kayayyakin suna da yawa, ciki har da masks, sanitary, kayayyakin da aka rufe, hanyoyin jiki da bututu.
Saboda haka, fiye da Australia, a ranar Alhamis a kan online British supermarket Ocado ya gabatar da rage tallace-tallace-tallace na Andres zuwa biyu 12 roll packs.
World Health Organization ya sayi COVID-19 pandemic
Maris, World Health Organization (WHO) ya sanar da tsari na tsari na COVID-19 - magani na coronavirus SARS-CoV-2 - a matsayin pandemic.
"Dangane da neno "pandemic" ne kawai daidai da kaddamar da wani magani, ba tare da kaddamar da matsaloli na musamman, WHO ya gabatar da bukatun don ƙirƙirar gundumar: "
“‘Dukkan ƙasƙanci za su iya canza mataki na wannan pandemic.’
"Kama da kasashe zauna, zauna, gyara, ƙirƙirar, rage da kuma ƙirƙirar mutane su a yanayin," ya ce Tedros Adhanom Ghebreyesus, Jirgin Gida na WHO. "
"We ne sosai ban sha'awa da ƙarfi da ƙarfi da ƙarfi da ƙarfi da ƙarfi da ƙarfi na ƙarfi."
Bayan Dr. Tom Frieden, da suka gabatar da Center for Disease Control da Prevention a Amurka, pandemic ne "tallace-tallace."
Kuma ya ce, a comments da aka gabatar da CNN a watan Fabrairu, "Mutane da jima'i, duk wani jima'i na jima'i na jima'i na jima'i ba da shawara daga fitarwa zuwa ci gaba a duniya."
Ghebreyesus ya gabatar da wani matsaloli, ya ce: "Mai ko da yaushe wani pandemic da aka haifar da coronavirus."
"Ta ce, "" kuma ba mu ko da wani pandemic cewa za a iya ƙarya a cikin wannan lokaci."
The sabon status a matsayin pandemic da yaushe ta WHO a watan Janairu ya gabatar da matsaloli da matsaloli a kan jama'a tsarkakewa na kasa da kasa.
The United States National Institute of Allergy and Infectious Disease, Dr. Anthony Fauci, ya ce game da tsibirin, "Bottom line, shi zai zama karfi."
Tare da Yuni, Associated Press ya sanar da cewa akwai karkashin 126,000 mataki na COVID-19 a duniya, wanda ya wuce fiye da 4,600 mata.
The 2019-20 coronavirus pandemic ne a ci gaba da pandemic na coronavirus jiki 2019 (COVID-19), wanda aka haifar da matsaloli na acute respiratory syndrome coronavirus 2 (SARS-CoV-2).
Tsarin Tsarin Tsarin Tsarin Tsarin Tsarin Tsarin Tsarin Tsarin Tsarin Tsarin Tsarin Tsarin Tsarin Tsarin Tsarin Tsarin Tsarin Tsarin Tsarin Tsarin Tsarin Tsarin Tsarin Tsarin Tsarin Tsarin Tsarin Tsarin Tsarin Tsarin Tsarin Tsarin Tsarin Tsarin Tsarin Tsarin Tsarin Tsarin Tsarin Tsarin Tsarin Tsarin Tsarin Tsarin Tsarin Tsarin Tsarin Tsarin Tsarin Tsarin Tsarin Tsarin Tsarin Tsarin Tsarin Tsarin Tsarin Tsarin Tsarin Tsarin Tsarin Tsarin Tsarin Tsarin Tsarin Tsarin Tsarin Tsarin Tsarin Tsarin Tsarin Tsarin Tsarin Tsarin Tsarin Tsarin Tsarin Tsarin Tsarin Tsarin Tsarin Tsarin Tsarin Tsarin Tsarin Tsarin Tsarki
Tare da 10 Afrilu 2020, fiye da 1.61 miliyan matakan COVID-19 da aka kwatanta a cikin 210 kasashe da yanki, tare da kira 97,000 mata.
game da 364,000 mutane da aka sauke.
Kasuwancin matsala a kasar Sin an sayar da 4%, yayin da a duniya shi ne daga 13,04% a Algeria zuwa 0,08% a New Zealand.
Jami'ar magani sun hada da fever, cough da matasa.
Ƙara za a iya hada da pneumonia da acute respiratory distress syndrome.
The lokaci daga ƙaddamarwa zuwa ƙaddamarwa na ƙaddamarwa yana da yawanci game da kwanaki 5, amma za a iya rufe daga kwanaki biyu zuwa kwanaki 14.
Duk da haka, ba za a sani wani vaccine ko wani musamman antiviral therapy.
Ƙararrawa Ƙararrawa Ƙararrawa Ƙararrawa Ƙararrawa Ƙararrawa Ƙararrawa Ƙararrawa Ƙararrawa Ƙararrawa Ƙararrawa Ƙararrawa Ƙararrawa Ƙararrawa Ƙararrawa Ƙararrawa Ƙararrawa Ƙararrawa Ƙararrawa Ƙararrawa Ƙararrawa Ƙararrawa Ƙararrawa
Ma'aikatar duniya sun haƙƙoƙi ta hanyar ƙirƙirar tafiya, kwarantena, shimfida, ayyukan daidaitaccen kudin, da kuma shimfida na wurare.
Pandemic ya ƙirƙirar matsakaici sosio-tattalin arziki a duniya, ƙirƙirar ko ƙirƙirar wasanni, ilimi, siyasa da kuma ilimi, da kuma ƙarƙirar matsakaici na kayayyakin da aka ƙarƙirar ta ban mamaki sayarwa.
Schools da jami'o'i da aka shigar ko a kasa ko a kasa a cikin 193 kasashe, dace game da 99.4% na duniya dalibai.
Tsarin yanar gizo game da magunguna a kan yanar gizo, kuma akwai matsaloli na xenophobia da ra'ayoyi ga kasar Sin, sauran mutane na Eastern da Southeast Asian albarkatun da matsaloli, da sauran daga yankin tare da matsaloli na matsaloli na virus.
Ƙararrawa tafiya da ƙararrawa na masana'antun masana'antun masana'antun masana'antun masana'antun masana'antun masana'antun masana'antun masana'antun.
Wasanni a Wuhan, kasar Sin (tallace-tallace na Hubei Province) ya gabatar da matsaloli na pneumonia na ban sha'awa a ranar 31 Disamba 2019, kuma bincike da aka fara a karkashin Janairu 2020.
Kasuwanci da yawa da aka haƙƙoƙi da Huanan Seafood Wholesale Market, don haka virus an san cewa yana da zoonotic asali.
The virus wanda ya haifar da matsa lamba yana da aka sani da SARS-CoV-2, mai sauƙi da aka samu a kan coronaviruses bat, pangolin coronaviruses, da SARS-CoV.The farko da aka sani da matsa lamba aka sauƙi ya samu a cikin 1 Disamba 2019, kuma wannan mutum ba da wani matsa lamba tare da matsa lamba mai sauƙi.
Of the early cluster of cases in Disamba 2019, two-thirds da aka samu da haske da kasuwanci.
Maris 13, 2020, wani takardun shaida daga South China Morning Post ya nuna cewa matsala da aka fara daga 17 Nuwamba 2019, a 55-year-old daga Hubei provincia, za a iya zama na farko.A 26 February 2020, WHO ya gabatar da cewa, kamar yadda nau'in matsala da aka rage a kasar Sin, amma a gaban da yawa a Italiya, Iran, da Korea, yawan nau'in matsala fiye da yawan nau'in matsala a kasar Sin don farko.
Za a iya zama muhimmanci underreporting na kasashe, musamman tsakanin waɗannan tare da karami magani.
Tare da 26 watan Fabrairu, yawancin matakan da aka kwatanta a cikin mutanen da suka wuce, tare da waɗannan 19 da aka ƙunshi 2.4% na matakan a duniya.British Chief Scientific Advisor, Patrick Vallance, ya rage cewa 60% na Birtaniya mutane za su zama magana kafin za a iya samun daidaitacce mai kyau.
Cases nurar da yawan mutane da aka yi gwaji ga COVID-19, da kuma cewa gwaji da aka gabatar da kyau bisa ga rasmi protocols.
Saboda 23 Maris, duk wani ƙasashen da aka ƙirƙirar fiye da 3% na mutane, da yawa ƙasashen da aka da takardun shaida don ba su ƙirƙirar da waɗanda suna da kawai m magani, kamar Italiya, Netherlands, Spain, da Switzerland.
A bincike da aka gabatar da 16 Maris ya gabatar da cewa a kasar Sin, fiye da 23 Janairu, 86% na COVID-19 lissafi suna ba da alama, kuma cewa wadannan lissafi ba tare da dokokin lissafi na 79% na lissafin lissafi.
Tattalin lissafi da aka gabatar da 30 Maris ya ƙara cewa yawan lissafi a Italiya suna da yawa fiye da matsala da aka gabatarwa.
Ƙararrawa na asali na basal ƙirƙirar yawan (R0) ga COVID-19 aka 1.4 zuwa 2.4.
A bincike da aka gabatar da US Center for Disease Control da Prevention ya ce cewa shi zai iya zama 5.7.
Mafi yawancin mutane tare da COVID-19 zaune.
Ga waɗanda ba, tsawon lokaci daga ci gaba da magani zuwa jiki ne tsakanin 6 da 41 kwanaki, tare da mafi yawancin 14 kwanaki.
A kan 10 Afrilu 2020, game da 97,000 matsaloli ya rubuta COVID-19.
A kasar Sin, a kan 5 Fabrairu, game da 80% na matsaloli suna a cikin mutane da suka wuce 60, da 75% ya dace da matsaloli, ciki har da matsaloli na gwiwa da tsarkakewa da tsarkakewa.
Ƙararrawa mai girma daga COVID-19 za a iya zama mafi girma, kamar yadda za a iya ba su hada da mutane da suka wuce ba tare da gwaji - misali a gida, a gundumar, da dai sauransu.
Partial bayanai daga Italiya ya nuna cewa yawan ƙarfin jiki a lokacin pandemic ya karkashin rasmi COVID ƙarfin jiki tare da factor na 4-5x.
"A spokeswoman na US Centers for Disease Control and Prevention (CDC) ya san cewa "Mai san cewa [a ƙaddamar da ƙaddamar da ƙaddamar da ƙaddamar da ƙaddamar da ƙaddamar da ƙaddamar da ƙaddamar da ƙaddamar da ƙaddamar da ƙaddamar da ƙaddamar da ƙaddamar da ƙaddamar da ƙaddamar da ƙaddamar da ƙaddamar da ƙaddamar da ƙaddamar da ƙaddamar da ƙaddamar da ƙaddamar da ƙaddamar da ƙaddamar da ƙaddamar da ƙaddamar da ƙaddamar da ƙaddamar da ƙaddamar da ƙaddamar da ƙaddamar da ƙaddamar da ƙaddamar da ƙaddamar da ƙaddamar da ƙaddamar da ƙaddamar da ƙaddamar da ƙaddamar da ƙaddamar da ƙaddamar da ƙaddamar da ƙaddamar da ƙaddamar da ƙaddamar da ƙaddamar da ƙaddamar da ƙaddamar da ƙaddamar da ƙaddamar da ƙaddamar da ƙaddamar da ƙaddamar da ƙaddamar da ƙaddamar. "
Ma'aikata na farko a waje daga kasar Sin ya zama a watan Fabrairu 1 a Filipina, kuma na farko a waje Asia ya zama a Faransa a watan Fabrairu 14.
Tare da 28 Fabrairu, fiye da ƙasƙanci na kasar Sin, fiye da ƙasƙanci na jima'i suna rubuta a Iran, Korea da Italiya.
Tare da 13 Maris, fiye da ƙasƙanci da ƙasƙanci da ƙasƙanci ya gabatar da matsala, a kowane ƙasƙanci ba tare da Antarctica.
Wadannan talakawan zauna da yankin da tsawon lokaci, da kuma daidaita da yawan gwaje-gwaje, ingancin ilimi tsarin, matsaloli yanayin, lokaci daga farko tsibirin, da kuma jama'a yanayin kamar umurni, jini, da jini, da jiki a cikakken lokaci. The daidaitacce-tallace-tallace ratio ya nuna yawan matsaloli divided da yawan matsaloli da aka magana a cikin wani lokaci.
Bisa ga takardar kebantawa na Johns Hopkins University, duniya matsaloli-tallace ratio ne 6.0% (97,039/1,617,204) a kan April 10, 2020.
Ƙararrawa suna daidaitacce da yankin.
A kasar Sin, takardun da matsaloli na matsaloli da matsaloli ya rage daga 17.3% (na mutane da matsaloli da matsaloli na 1-10 Janairu 2020) zuwa 0.7% (na mutane da matsaloli da matsaloli da matsaloli da matsaloli bayan 1 Fabrairu 2020).Ba da matsaloli sun hada da matsaloli na matsaloli na matsaloli (CFR), wanda ya nuna matsaloli na matsaloli na matsaloli da matsaloli na matsaloli, da matsaloli na matsaloli na matsaloli (IFR), wanda ya nuna matsaloli na matsaloli na matsaloli (diagnosed da kuma dace) da matsaloli na matsaloli.
Wadannan takardun shaida ba za a yi amfani da lokaci da kuma suka wuce da yawanci daga jima'i zuwa kwarewa.
Manyan ilimi da suka gabatar da wannan yawan ga yawanci.
The University of Oxford Center for Evidence-Based Medicine ya ƙara cewa matsaloli na jima'i na jima'i don pandemic a cikakken shi ne tsakanin 0.1% da 0.39%.
Ƙararrawa na ƙararrawa na wannan ƙararrawa ne daidai da sakamakon na farko na tsari gwaje-gwaje ga COVID-19 a Jamus, da kuma wani binciken takardar shaida da inganta na gwaje-gwaje a kan CFR shaida.
WHO ya ce cewa pandemic za a iya sarrafa.
Ƙararrawa da ƙararrawa na ƙararrawa ne mai ban sha'awa da kuma za a iya daban-daban da yanki.
" Maciej Boni na Penn State University ya ce, "Left unchecked, jima'i na jima'i na jima'i, kuma sa'an nan za su farawa a lõkacin da magungunan jima'i ba tare da gaskiya. "
"Lalle ne sa'an nan ba za a yi wani daidaici tsari a yanzu game da kada wannan zai zama."
"Zhong Nanshan, mataimakin magani na kasar Sin, ya gabatar da cewa 'yan za a iya fara a watan Yuni' idan duk kasashe za su iya ƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙiri. "
"A 17 Maris, Adam Kucharski na London School of Hygiene & Tropical Medicine ya ce cewa SARS-CoV-2 "ya zama ajiya, iya zama a shekara ko biyu."
"Dangane da bincike na Imperial College da aka tafi da Neil Ferguson, jinkirin jinkirin jinkirin jinkirin jinkirin jinkirin jinkirin jinkirin jinkirin jinkirin jinkirin jinkiren jinkirin jinkirin jinkirin jinkirin jinkirin jinkirin jinkirin jinkirin jinkirin jinkirin jinkirin jinkiren jinkirin jinkirin jinkirin jinkirin jinkirin jinkirin jinkirin jinkirin jinkirin jinkirin jinkirin jinkirin jinkirin jinkirin jinkirin jinkirin jinkirin jinkirin jinkirin jinkirin jinkirin jinkirin jinkirin jinkirin jinkirin jinkirin jinkirin jinkirin jinkirin jinkirin jinkirin jinkirin jinkirin jinkirin jinkirin jinkirin jinkir jinkir jinkir jinkir jinkir jinkirjjjjjjjjjjjjjjjjjjjjjjjjjjjjjjjjjjjjjjjjjjjjjjjjjjjjjjjjjjjjjjjjjjjjjjjjjjjjjjjjjjjjjjjjjjjjjjjjjjjjjjjjjjjjjjjjjjjjjjjjjjjjjjjjjjjjjjjjjjjjjjjjjjjjjjjjjjjjjjjjjjjjjjjjjjjjjjjjjjjjjjjjjjjjjjjjjjjjjjjjjjjjjjjjjjjjjjjjjjjjjjjjjjjjjjjjjjjjjjjjjjjjjjjjjjjjjjjjjjjjjjjjjjjjjjjjjjjjj
"William Schaffner na Vanderbilt University ya ce, "Ina san cewa shi ne m cewa wannan coronavirus - saboda shi ne mai sauƙi mai amfani da - za tafi cikakken" da kuma shi "ba za a yi a cikin magani, yin wani comeback kowane shekara". "
The virulence na comeback za a rike da karkashin immunity da kuma mataki na mutation.
Symptoms na COVID-19 za a iya dace-specific kuma mutane da aka jima'i za a iya zama asymptomatic.
The biyu mafi girma symptoms ne fever (88%) da tsanani (68%).
Ranar kwarewa sun hada da matsa lantarki, ƙirƙirar matsa lantarki (phlegm), matsa lantarki, matsa lantarki, muscle da matsa lantarki, matsa lantarki, matsa lantarki, matsa lantarki, matsa lantarki, hemoptysis, diarrhea, ko cyanosis.The WHO ya ce cewa game da daya daga cikin hudu ya zama matsa lantarki da kuma yana da matsa lantarki.
The U.S. Centers for Disease Control da Prevention (CDC) lists gwiwar matsaloli kamar matsaloli matsaloli, daidaitacce matsa lamba matsa lamba ko matsa lamba, daidaitacce matsa lamba, da matsa lamba matsa lamba, da kuma bluish lamba ko lamba; m magani ne mai sauƙi idan wadannan matsa lamba suna samuwa.Yar ƙarin ci gaba na magani za a iya ƙirƙirƙirar matsa lamba, acute respiratory distress syndrome, sepsis, septic shock da ya fi.
Wadannan mutane da aka ƙaddamar da magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magunguna.
Tattalin ciniki na asymptomatic ratio zaune daga wasu zuwa 44%.
Tsarin ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar
Dukkan bayanai game da yadda magungunan magunguna yana da aka kammala.
Yadda za a yi amfani da magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magunguna.
Jirgin bincike da aka samu cewa wani ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar.
Wadannan sun haƙƙoƙi cewa virus za a iya ƙirƙirƙirar ta hanyar hanyoyin hanyoyin hanyoyin hanyoyin hanyoyin hanyoyin hanyoyin hanyoyin hanyoyin hanyoyin hanyoyin hanyoyin hanyoyin hanyoyin hanyoyin hanyoyin hanyoyin hanyoyin hanyoyin hanyoyin hanyoyin hanyoyin hanyoyin hanyoyin hanyoyin hanyoyin hanyoyin hanyoyin hanyoyin hanyoyin hanyoyin hanyoyin hanyoyin hanyoyin hanyoyin hanyoyin hanyoyin hanyoyin hanyoyin hanyoyin hanyoyin hanyoyin hanyoyin hanyoyin hanyoyin hanyoyin hanyoyin hanyoyin hanyoyin hanyoyin hanyoyin hanyoyin hanyoyin hanyoyin hanyoyin hanyoyin hanyoyin hanyoyin hanyoyin hanyoyin hanyoyin hanyoyin hanyoyin hanyoyin hanyoyin hanyoyin hanyoyin.
Tsarin cutar za a iya fara a cikin ƙaunar ko ƙaunar mutane da aka kusa ko zai iya zama a cikin ƙaunar.
wasu magani kamar intubation da kardiopulmonary resuscitation (CPR) za a iya ƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙiri.
Yana zai iya ƙirƙirar a lokacin da mutum ya sauke wani ƙarfi, ciki har da ƙarfi, kuma sa'an nan ya sa da mata, ƙafa, ko ƙafa.
Duk da akwai matsaloli cewa za a iya ƙirƙirar ta hanyar matsaloli, wannan ra'ayoyi ya zama low.
The Government of China ya ƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙira.
Ma'aikata da aka yi amfani da magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magunguna.
Ranar ra'ayi na asymptomatic matakan da aka gabatar da labaru, amma asymptomatic transmission da aka sani da wasu kasashe a lokacin da kontak tracing bincike.
The European Center for Disease Prevention and Control (ECDC) ya ce da cewa ba tare da gaskiya ba tare da abin da ya sa dace da magani, wani mutum ya ƙaddamar da biyu zuwa uku.
Kyakkyawan, virus aka samu da za a iya samun up to uku kwanaki a kan roba (polypropylene) da 304 karfe, a kan wani rana a kan karfe, da kuma up to four hours a kan copper.
Wannan, duk da haka, yana daidaitacce bisa ga umarnin da zafin jiki. Pets da sauran dabbobi da aka yi test positive ga COVID-19.
Duk da haka, duk da haka, duk da haka, duk da haka, duk da haka, duk da haka, duk da haka, duk da haka, duk da haka, duk da haka, duk da haka, duk da haka, duk da haka.
Mafi acute respiratory syndrome coronavirus 2 (SARS-CoV-2) ne mai ban mamaki virus, na farko da aka ƙaddamarwa daga mutane uku tare da pneumonia da aka haɗu da matsaloli na acute respiratory disease a Wuhan.
Dukkan ra'ayoyi na sabon SARS-CoV-2 virus suna a cikin related coronaviruses a cikin jiki.Out of the human body, virus ne fatan da kasuwanci sabis, wanda ya haifar da sha'awa.SARS-CoV-2 yana da sha'awa da asali SARS-CoV.
Yana daidai cewa yana da zoonotic asali.
Genetical bincike ya nuna cewa coronavirus genetically clusters tare da gundumar Betacoronavirus, a subgenus Sarbecovirus (gundumar B) tare da biyu bat-derived sassa.
Yana 96% identical a cikakken genom level da sauran bat coronavirus samfurin (BatCov RaTG13).
A watan Fabrairu 2020, masana'antun masana'antun masana'antun masana'antun masana'antun masana'antun masana'antun masana'antun masana'antun masana'antun masana'antun masana'antun masana'antun masana'antun masana'antun masana'antun masana'antun masana'antun masana'antun masana'antun.
Full-genome hadin gwiwa har yanzu ya samu a cikin fiye da 92% na lantarki kayayyakin da aka saita tsakanin pangolin coronavirus da SARS-CoV-2, wanda shi ne cika don tabbatar da pangolins za su zama masana'antun.
Ƙididdiga ta hanyar viruses za a iya ƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙira.
A bincike da ya gabatar da PCR to CT a Wuhan ya nuna cewa CT ne da yawa mafi m fiye da PCR, ba tare da fiye da kyakkyawan, tare da yawa daga cikin halitta halitta da ke daidaita da sauran pneumonia da magani.
"A kan Maris 2020, American College of Radiology ƙirƙirar cewa "CT ba za a yi amfani da shigarwa don ko a matsayin gwaji na farko don magana COVID-19". "
WHO ya gabatar da wasu RNA gwaje-gwaje protocols ga SARS-CoV-2, tare da na farko ya gabatar da 17 Janairu.
Test yana amfani da real-time reverse transcription polymerase chain reaction (rRT-PCR).
Testing za a iya yi a kan respiratory ko damu samfurori.
Mataki suna samuwa a cikin wasu hours zuwa kwanaki.
Yawancin wannan gwaji an yi a kan nasopharyngeal swab amma wani throat swab za a iya amfani da.A yawan gwaje-gwaje da kamfanoni suna ci gaba serological gwaje-gwaje, wanda ya samu antibodies.
Tare da 6 Afrilu 2020, ba tare da abin da aka yiwuwa da kyau ya yiwuwa don yiwuwa don amfani da yawa.
A Amurka, wani serological gwajin da aka ci gaba da Cellex an karfafa don amfani da tsabar kudi kawai ta certificated labs.
Characteristic imaging sassa a kan radiographs da computerized tomography (CT) na mutane wanda ne symptomatic sun hada da asymmetric peripheral ground glass opacities da absent pleural effusions.
The Italian Radiological Society yana ƙirƙirar kasa da kasa online databases na hotunan imitation ga kwarewa matsala.
Saboda matsa lamba tare da sauran magani, kamar adenovirus, imitation ba tare da PCR confirmation ne na karfi specificity a canza COVID-19.
A manyan bincike a kasar Sin ya hadin gwiwar CT tare da PCR, kuma ya nuna cewa har ila yau da kullum don magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magunguna.
Artificial intelligence-based convolutional neural networks da aka ci gaba don gane imagery sassa na virus tare da biyu X-ray da CT.
Takaddun shaida don ƙirƙirar ƙirƙirar magani sun hada da inganta da kyau kwarewa, haɓaka hanyoyin, kawar da mata, ƙaunar, ko ƙaunar tare da hanyoyin ba tare da hanyoyin ba, da kuma cika ko ajiya a cikin ƙaunar da kuma sa da ƙaunar da aka sauri a cikin kayayyakin rufi.
Ma'aikatar da za a iya dauke da jima'i na jima'i an sha'awa su yi amfani da wani jima'i maski a jama'a.
Manyan kasa da kasa da kasa da kasa da kasa da kasa da kasa da kasa da kasa da kasa da kasa da kasa da kasa da kasa da kasa da kasa da kasa da kasa da kasa da kasa da kasa da kasa da kasa da kasa da kasa da kasa da kasa da kasa da kasa da kasa da kasa da kasa da kasa da kasa da kasa da kasa da kasa da kasa da kasa da kasa da kasa da kasa da kasa da kasa da kasa da kasa da kasa da kasa da kasa da kasa.
Duk da haka, magunguna ya samu mataki na jama'a a cikin manyan ƙasa na duniya.
Wannan yana da cewa magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan.
The amfani da location data daga mobile phones ta gabatarwa don wannan bukatun da haƙƙoƙi privacy matsala, tare da Amnesty International da kuma fiye da 100 sauran shirye-shiryen ya ba da hukunci da haƙĩƙa game da wannan irin zane.
Manyan mobile apps da aka gyara ko dace don amfani da kyauta, kuma a kan April 7, 2020, fiye da ƙoƙwalwar masu sana'a suna aiki a kan privacy-friendly bayani, kamar amfani da Bluetooth to log user's proximity to other mobile phones.
Sa'an nan masu amfani za su samu wani lissafi idan za su zama a tsakiya tare da wani mutum wanda ya yi test positive ga COVID-19.Misconceptions ne tsaye game da yadda za a canza jima'i; misali, rufe nasu da gargling tare da tsari ne ba da kyau.
Ko da wani vaccine COVID-19, duk da yawa masana'antu suna aiki don samar da wani.
Tallace-tallace mai ban sha'awa don ƙirƙirar magani.
CDC yana ƙirƙirar da mutane da suka saukewa tare da sabis da ruwa a cikin kowace 20 seconds, musamman bayan ya zo toaletta ko lokacin da hanyoyin da aka dace; kafin kula; da kuma bayan su haɓaka nasu, cika, ko ajiya.
Wannan shi ne saboda fiye da jiki na mutum, virus ne fatal da sabis na gida, wanda ya shigar da hankali.
CDC fitar da haka amfani da na'ura mai ban sha'awa na asali na asali tare da har zuwa 60% na asali a kan yawan kai a lokacin da sabis da ruwa ba za a iya samuwa.
WHO yana shawarar mutane don ba su zo mata, ƙauna, ko ƙauna tare da ƙaunawa.
Surfaces za a iya ƙirƙirƙirar tare da wani yawan sanyaya (a cikin minti na ƙirƙirar ƙirƙirar don ƙirƙirar karfe), ciki har da 62-71% ethanol, 50-100% isopropanol, 0.1% sodium hypochlorite, 0.5% hydrogen peroxide, da 0.2-75% povidone-jodin.
Ma'auni, kamar benzalkonium chloride da chrohexidine gluconate, suna da karfi.
CDC yana ƙirƙirar da cewa idan wani COVID kasuwa ne sosai ko ƙirƙirar a birni ko daycare, duk yanki kamar ofishin, banki, yanki, yanki na lantarki kamar tablets, touchscreens, keyboards, remote controls, da ATM masana'antu da aka yi amfani da mutane da aka jima'i, za su daidaita.
Health shirye-shiryen da shawarar cewa mutane za su ƙarya da ƙarya da ƙarya tare da ƙaryawa ko ƙaryawa a lokacin coughing ko ajiyawa, da kuma ƙirƙirar wani ƙaryawa sa'an nan.
Ƙararrawa masks ne mai ban sha'awa ga waɗanda za su iya rage, kamar yadda haɓaka maski za a iya kammala ƙarfi da tafiya tsawon da zafin jiki da aka saukar a lõkacin da suka tallace-tallace, ajiya, da ajiya.
WHO ya ba da amsawa game da lokacin da kuma yadda za a yi amfani da masks.
Stephen Griffin, wani virologist a University of Leeds, ya ce: "Kumawa da maski za a iya rage ƙwayar [da] mutane don haɓaka mata, wanda shi ne mai girma kayan magani tare da ba tare da kyau hanyoyin halitta."
WHO ya ƙirƙirar haɓaka maskara da mutane masu sana'a kawai idan su ne a high risk, kamar da waɗanda suna taimakawa da mutum tare da COVID-19, duk da suka sani cewa ƙirƙirar maskara za su taimakawa mutane da ke ba da sha'awa.
Manyan ƙasashen da aka fara su taimakawa yin amfani da hanyoyin jima'i na masu zaman kansu.
A Amurka, CDC yana ƙirƙirar ƙirƙirar haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin.
Hong Kong yana ba da bukatun ƙirƙirar maski a lokacin da tafiya ta jama'a ko daidaita a cikin wurare.
Tsarin Tsarin Tsarin Tsarin Tsarin Tsarin Tsarin Tsarin Tsarin Tsarin Tsarin Tsarin Tsarin Tsarin Tsarin Tsarin Tsarin Tsarin Tsarin Tsarin Tsarin Tsarin Tsarin Tsarin Tsarki
Tsakiya da Slovakia suna ban sha'awa a cikin jama'a ba tare da na'ura mai rufi da kuma ba tare da na'ura.
Yau, 16 Maris, Vietnam ya ba da sha'awa ga kowane mutum a lokacin da ya zo a cikin yanki don taimakawa da shi da sauran.
Austria ya ƙunshi cewa kowane mutum wanda ya zo a cikin masana'antu ya kamata a mayar da maskara.
Isra'ila ya ba da sha'awa ga dukan abokan ciniki don haɓaka maskara a cikin jama'a.
Taipei, wanda ya samar da fiye da miliyan masks a kowace rana tun watan Maris, ya ba da bukatun da abokan ciniki a cikin jiragen kasa da jirgin kasa da jirgin kasa da kasa da jirgin sama don ƙirƙirar masks a kan 1 Afrilu.
Panama ya ƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙiri.
Face masks da aka amfani da yawa a Japan, South Korea, Malaysia, da Singapore.
Social distancing (kowane da aka sani da jiki distancing) ya hada da matsaloli na jima'i da aka tsara don rarraba da jima'i ta hanyar rage tsari tsakanin mutane.
Methods sun hada da karantina; travel kudi; da kuma shigar da koyarwa, wurare, stadiums, cinikayya, ko masana'antu.
Ma'aikata za su iya amfani da hanyoyi na jima'i ta hanyar riga a cikin gida, rage tafiya, rage ƙarfi, yin amfani da haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin.
Manyan gundumar suna yanzu ƙirƙirƙirar ko ƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙiri.
Ƙarin ƙirƙirar ƙirƙirar ƙirƙirar ƙirƙirar ƙirƙirar ƙirƙirar ƙirƙirar ƙirƙirar ƙirƙirar ƙirƙirar ƙirƙirar ƙirƙirar ƙirƙirar ƙirƙirar ƙirƙirar ƙirƙirar ƙirƙirar ƙirƙirar ƙirƙirar ƙirƙirar ƙirƙirar ƙirƙirar ƙirƙirar ƙirƙirar ƙirƙirar ƙirƙirar ƙirƙirar ƙirƙirar ƙirƙirar ƙirƙirar ƙirƙirar ƙirƙirar ƙirƙirar ƙirƙirar ƙirƙirar ƙirƙirar ƙirƙirar ƙirƙirar ƙirƙirar ƙirƙirar ƙirƙirar ƙirƙirar ƙirƙirar ƙirƙirar ƙirƙirar ƙirƙirar ƙirƙirƙirar ƙirƙirƙirar.
"A 22 Maris 2020, Jamus ya ban sha'awar da mutane fiye da biyu.Yar da mutane da mutane tare da matsalolin matsaloli kamar diabetes, matsaloli, matsaloli, matsaloli, matsaloli, da kuma matsaloli tsarin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin.
"The amfani da asali "social distancing" ya ƙirƙirar matsaloli cewa mutane za su yi aiki a cikakken masana'antun jima'i, fiye da ƙirƙirƙirar su zama a ci gaba da hanyoyi da sauran ta hanyar hanyoyin yanayi.
Wadannan sun hada da hanyoyi don kawai samun jima'i tare da wani mutum da ka samu, wanda ba da virus ko magana na virus.
Self-isolating a cikin gida da aka ba da shawarar ga waɗannan da aka magana da COVID-19 da waɗannan waɗanda suka rufe su da jima'i.
Ƙungiyoyi na Ƙungiyar Ƙungiyar Ƙungiyar Ƙungiyar Ƙungiyar Ƙungiyar Ƙungiyar Ƙungiyar Ƙungiyar Ƙungiyar Ƙungiyar Ƙungiyar Ƙungiyar Ƙungiyar Ƙungiyar Ƙungiyar Ƙungiyar Ƙungiyar Ƙungiyar Ƙungiyar Ƙungiyar Ƙungiyar Ƙungiyar Ƙungiyar Ƙungiyar Ƙungiyar Ƙungiyar Ƙungiyar Ƙungiyar Ƙungiyar Ƙungiyar Ƙungiyar Ƙungiyar Ƙungiyar Ƙungiyar Ƙungiyar Ƙungiyar Ƙungiyar Ƙungiyar Ƙungiyar Ƙungiyar Ƙungiyar Ƙungiyar Ƙungiyar Ƙungiyar Ƙungiyar Ƙungiyar Ƙungiyar
Ma'aikatar kwarantena da aka ba da ƙarfi ga waɗanda suke a high-risk groups.
Ma'aikatar da za a iya daidaita da mutum tare da COVID-19 da kuma waɗanda suka daidaita a cikin kasashen ko yankin tare da ƙirƙirar ƙirƙirar ƙirƙirar da aka amsa a cikin 14 kwanaki daga lokaci na karshe m ƙirƙirar.
Takaddun shaida a cikin ƙirƙirar tsuntsaye na tsuntsaye na tsuntsaye na tsuntsaye na tsuntsaye na tsuntsaye na tsuntsaye.
Ƙararrawa da aka yi a cikin mataki na mataki da aka tsara don rarraba da ƙirƙirar mutane da aka rarraba, da kuma kafa sauran ƙirƙirar ƙirƙirar ƙirƙirar ƙirƙirar da ƙirƙirar ƙirƙirar don ƙirƙirar ƙirƙirar ƙirƙirar ƙirƙirar ƙirƙirar.
Kuma a lokacin da ba za a iya haɓaka ƙaddamar da ƙaddamar da ƙaddamar da ƙaddamar da ƙaddamar da ƙaddamar da ƙaddamar da ƙaddamar da ƙaddamar da ƙaddamar da ƙaddamar da ƙaddamar da ƙaddamar da ƙaddamar da ƙaddamar.
Ƙararrawa da ƙararrawa da ƙararrawa da ƙararrawa da ƙararrawa da ƙararrawa za a iya dace a cikin wannan lokaci.
Ƙungiyoyin ƙungiyoyin ƙungiyar ƙungiyar ƙungiyar ƙungiyar ƙungiyar ƙungiyar ƙungiyar ƙungiyar ƙungiyar ƙungiyar ƙungiyar ƙungiyar ƙungiyar ƙungiyar ƙungiyar ƙungiyar ƙungiyar ƙungiyar ƙungiyar ƙungiyar ƙungiyar ƙungiyar ƙungiyar ƙungiyar ƙungiyar ƙungiyar ƙungiyar ƙungiyar ƙungiyar ƙungiyar ƙungiyar ƙungiyar ƙungiyar ƙungiyar ƙungiyar ƙungiyar ƙungiyar ƙungiyar ƙungiyar ƙungiyar ƙungiyar ƙungiyar ƙungiyar ƙungiyar ƙungiyar ƙungiyar ƙungiyar ƙungiyar ƙungiyar ƙungiyar ƙungiyar ƙungiyar ƙungiyar ƙungiyar ƙungiyar ƙungiyar ƙungiyar ƙungiyar ƙungiyar ƙungiyar ƙungiyar ƙungiyar ƙungiyar ƙungiyar ƙungiyar ƙungiyar ƙungiyar ƙungiyar ƙungiyar ƙungiyar ƙungiyar ƙungiyar ƙungiyar ƙungiyar ƙungiyar ƙungiyar ƙungiyar ƙungiyar ƙungiyar.
Wannan ya rage shigo na sabis da aka ƙaddamar da lokaci ga magungunan magungunan da matsaloli.
Non-pharmaceutical ƙirƙirƙirar da za a iya ƙirƙirƙirar ƙirƙirar ƙirƙirar ƙirƙirar ƙirƙirar ƙirƙirar ƙirƙirar ƙirƙirar ƙirƙirar ƙirƙirar ƙirƙirar ƙirƙirar ƙirƙirar ƙirƙirar ƙirƙirar ƙirƙirar ƙirƙirar ƙirƙirar ƙirƙirar ƙirƙirar ƙirƙirar ƙirƙirar ƙirƙirar ƙirƙirar ƙirƙirar ƙirƙirar ƙirƙirar ƙirƙirar ƙirƙirar ƙirƙirar ƙirƙirar ƙirƙirar ƙirƙirar ƙirƙirar ƙirƙirar ƙirƙirar ƙirƙirar ƙirƙirar ƙirƙirar ƙirƙirar ƙirƙirƙirar ƙirƙirar ƙirƙirar ƙirƙirar ƙirƙirƙirar ƙirƙirƙirar ƙirƙirƙirar ƙirƙirar ƙirƙirƙirar ƙirƙirar ƙirƙirƙirƙirar ƙirƙirƙirƙirƙirƙirar ƙirƙirar ƙirƙirƙirar ƙirƙirƙirar ƙirƙirƙirar ƙirƙirƙirƙirƙirar ƙirƙirƙir.
sauran kasashen da aka ƙirƙirƙirar wani daban-daban da ake bukata don ƙirƙirar fitarwa na virus.
South Korea ya kafa masana'antu screening da lokalized kwarantena, da kuma ya ba da alamar game da ƙirƙirar da mutane da aka rage.
Singapore ya ba da taimako na kudi ga waɗanda aka karanta su, kuma ya ƙirƙirar babban kudi ga waɗanda suka ba su yi.
Taiwan ya ƙirƙirƙirar samar da maskara da kuma ya saukar da kayayyakin magani.Simulations ga Birtaniya da Amurka sun nuna cewa mitigation (samar da fitarwa amma ba tare da ba) da suppression (samar da fitarwa ci gaban) yana da matsaloli.
Takaddun shaida na mafi kyau za a iya rage ƙananan matsaloli tare da 2/3, kuma matsaloli ta yarda, amma ba za a yi amfani da hundreds of thousands na matsaloli da kuma matsaloli tsarin suna ƙaddamarwa.
Suppression za a iya dace, amma ya kamata a ci gaba har zuwa lokacin da virus ne tsirar a cikin mutane (ko har zuwa vaccine ya zama samuwa, idan ya zama farko), kamar yadda transmision ba za a sauƙi sauri a lõkacin da hanyoyin da aka rage.
Dubawa a tsawon lokaci don ƙirƙirar pandemic yana ƙirƙirar sosai da tattalin arziki.
Yanzu antiviral magani ba da takardar shaida ga COVID-19, amma ci gaba da ci gaba, ciki har da gwaje-gwaje na samfurori.
Ƙididdigawa da magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magunguna.
Bisa ga matsa lamba, oxygen therapy, intravenous fluids, da kuma halitta taimako za a iya bukatar.
The amfani da steroids za a iya haɓaka matsaloli.
Manyan magungunan da aka gabatarwa don magungunan wasu magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magunguna.
"WHO kuma ya ce cewa wasu "tallace-tallace da gida" za a iya samar da sauƙi na magana da SARS-CoV-19. "
Ƙirƙirar iya aiki da kuma ƙirƙirar tattalin arziki ga bukatun COVID-19 ma'aikata da WHO ta alama a matsayin matsaloli na tsari.
ECDC da Jami'ar Jami'ar Jami'ar Jami'ar Jami'ar da Jami'ar da Jami'ar da Jami'ar da Jami'ar da Jami'ar da Jami'ar da Jami'ar da Jami'ar da Jami'ar da Jami'ar da Jami'ar da Jami'ar da Jami'ar da Jami'ar da Jami'ar da Jami'ar da Jami'ar da Jami'ar da Jami'ar da Jami'ar da Jami'ar da Jami'ar da Jami'ar da Jami'ar da Jami'ar da Jami'ar da Jami'ar da Jami'ar da Jami'ar da Jami'ar da Jami'ar da Jami'ar da Jami'ar da Jami'ar da Jami'ar da Jami'ar da Jami'ar.
Yana da daban-daban sayarwa game da abin da ya fara na farko (tallace ne Patient Zero).
First known case of the novel coronavirus za a iya daidaita zuwa 1 Disamba 2019 a Wuhan, Hubei, China.
A cikin watan, yawan matsala na coronavirus a Hubei aka farawa.
Wadannan sun hada da Huanan Seafood Wholesale Market, wanda kuma tallace-tallace haihuwa, da wani jima'i shi ne cewa virus ya zo daga daya daga wadannan haihuwa; ko, da sauran matsaloli, yana da zoonotic asali.A pneumonia cluster na sanannun ƙaunar da aka kammala a kan 26 Disamba da ya zo Zhang Jixian a Hubei Provincial Hospital, wanda ya gabatar da Wuhan Jianghan CDC a kan 27 Disamba.
"A 30 Disamba, wani gabatarwa na magunguna a Wuhan Central Hospital ya alamar da ma'aikatar da wani "SARS-kayan coronavirus". "
8 na wadannan dalibai, ciki har da Li Wenliang, aka amsa ta polisin don ƙirƙirar gabatarwa, kuma wani, Ai Fen, aka rage ta hanyar ma'aikata don ƙirƙirar alamar.
Wuhan Municipal Health Commission ya saukarwa a kan 31 Disamba da ya gabatar da WHO.
Tsarin matsaloli na ban sha'awa na ban sha'awa a Wuhan da aka ƙirƙirar bincike a karkashin watan Janairu. A cikin matsaloli na matsaloli, yawan matsaloli ya ƙarfafawa game da kowane saba da yarda rana.
A karshe da karshen Janairu 2020, virus ya ƙirƙirar zuwa sauran kasar Sin, da aka taimakawa ta Chinese New Year's Migration da Wuhan da ya zama wani jirgin kasa hub da manyan jirgin kasa gabatarwa.
Yuni 20th, China ya gabatar da fiye da 140 sabon matsala a cikin wani rana, ciki har da biyu a Beijing da daya a Shenzhen.
Kasuwanci takardun shaida yana nuna cewa 6,174 mutane ya ci gaba da magani a kan 20 Janairu 2020.A cikin 26 Maris, Amurka ya ci gaba da China da Italiya tare da mafi girma yawan kwarewa a duniya.A cikin 9 Aprili 2020, fiye da 1,61 miliyan kwarewa da aka kwatanta a duniya; fiye da 97,000 mutane da kuma fiye da 364,000 da aka samu.
game da 200 ƙasashen da ƙasashen da aka ƙaddamar da wani matsala.
Saboda pandemic a Turai, da yawa kasashe a cikin Schengen Area ya haƙƙoƙi harkokin tsari da aka kafa ƙirƙirar ƙarfi.
Kasuwanci sun hada da ƙirƙirar ƙirƙirar ƙirƙirar kamar karantina (yafi da aka sani da ƙirƙirar ƙirƙirar ƙirƙirar ƙirƙirar ƙirƙirar ƙirƙirar ƙirƙirar ƙirƙirar ƙirƙirar ƙirƙirar ƙirƙirar ƙirƙirar ƙirƙirar ƙirƙirar ƙirƙirar ƙirƙirar ƙirƙirar ƙirƙirar ƙirƙirar ƙirƙirar ƙirƙirar ƙirƙirar ƙirƙirar ƙirƙirar ƙirƙirar ƙirƙirar ƙirƙirar ƙirƙirar ƙirƙirar ƙirƙirar ƙirƙirar ƙirƙirar ƙirƙirar ƙirƙirar ƙirƙirar ƙirƙirar ƙirƙirar ƙirƙirar ƙirƙirar ƙirƙirar ƙirƙirƙirar ƙirƙirƙirar ƙirƙirar ƙirƙirƙirar ƙirƙirar ƙirƙirƙirar ƙirƙirƙirar ƙirar ƙirƙirƙirƙirƙirar ƙirƙirƙirƙirar ƙirƙirar ƙirƙirar ƙirƙirƙirƙirar ƙirar ƙirƙirƙirar ƙirƙirƙirƙirar ƙirƙir.
26 Maris, 1.7 biliyan mutane a duniya suna a cikin wani nau'i na shigarwa, wanda ya fara zuwa 2.6 biliyan mutane biyu da suka wuce - kusa da uku na duniya.
First confirmed case of COVID-19 has been traced back to 1 Disamba 2019 a Wuhan; daya unconfirmed report ya ce da farko case ya kasance a 17 Nuwamba.
Dr. Zhang Jixian ya gabatar da ƙungiyoyi na ƙungiyoyi na ƙungiyoyi na ban sha'awa a ranar 26 Disamba, game da abin da likita ya gabatar da Wuhan Jianghan CDC a ranar 27 Disamba.
Ma'aikatar jima'i na samfurori na magani a 27 Disamba 2019 ya nuna matsayi na wani SARS-kayan coronavirus.
Wuhan Municipal Health Commission ya gabatar da hukunci a ranar 31 Disamba.
WHO da aka karanta a cikin wannan rana.
"Kama wadannan bayanin da aka kwatanta, dokokin a Wuhan aka amsa ta polisin don 'yaushe rumori' game da tsari. "
"The National Health Commission na kasar Sin na farko ya ce cewa ba da "clar evidence" na 'man-to-man transmision. "
"A karshen watan Janairu, kasar Sin ya fara wani ƙarfi hadin gwiwa da ya bayyana ta Tsarin Tsarin Tsarin Tsarin Tsarin Tsarin Tsarin Tsarin Tsarin Xi Jinping a matsayin 'ya'yan 'ya'yan 'ya'yan 'ya'yan 'ya'ya'yan virus. "
"A cikin abin da aka bayyana a matsayin "the largest quarantine in human history" , a cordon sanitary da aka gabatar da 23 Janairu ya gabatar da tafiya a cikin da kuma daga Wuhan, wanda aka ƙirƙirƙirar a cikin cikakken 15 birane a Hubei, da ke ƙarƙirar kusa da 57 miliyan mutane. "
Ƙararrawa Ƙararrawa Ƙararrawa Ƙararrawa Ƙararrawa Ƙararrawa
Tsarin Tsarin New Year (Januwari 25) suna cancelled a wasu wurare.
Ma'aikatar da aka gabatar da gine-gine na gida, Huoshenshan Hospital, wanda aka kammala a cikin 10 kwanaki.
Sa'an nan da wani likita aka gina, Leishenshan Hospital, don ƙirƙirar dalibai.
Ƙaddamar da gine-gine magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan.
Yau jami'o'i da kuma dalibai a kowace duniya da aka rufe.
Hong Kong da Macau ƙirƙirar da yawa, musamman a kan dalibai da jami'o'i.
Tare-tallace-tallace aikace-aikace da aka kafa a cikin wasu yankin na kasar Sin.
Tattaunawa da ƙirƙirar tafiya a cikin da kuma daga Hubei.
Ƙararrawa ta jama'a ta jirgin kasa da aka ƙirƙirƙirar, da kuma musayar a cikin kasar Sin aka rufe lokaci.
Ƙungiyoyi na Ƙungiyar Ƙungiyar Ƙungiyar Ƙungiyar Ƙungiyar Ƙungiyar Ƙungiyar Ƙungiyar Ƙungiyar Ƙungiyar Ƙungiyar Ƙungiyar Ƙungiyar Ƙungiyar Ƙungiyar Ƙungiyar Ƙungiyar Ƙungiyar Ƙungiyar Ƙungiyar Ƙungiyar Ƙungiyar Ƙungiyar Ƙungiyar Ƙungiyar Ƙungiyar Ƙungiyar Ƙungiyar Ƙungiyar Ƙungiyar Ƙungiyar Ƙungiyar Ƙungiyar Ƙungiyar Ƙungiyar Ƙungiyar Ƙungiyar Ƙungiyar Ƙungiyar Ƙungiyar Ƙungiyar Ƙungiyar Ƙungiyar Ƙungiyar Ƙungiyar Ƙungiyar Ƙungiyar Ƙungiyar Ƙungiyar Ƙungiyar Ƙungiyar Ƙungiyar Ƙungiyar Ƙungiyar Ƙungiyar Ƙungiyar Ƙungiyar Ƙungiyar Ƙungiyar Ƙungiyar Ƙungiyar Ƙungiyar Ƙungiyar Ƙungiyar Ƙungiyar Ƙungiyar Ƙungiyar Ƙungiyar Ƙungiyar Ƙungiyar Ƙungiyar Ƙungiyar Ƙungiyar Ƙungiyar Ƙungiyar Ƙungiyar Ƙungiyar Ƙungiyar Ƙungiyar
Saboda haka, Beijing ya ƙirƙirar 14 na yau da kullum kwarantena ga dukan kasashen waje abokan ciniki a cikin birnin. A 23 Maris, kasar Sin na kasar Sin kawai wani matsaloli ya ƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙiri.
Maris 24, 2020, Chinese Prime Minister Li Keqiang ya gabatar da cewa ƙirƙirar kashi na kasa da kasa da aka karkashin ƙirƙirƙirar da ƙirƙirar ƙirƙirar da aka ƙirƙirar a kasar Sin.
Samun yau da kullum, kammalawa a Hubei, ba tare da Wuhan, da biyu watanni bayan ƙaddamar da ƙarƙirar da aka ƙirƙirar. The Chinese Ministry of Foreign Affairs ya gabatar da 26 Maris 2020 cewa dubawa don visa ko ƙarƙirar ƙarƙirar shiga za a saukar da 28 Maris, tare da ba tare da wani bayani game da kada wannan hadin gwiwa.
Ma'aikata da suka so a cikin kasar Sin za su bukatar visa a cikin masana'antu na kasar Sin ko Consulates.
China ta ƙirƙirar kasuwanci da masana'antu don ƙirƙirar 30 Maris, kuma ya ba da kudi-kudi shirye-shirye ga masana'antu. The State Council ya ƙirƙirar wani rana na tsarkakewa don fara tare da kasa da uku minti na tsarkakewa a kan 10:00 a watan Afrilu, a kan Qingming Festival, duk da ƙirƙirar ƙirƙirar ƙirƙirar ya ba da sha'awar a kan yanar gizo a kan layi don ƙirƙirar ƙirƙirar COVID-19.
COVID-19 ya gabatar da cewa ya ƙaddamar da South Korea a 20 Janairu 2020 daga China.
Kasuwanci na duniya ya gabatar da karfi ƙarfi a cikin matsaloli da aka gabatar da matsaloli a watan Fabrairu 20, mafi girma a kan wani gundumar a Daegu na wani sabon al'umma da aka sani da Shincheonji Church of Jesus.
Shincheonji mai ban sha'awa da ke ziyarci Daegu daga Wuhan da aka kwatanta cewa shi ne asali na tsarkakewa.
Tare da 22 Fabrairu, daga cikin 9,336 dalibai na gundumar, 1,261 kowace 13% ya gabatar da matsaloli. South Korea ya gabatar da mafi girma matsaloli a 23 Fabrairu 2020.
Yau, 28 watan Fabrairu, fiye da 2,000 matsala da aka kwatanta a Korea, zuwa 3,150 a watan Fabrairu 29.
Dukkan asali na Korea ta Kudu aka karanta bayan gwaje-gwaje ya gabatar da cewa uku ma'aikata suna jiki ga virus.
South Korea ya kafa abin da aka sani da mafi girma da kuma mafi kyau shirye-shirye a duniya don ƙirƙirar jama'a ga virus, da kuma ƙirƙirar dukkan mutane da aka riga da kuma ƙirƙirar da kwarewa ga waɗanda suka riga su.
Ƙididdiga tsarin da aka hada da mahimmanci tsibirin ƙirƙirar ƙirƙirar ƙirƙirar ƙirƙirar ƙirƙirar ƙirƙirar ƙirƙirar ƙirƙirar ƙirƙirar ƙirƙirar ƙirƙirar ƙirƙirar ƙirƙirar ƙirƙirar ƙirƙirar ƙirƙirar ƙirƙirar ƙirƙirar ƙirƙirar ƙirƙirar ƙirƙirar ƙirƙirar ƙirƙirar ƙirƙirar ƙirƙirar ƙirƙirar ƙirƙirar ƙirƙirar ƙirƙirar ƙirƙirar ƙirƙirar ƙirƙirar ƙirƙirar ƙirƙirar ƙirƙirar ƙirƙirar ƙirƙirar ƙirƙirar ƙirƙirar ƙirƙirar ƙirƙirar ƙirƙirar ƙirƙirar ƙirƙirar ƙirƙiri.
South Korea ta shirye-shirye aka sani da shi ne mai kyau a ƙirƙirar tsibirin ba tare da ƙirƙirar birane. The South Korean kamfanoni aka farko polarised a kan shawarar tsibirin Moon Jae-in.
Manyan Koreans ya rubuta ƙirƙirar da ke ba da sha'awar da Moon game da abin da suka ce za su yi amfani da gabatarwa a kan tsarkakewa, ko zauna da yanar gizo.
23 Maris, ya rubuta cewa South Korea yana da ƙarfi a cikin wani rana tsari a cikin hudu makonni.
Yanzu 29 Maris ya sanar da cewa daga 1 Aprili, duk wani sabon abokan cin abokin cin abokin cin abokin cin abokin cin abokin cin abokin cin abokin cin abokin cin abokin cin abokin cin abokin cin.
Tsarin media ya gabatar da 1 Afrilu, South Korea ya samu bukatun taimako don gwaji virus daga 121 daban-daban kasashen.
Iran ya gabatar da matsala na farko na SARS-CoV-2 magani a watan Fabrairu 19 a Qom, inda, a kan Ministry of Health and Medical Education, biyu mutane ya zama ma'aikatan wannan rana.
Ma'aikata na farko da aka gabatar da gabatarwa na gabatarwa sun hada da gabatarwa na kwarewa da sauran al'amurran al'amurran al'amurran al'amurran al'amurran al'amurran al'amurran al'amurran al'amurran al'amurran al'amurran al'amurran al'amurran al'amurran.
Iran ya ƙirƙirar 5 trillion rials don ƙirƙirar virus.
Shafin Hassan Rouhani ya ce a watan Fabrairu 26, 2020 cewa ba da aikace-aikace don karantina yanayi da aka haifar da matsaloli, kuma kawai mutane za su zama karantina.
Plans don ƙirƙirar tafiya tsakanin kasashe da aka gabatar a watan Maris, ba tare da ƙananan tafiya tsakanin kasashe a karkashin Persian New Year Nowruz.
Shia shrines a Qom da aka rufe ga ma'aikata har zuwa 16 Maris 2020.Iran ya zama cibiyoyin tsari na magungunan virus bayan China a watan Fabrairu.
Tare da ƙananan tsare-tsaren tsare-tsaren a Iran, fiye da shekaru kowane kasashen da aka ƙirƙirƙirar matakansa zuwa Iran da 28 watan Fabrairu, wanda ya nuna cewa matakan tsare-tsaren za a iya zama m fiye da 388 matakan da aka gabatar da Iran a wannan lokaci.
Iran ta gabatar da ƙirƙirar ƙirƙirar, tare da 23 daga cikin 290 ma'aikata ya gabatar da cewa ya gabatar da jiki na virus a 3 Maris.
12 Maris, Human Rights Watch ya haƙƙoƙi masana'antu na Iran don haƙƙoƙin haƙƙoƙin haƙoƙin haƙoƙin haƙoƙin haƙoƙin haƙoƙin haƙoƙin haƙoƙin haƙoƙin haƙoƙin haƙoƙin haƙoƙin haƙoƙin haƙoƙin haƙoƙin haƙoƙin haƙoƙin haƙoƙin haƙoƙin haƙoƙin haƙoƙin haƙoƙin haƙoƙin haƙoƙin haƙoƙin haƙoƙin haƙoƙin haƙoƙin.
Ya ce cewa akwai mafi girma ra'ayoyi na magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magunguna.
Ma'aikatar Iran ta 15 Maris ya gabatar da 100 matsala a cikin wani rana, mafi girma a cikin kasar daga lokacin da matsala ya fara.
Har ila yau, 12 masana'antu na Iran da kuma masana'antun gwiwa na Iran suna mafarki daga magani a kan 17 Maris.
Tare da 23 Maris, Iran ya samu 50 sabon mataki a kowace sa'a da wani sabon mataki a kowace minti saboda coronavirus.
Yawancin WHO ya ce, za a iya zama fiye da cinye-fiye da matsala a Iran fiye da abin da aka gabatar da.
Yana da ƙaddamar da cewa ƙirƙirar Amurka da Iran za a iya haifar da kudi na Iran don haɗari da magungunan virus.
The UN High Commissioner for Human Rights ya haƙĩƙa da ƙungiyar kasuwanci da za su rage ga kasashe da aka rarraba da pandemic, ciki har da Iran.
Tsarin tsarkakewa ya gabatar da ƙaddamar da Italiya a 31 Janairu, a lokacin da biyu masana'antu na kasar Sin ya gabatar da tsari ga SARS-CoV-2 a Roma.
Kasuwanci da aka farawa da yawa, wanda ya sa Italiya ta ƙirƙirar dukan jiragen sama zuwa da kuma daga China da ya gabatar da hali na ban sha'awa.
Yanzu 22 Fabrairu, Cibiyar Ministan ya gabatar da wani sabon hukunci don ƙirƙirar magani, ciki har da karantawa fiye da 50,000 mutane daga 11 daban-daban gundumar a Northern Italy.
"Tare Giuseppe Conte ya ce, "A cikin yanayi na tsuntsaye, ajiya da yaushe ba za a samar da. "
"A 4 Maris, Italiya ta tallace-tallace dukan dalibai da jami'o'i a duniya a matsayin Italiya ya zama 100 matsala. "
Duk wani babban sporting events, ciki har da Serie A football matches, za a yi a girmama kafin Afrilu, amma a 9 Maris, duk da sport da aka shigar da cikakken a kowace watan.
Maris 11th, Prime Minister Conte ya ba da hukunci don saukar da dukkan kasuwanci ba tare da masana'antu da ma'aikata.A 6 Maris, Italian College of Anesthesia, Analgesia, Resuscitation da Intensive Care (SIAARTI) ya gabatar da zane-zane na fasaha game da takardun shaida da za a iya amfani da.
19 Maris, Italiya ya ƙara kasar Sin a matsayin duniya tare da mafi girma daga coronavirus-rabi a duniya bayan rabo 3,405 daga pandemic.
22 Maris, ya rubuta cewa Rasha ya gabatar da fiye da jiragen sama tare da kayan aiki magani a Italiya.
Tare da 5 Afrilu, akwai 128,948 kwarewa, 15,887 kwarewa, da 21,815 kwarewa a Italiya, tare da mafi yawan kwarewa a yankin Lombardy.
CNN ya gabatar da cewa ƙungiyar Italiya na manyan manyan yawanci da kuma ba za a iya gwaje-gwaje dukan waɗanda suna da virus har yanzu za su iya taimakawa da high fatality.
Inganta na Birtaniya a kan virus ya fara a matsayin daya daga cikin mafi kyau daga cikin kasashe da aka rarraba, kuma har zuwa 18 Maris 2020, Birtaniya na Birtaniya ba da wani nau'i na jima'i na jima'i ko masana'antun jima'i a kan abokan ciniki.
Saboda haka, gabatarwar gabatarwa da aka ba da hukunci ga matsaloli da matsa lissafi a cikin matsaloli da masu zaman kansu.A 16 Maris, Prime Minister Boris Johnson ya gabatar da shawarar ba tare da dukkan haƙĩƙa tafiya da sosai tsari, ya ce mutane aiki daga cikin gida inda za a yiwuwa da hankali kamar pubs, masana'antu, da sinadaran.
Yau, 20 Maris, kamfanoni ya gabatar da duk haƙƙoƙoƙoƙoƙoƙoƙoƙoƙoƙoƙoƙoƙoƙoƙoƙoƙoƙoƙoƙoƙoƙoƙoƙoƙoƙoƙoƙoƙoƙoƙoƙoƙoƙoƙoƙoƙoƙoƙoƙoƙoƙoƙoƙoƙoƙoƙoƙoƙoƙoƙoƙoƙoƙoƙoƙoƙoƙoƙoƙoƙoƙoƙoƙoƙoƙoƙoƙoƙoƙoƙoƙoƙoƙoƙoƙoƙoƙoƙoƙoƙoƙoƙoƙoƙoƙoƙoƙoƙoƙoƙoƙoƙoƙoƙoƙoƙoƙoƙoƙoƙoƙoƙoƙoƙoƙoƙoƙoƙoƙoƙoƙoƙoƙoƙoƙoƙoƙoƙoƙoƙoƙoƙoƙoƙoƙoƙoƙoƙoƙoƙoƙoƙoƙoƙoƙoƙoƙoƙoƙoƙoƙoƙoƙoƙoƙoƙoƙoƙoƙoƙoƙoƙoƙoƙoƙoƙoƙoƙoƙoƙoƙoƙoƙoƙoƙoƙoƙoƙoƙoƙoƙoƙoƙoƙoƙoƙoƙoƙoƙo.
Wasu da hanyoyin da suka wuce, wadannan kudi da aka ƙirƙirƙirar ta polisin ta hanyar ƙirƙirar kudi da kuma ƙirƙirar gundumar.
"Majin kasuwanni da aka amsa don shigar, tare da ƙarshe ga kasuwanni da aka sayar da 'essential', ciki har da masana'antu, magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magunguna. "
Yau, 20 Janairu, na farko da aka gabatar da matsala na COVID-19 a Pacific Northwest State of Washington a cikin mutum wanda ya zo daga Wuhan a 15 Janairu.
White House Coronavirus Task Force aka kafa a kan 29 Janairu.
Yuni 31th, Trump ta gabatarwa ya gabatar da matsaloli na al'ada, da kuma ya ƙirƙirar ƙirƙirar zuwa tafiya daga kasar Sin.
A 28 Janairu 2020, Center for Disease Control - da mafi girma jama'a jima'i cibiyoyin na Amurka - ya gabatar da su ya ci gaba da hanyoyin gwaje-gwaje.
Duk da haka, Amurka yana da matsala a cikin gwaje-gwaje, wanda ya ƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙiri.
Tsarin gwaje-gwaje aka ƙaddamar da matsaloli na gwaje-gwaje da aka samar da gabatarwa a watan Fabrairu, matsaloli na gwaje-gwaje na gabatarwa don gabatarwar gwaje-gwaje (da ilimi, kamfanoni da magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magunguna.
By 27 Fabrairu, The Washington Post ya gabatar da fiye da 4,000 gwaje-gwaje da aka yi a Amurka.
By 13 Maris, The Atlantic ya sanar da fiye da 14,000 gwaje-gwaje da aka yi.
"A cikin 22 Maris, Associated Press ya gabatar da: "Ba da yawa mutane da yana da matsaloli da magunguna da magungunan magungunan da suka wuce sa'o'i ko kwanakin ga gwaje-gwaje.""Dai da farko na matsaloli a Amurka aka kwatanta a Washington na 29 Fabrairu, Guverner Jay Inslee ya gabatar da matsaloli, wani aiki da aka karshe da sauran bangarori. "
Schools a Seattle yanki ya cancelled dalibai a 3 Maris, da kuma a karkashin Maris, dalibai a ko'ina cikin duniya da aka shigar.A 6 Maris 2020, Amurka aka shawarar da tsari ga matakan da sabon coronavirus a cikin kasar da wani jiki na Epidemiologists a Imperial College London.
Samun wannan rana, Ubangiji Trump ya ƙirƙirar Aikace-aikace da Aikace-aikace na Coronavirus, wanda ya samar da $ 8.3 biliyan a cikin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗi.
Kasuwanci ya ƙirƙirar jiragen kasa tafiya, cancelled conferences, da kuma taimakawa ma'aikata don aiki daga gida.
Maris 11th, Trump ya gabatar da ƙarƙirar tafiya ga manyan Turai, ba tare da Birtaniya, a cikin 30 kwanaki, a karkashin Maris 13.
Bayan rana, ya ƙirƙirar ƙirƙirar ƙirƙirar da ƙirƙirar Birtaniya da Ireland.
13 Maris, ya gabatar da kasa da kasa da kasa da kasa da kasa da kasa da kasa da kasa da kasa da kasa da kasa da kasa da kasa da kasa da kasa da kasa da kasa da kasa da kasa da kasa da kasa da kasa da kasa da kasa da kasa.
Tare da 15 Maris, da yawa kasuwanni da aka shigar ko shigar kowace hours a cikin Amurka don daidaituwa don taimakawa da fitarwa na virus.
Tare da 17 Maris, jima'i na jima'i ya gabatar da a cikin duk 50 bangarori da kuma a District of Columbia. A 23 Maris, ya gabatar da cewa New York City yana da 10,700 mataki na coronavirus, fiye da yawan jima'i a South Korea.
A 25 Maris, guverner ya ce cewa jima'i na jima'i yana yi aiki, kamar yadda takardun jima'i na jima'i na jima'i ya rage daga 2.0 kwanaki zuwa 4.7 kwanaki.
Kamar yadda 28 Maris, akwai 32,308 kwarewa a New York City, kuma 672 mutane da aka fãce daga virus.A 26 Maris, Amurka da aka sanar da cewa yana da mafi kwarewa kwarewa da coronavirus matsala fiye da wani sauran kasa a duniya, ciki har da China da Italiya.A cikin 8 Afrilu, 400,335 kwarewa da aka gabatar da a Amurka, da 12,841 mutane da aka fatan.
Tare da sayarwa na masana'antu a kan 30 Maris, U.S. President Trump ya gabatar da ƙirƙirar jima'i na jima'i zuwa 30 Aprili.
Saboda wannan rana, USNS Comfort, wani magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan.
3 Afrilu, Amurka ya zama 884 matsala daga coronavirus a cikin lokaci na 24 hours.
A New York, matakan da aka ƙara 100,000 mutane a watan Aprili 3.The White House da aka rarraba domin ya rarraba ra'ayoyi da kuma ya ƙirƙirar sabis ta hanyar ƙirƙirar masana'antu da masana'antun kimiyya don ƙirƙirar jama'a al'amuran da al'amurran da aka kwatanta da virus tare da gabatarwa na Vice-President Mike Pence.
Ƙungiyoyi na Trump ta management na krizin da aka ƙaddamar da ƙungiyoyi a karkashin yanki.
Dukkan masu kwarewa da masu kwarewa na Amurka sun haƙƙoƙi cewa Amurka yana da jiki a cikin kayayyakin da muhimmanci kayayyakin, ciki har da kayayyakin magani, daga China.
An analysis na jirgin kasa tafiya patterns aka amfani da maps da kuma fassara patterns na spread da aka buga a cikin The Journal of Travel Medicine a gundumar Janairu 2020.
Bisa ga 2018 bayanai daga International Air Transport Association, Bangkok, Hong Kong, Tokyo, da Taipei yana da mafi girma na abokan ciniki daga Wuhan.
Dubai, Sydney, da Melbourne da aka sanar da su ne mai ban sha'awa ga mutane da tafiya daga Wuhan.
Bali aka yiwuwa a cikin 20 mafi kyau cibiyoyin cibiyoyin cibiyoyin a cikin matsakaici, yayin da masana'antu a Australia aka sani da mafi kyau. Australia ya gabatar da Tsarin Tsarin Tsarin Tsarin Tsarin Tsarin Tsarin Tsarin Tsarin Tsarin Tsarin Tsarin Tsarin Tsarin Tsarin Tsarin Tsarin Tsarin Tsarin Tsarin Tsarin Tsarin Tsarin Tsarin Tsarin Tsarin Tsarin Tsarin Tsarin Tsarin Tsarin Tsarin Tsarin Tsarin Tsarin Tsarin Tsarin Tsarin Tsarin Tsarin Tsarin Tsarin Tsarin Tsarin Tsarin Tsarin Tsarin Tsarin Tsarin Tsarin Tsarin Tsarin Tsarin Tsarin Tsarin Tsarin Tsarin Tsarin Tsarin Tsarin Tsarin Tsarin Tsarin Tsarin Tsarin Tsarin Tsarin Tsarin Tsarin Tsarin Tsarin Tsarin Tsarin Tsarin Tsarin Tsarin Tsarin Tsarin Tsarin Tsarin Tsarin Tsarin Tsarin Tsarin Tsarin Tsarin Tsarin Tsarin Tsarin Tsarin Tsarin Tsarin Tsarin Tsarin Tsarin Tsarin Tsarin.
Yana ya ce cewa yawa ba za a kammala game da COVID-19, da kuma cewa Australia za su karɓar ƙarfi da lantarki a cikin tsari da pandemic.
21 Maris, a cikin Australia an sayar da tsare-tsaren biosafety.
Saboda da ingancin karantina na jama'a ta jirgin kasa a Wuhan da Hubei, wasu kasashe da aka shirya don ƙirƙirƙirar abokan ciniki da kamfanoni daga yanki, musamman ta hanyar shiryawa jirgin kasa na gida, tare da kamfanoni na kasar Sin samar da kyauta.
Canada, Amurka, Japan, Indiya, Sri Lanka, Australia, Faransa, Argentina, Jamus, da kuma Thailand suna daga cikin na farko a shirya evacuation na abokan ciniki.
Pakistan ya ce cewa ba za a gyara abokan ciniki daga kasar Sin.
7 Fabrairu, Brazil ya ƙirƙirar 34 Brazilians ko ma'aikata, fiye da four Poles, wani Chinese, da wani Indians.
Tsarin Poland, China, da kuma Indiya zaunawa a Poland, inda jirgin kasa na Brazil ya yi ajiya kafin ta tafiya zuwa Brazil.
Brazilians da suka zo a Wuhan aka karantawa a cikin karatun karatun kusa da Brasília.
Saboda wannan rana, 215 Canadians (176 daga na farko jirgin da kuma 39 daga na biyu jirgin da aka rufe ta Amurka) aka rufe daga Wuhan zuwa CFB Trenton don karantawa a cikin makonni biyu.
11 Fabrairu, wani jirgin sama da 185 Canadians daga Wuhan ya shiga a CFB Trenton.
Australian magungunan da aka haifar da 277 mutane a 3 da 4 Fabrairu zuwa Christmas Island Detention Center, wanda aka yi amfani da a matsayin kwarantena cibiyoyin, inda suka zama a cikin 14 kwanaki.
A New Zealand evacuation flight ya zo a Auckland a watan Fabrairu 5, da abokan ciniki (da wasu daga Australia da Pacific) aka karantawa a wani na'urorin jiragen ruwa a Whangaparoa, a karkashin Auckland.
15 Fabrairu, Amurka ya gabatar da cewa za su ƙirƙirar Americans a karkashin jirgin kasa Diamond Princess.
21 Fabrairu, wani jirgin sama tare da 129 Canadian abokan ciniki da aka tsammani daga Diamond Princess ya shiga a Trenton, Ontario.
Maris 14, a cikin jirgin South African Airways jirgin da aka rarraba ta South African Government ya ƙirƙirar 112 Jami'ar Jami'ar Africani.
Medical screening da aka aiki kafin farawa, kuma four South Africans wanda ya nuna samfurori na coronavirus da aka ba a kansa don rage jiki.
kawai South Africans wanda ya gabatar da matsaloli mai matsaloli ya saƙoƙi.
Tsarin gwaje-gwaje, duk South Africans, ciki har da jirgin saman jirgin sama, pilots, hotel ma'aikata, police da askarwa da aka jera a cikin jima'i na jima'i, wanda, a matsayin ƙarfi, duk haƙƙĩƙa a karantawa da karantawa a cikin lokaci na 14 kwanaki a The Ranch Resort.
20 Maris, Amurka ya fara tsare-tsarensa daga Iraq saboda pandemic.
5 Fabrairu, masana'antu na kasar Sin ya ce cewa 21 ƙasashen (ciki hada da Belarus, Pakistan, Trinidad da Tobago, Misira, da Iran) ya gabatar da taimako a kasar Sin.
Manyan Chinese dalibai a cikin jami'o'i na Amurka ya gabatar da su taimakawa don taimakawa don taimakawa a cikin sassa-sassa na kasar Sin, tare da shirye-shirye a cikin yankin Chicago mafi girma ya sanar da za a iya taimakawa 50,000 N95 masks zuwa magungunan magungunan a Hubei provincia a kan 30 Janairu.
"A 5 Fabrairu, Bill da Melinda Gates ya gabatar da $ 100 miliyan don WHO don karfafawa bincike da magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magunguna."
Interaksyon ya gabatar da cewa kasar Sin ya gabatar da 200,000 masks zuwa Philippines a watan Fabrairu 6, bayan Senator Richard Gordon ya gabatar da 3,16 miliyan masks zuwa Wuhan.
19 Fabrairu, Singapore Red Cross ya gabatar da cewa za a saita $ 2.26 miliyan don taimako zuwa China.
Japan ƙirƙirar miliyan maski zuwa Wuhan, Turkey ƙirƙirar kayan aiki, Rasha ƙirƙirar fitarwa fitarwa zuwa Wuhan, Malaysia ƙirƙirar ƙirƙirar fitarwa fitarwa fitarwa fitarwa 18 miliyan zuwa China, Jamus ƙirƙirar fitarwa fitarwa fitarwa ciki har da 10,000 Hazmat shiryawa, da Amurka ƙirƙirar fitarwa fitarwa fitarwa 17,8 miliyan zuwa China da ƙirƙirar ƙirƙirar kudi na $ 100 miliyan don haɗari zuwa kasashe.
Maris, China, Cuba da Rasha za su gabatar da kayayyakin magani da masana'antu don taimakawa Italiya tare da matsaloli na coronavirus.
Businessman Jack Ma ya gabatar da 1.1 miliyan gwaje-gwaje kit, 6 miliyan maskiya, da kuma 60,000 haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin.
Bayan haka, ya gabatar da 5,000 gwaje-gwaje kits, 100,000 na'ura mai rufi da 5 na'ura mai rufi zuwa Panama.
Netherlands, Spain, Turkey, Georgia, da kuma Czech Republic ya gabatar da matsala game da maski da kuma gwaji kits.
Saboda haka, Spain ya sauke 58,000 Chinese-made coronavirus gwaji kits tare da wani daidaitacce na kawai 30%, yayin da Netherlands ya sauke 600,000 Chinese face masks wanda aka gabatarwa.
Birtaniya ya sauke 100,000 masks ba da amfani, da aka kwatanta cewa su ne daga kasar Sin, amma suka yi daga Colombia.
Duk da haka, taimako na kasar Sin yana da kyau a cikin sassa na Latin America da kuma Afrika.A 2 Aprili, World Bank ya fara ayyuka don taimakawa da mahimmanci ga kasashe masu ci gaba.
WHO ya gabatar da kyakkyawan kasar Sin don ƙirƙirar da kuma ƙirƙirar jiki na jiki.
"WHO ya nuna da tsari tsakanin tsari SARS na 2002-2004, a cikin abin da masana'antu na kasar Sin aka shawarar da ra'ayoyi da ke haifar da ƙirƙirar ƙirƙirar da ƙirƙirar ƙirƙirar, da tsari na yanzu a cikin abin da kasa da kasa "suna samar da ƙarƙirar ƙirƙirar don ƙirƙirar ban mamaki a kan Lunar New Year kudi". "
Gauden Galea na WHO ya ce a 23 Janairu, a gyara da takaddun sha'awar cibiyar sadarwa a Wuhan, cewa ba tare da cewa shi shi ne "daidai ba a kan sha'awar da WHO ya gabatar da", shi ne kuma "mafi muhimmanci alama na ƙirƙirar ƙirƙirar jiki a cikin wuri da shi ne mafi ƙididdiga" da ya kira shi "daidai a cikin hadin gwiwar jama'a."A 30 Janairu, bayan ƙirƙirar ƙirƙirar jiki daga mutum zuwa mutum fiye da yawan matakan a wasu kasashe, WHO ya gabatar da ƙirƙirar jiki na jiki na jiki na duniya (PHEIC), na sassa PHEIC daga lokacin da ƙirƙirƙirar jiki ya kafa a cikin 2009 swine flu. "
Tedros Adhanom, Jami'ar WHO, ya ce cewa PHEIC ne saboda "risk na duniya, musamman ga kasashe na low da mid-income da ba tare da matsakaici health systems."
Saboda ƙirƙirar tafiya, Tedros ya gabatar da cewa "da gaskiya ba za a iya haƙĩƙa da hanyoyin da ke ba za a haƙĩƙa haƙĩƙa da tafiya da kasuwanci" da kuma cewa "WHO ba shawarar haƙƙĩƙa da kasuwanci da kasuwanci."
"A 5 Fabrairu, WHO ya ba da sha'awar da jama'a na duniya don $ 675 miliyan don taimakawa da shirye-shirye na zane-zane a cikin masana'antu na low-daidaitacce, tsari da mahimmanci don taimakawa waɗanda "ma'aikata ba da shirye-shirye don ƙirƙirar mutane da aka ƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙiri."
Tedros ya ƙaddamar da ƙaddamar da cewa "Mai mu ne kawai m kamar yadda mu ƙaunar ƙaunar ƙaunar" da kuma haƙĩƙa da jama'a da kasa da kasa da kasa don "tallace a yau ko bayar da mafi sauƙi".A 11 watan Fabrairu, WHO a cikin takaddun shaida ya kafa COVID-19 a matsayin sunan na jiki. "
"A cikin wannan rana, Tedros ya ce cewa Jami'ar Jami'ar Jami'ar António Guterres ya gabatar da don samar da "makin duniya Jami'ar Jami'ar a yanayin."
" A UN Crisis Management Team aka ƙirƙirƙirar a karkashin haka, samar da shirye-shirye na Jami'ar da cikakken yanayin, wanda WHO ya ba za a iya 'yaushe a kan jiki yanayin, yayin da sauran shirye-shiryen za su iya ƙirƙirƙirar da kwarewa don ƙirƙirar sosai, tattalin arzikin da ci gaba da matsaloli."
"A 14 Fabrairu, wani Jami'ar Jami'ar Jami'ar tare da China da WHO ya kafa don samar da kasashen waje da WHO masana'antu a kasar Sin don taimakawa a cikin gida da inganta "daidaitaccen da ƙaddamar da jiki" ta hanyar shirye-shiryen aiki da kwarewa tare da mahimmanci na kasa da kasa da kuma shirye-shiryen yanayin yanar gizo don inganta "ya'idaitaccen yanar gizo a gundumar da gundumar, ciki har da ma'aikata da ma'aikata."A 25 Fabrairu, WHO ya gabatar da cewa "daban da duniya ya yi da mafi kyau don shirye-shirye ga wani m coronavirus pandemic," ya ce cewa yayin da yana da karshe don kira shi wani pandemic, masana'antu za su ne "a cikin mataki na jiki". "
Saboda 28 Fabrairu, masana'antun masana'antun masana'antun coronavirus a duniya za a rage daga "high" zuwa "very high", da mafi girma matakan alamar da matakan matakan. "
“Mike Ryan, Executive Director na WHO ta Health Emergency Program, ya haƙƙoƙi a cikin alamar da cewa “This is a reality check for every government on the planet: Wake up.”
"A wannan magani zai iya zama a gare shi, kuma za ka kamata ka so", "suna cewa hakkin yanayin da za a iya taimakawa da duniya don taimakawa da "wuri mafi girma." "
Ryan ya gabatar da cewa takardun shaida ba za a ba da hakikanci na jama'a tsarkakewa don sayi wani duniya pandemic, kuma ya ce cewa wani takardun shaida za su karanta: "Mai a cikin mahimmanci, mu yi karanta da cewa kowane mutum a duniya za a karanta da wannan virus."
11 Maris, WHO ya gabatar da matsaloli na coronavirus a pandemic.
"The Director-General ya ce da cewa WHO ne "mai ban sha'awa da ƙarfi da ƙarfi da ƙarfi da ƙarfi da ƙarfi da ƙarfi na ƙarfi" ".The WHO da aka kwatanta da matsala ga abin da aka sani a matsayin ƙarshe tsari na pandemic, ciki har da ƙaddamar da dabbobi na jima'i na jima'i da jima'i a matsayin pandemic. "
Tare da ƙirƙirar WHO na General Director Tedros Adhanom don ƙirƙirar ƙirƙirar, wanda 733,000 mutane ya rubuta a ranar 6 Aprili.
A 26 Maris 2020, da yawa masu sana'a na UN na lantarki ya rage matsaloli da hakkin kowane mutum a lokacin COVID-19 pandemic.
Jami'ar gabatarwa ya ce cewa kowane mutum yana da hakkoki ga matsaloli mai sauƙi da kuma kasar yana da wannan wajibi.
The group ya ƙunshi cewa matsaloli na kayayyakin ko magungunan jiki ba za a yi amfani da wani hakikanci ga matsaloli ga wani takardun jiki.
Ma'aikata sun nuna cewa kowane mutum yana da hakkoki ga matsaloli, ciki har da mutane tare da matsaloli, masu mahimmanci, mutane mai girma, mutane da aka ƙunshi a cikin gida, masu ban mamaki, mutane da suka zo a cikin matsaloli, mutane a cikin kudade, da kuma ra'ayoyi da sauran mahimmanci da ake bukata da kudade.
Kasuwancin kasa da kasa da kasa da kasa da kasa suna magana da kasuwa na kasa da kasa da kasa da kasa da kasa da kasa da kasa na COVID-19.
The Organization for Economic Co-operation and Development ya kafa wani yanar gizo don samar da lokaci da cikakken bayanai game da takaddun shaida a cikin kasashe a duniya, kazalika da mataimakin da sabis.
Tare da ilimi don ƙirƙirar ilimi tsarin da kuma duniya tattalin arziki don ƙirƙirar da matsaloli na tafiya, cibiyar dijital ya hada da Country Policy Tracker, da kuma ya zo don taimakawa masana'antun da ke taimakawa da wani tsari na duniya ga matsaloli na coronavirus.
Tsarin kasar Sin ya dace da Amurka, Birtaniya Ministan for Cabinet Office Michael Gove, da Brazil president Jair Bolsonaro's son Eduardo Bolsonaro domin ta aiki da pandemic, wanda ya fara a kasar Sin na Hubei.
Manyan gabatarwa na tsakiya na Tsakiya na Tsakiya (CPC) aka rabo a kan ƙirƙirar tsakiya na tsakiya a Tsakiya ta Central, wani al'amala na tsammani da matsaloli na fasaha na tsakiya a kan tsakiya a waɗanda yankin.
wasu commentators san cewa wannan matsaloli da aka tsara don haɓaka Xi Jinping, Jami'ar Jami'ar Tsarin Tsarin Tsarin Tsarin Tsarin Tsarin Tsarin Tsarin Tsarin Tsarin Tsarin Tsarin Tsarin Coronavirus.
Wadannan masana'antu na kasar Sin, kamar Zhao Lijian, ya ba da shawarar da ƙaddamar da tsari na coronavirus da aka fara a Wuhan, a karkashin hadin gwiwa game da COVID-19 wanda ke tafi daga Amurka ko Italiya.
The U.S. Administration na Donald Trump ya ce da coronavirus a matsayin "Chinese virus" ko "Wuhan virus" ya ce da cewa "Censorship na China ya ƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙira."
The Daily Beast ya samu wani gabatarwar gabatarwa na Amurka wanda ya ƙunshi wani lissafin lissafin lissafin lissafi tare da matsaloli na National Security Council, tare da lissafin da aka tsada a matsayin "All is about China."
"Ayyuka kamar Politico, Foreign Policy, da Bloomberg suna gabatar da cewa sha'awar kasar Sin don ƙirƙirar taimako zuwa masana'antun jima'i na jima'i ne sassa a cikin tsari na al'amurran al'amurran. "
“The EU Foreign Policy Chief Josep Borrell haƙƙoƙi cewa akwai “a geo-political component ciki har da wani ci gaban domin matsa lamba ta hanyar girma da ‘policy of generosity’.”
"Borrell ya ce da cewa "China ne daidaici ƙirƙirar cewa, ba tare da Amurka, shi ne mai kwarewa da kuma daidaitaccen partner.""
China ya haƙƙoƙi da Amurka don haifar da lissafinsa daga Syria, Venezuela da Iran, yayin da ya rufe taimakon taimako zuwa ƙasashen biyu.
Jack Ma ya ƙirƙirar 100,000 masks zuwa Cuba da aka ƙirƙirƙirar da ƙirƙirar Amurka a 3 Afrilu.
Kasuwanci na Amurka da aka ƙaddamar da ƙaddamar da taimakon taimakon taimakon taimakon taimakon taimakon taimakon taimakon taimakon taimakon taimakon taimakon taimakon taimakon taimakon taimakon taimakon taimakon taimakon taimakon taimakon taimakon taimako.
Kuma akwai masks-tallace-tallace-tallace tsakanin sauran kasashe, kamar Jamus, Austria da Switzerland; kuma Czech Republic da Italiya.
Bugu da haka, Turkey ya ƙirƙirar da hundreds na'ura mai rufi don Spain.
Ma'aikatar Italiya a karkashin watan Maris ya gabatar da mahimmanci na Turai a kan daidaita da Italiya a cikin coronavirus.
Mauricio Massari, mashawar Italiya a cikin EU, ya ce: "Hali China ya haƙƙoƙi bilateral. "
"Babu, wannan ba ne mai kyau al'umma na Turai."
22 Maris, bayan wani telecall tare da Italiya Prime Minister Giuseppe Conte, Rasha President Vladimir Putin shirya da Rasha na Rasha ta ƙirƙirar magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magunguna.
"La Stampa" ta Italiya ya ce wani anonymous "tallace-tallace kimiyya kayan" cewa 80% na Rasha ta taimako ne "mai ko da yawa amfani ga Italiya".
"The kayan haƙĩƙa Rasha ta fara a cikin wani 'geopolitical da diplomatic' 'fitarwa. "
The President of Lombardy, Attilio Fontana, da Italiya ta Foreign Minister Luigi Di Maio ya ƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙiri.
Russia kuma ya sa da jirgin sama tare da taimako na magani zuwa Amurka.
Dmitry Peskov, kamfanoni na Kremlin, ya ce: "Kada ya ba da taimako ga kamfanoni na Amurka, [Putin] ya ƙunshi cewa a lokacin da masana'antun masana'antu da kayan aiki na Amurka za su iya ƙirƙirƙirƙirƙirƙirƙirƙirƙiri."
"NATO 'Defender 2020' ma'aikata a Jamus, Poland, da Baltic ƙasashe, da mafi girma NATO ma'aikata bayan karshen Cold War, za a yi a ƙarfi. "
Kate Hudson, Jami'ar Jami'ar Jami'ar Jami'ar Jami'ar Jami'ar Jami'ar Jami'ar Jami'ar Jami'ar Jami'ar Jami'ar Jami'ar Jami'ar Jami'ar Jami'ar Jami'ar Jami'ar Jami'ar Jami'ar Jami'ar Jami'ar Jami'ar Jami'ar Jami'ar Jami'ar Jami'ar Jami'ar Jami'ar Jami'ar Jami'ar Jami'ar Jami'ar Jami'ar Jami'ar Jami'ar Jami'ar Jami'ar Jami'ar Jami'ar Jami'ar Jami'ar Jami'ar Jami'ar Jami'ar Jami'ar Jami'ar Jami'ar Jami'ar Jami'ar Jami'ar Jami'ar Jami'ar Jami'ar Jami'ar Jami'ar Jami'ar Jami'ar Jami'ar Jami'ar Jami'ar Jami'ar Jami'ar Jami'ar Jami'ar Jami'ar Jami'ar Jami'ar Jami'ar Jami'ai
Iran ta president Hassan Rouhani ya gabatar da barci zuwa masana'antun duniya da ya ba da taimako a kan 14 Maris 2020, ya ce da ƙasa ya ci gaba da ci gaba da ci gaba da ci gaba da ci gaba da ci gaba da ci gaba da ci gaba da ci gaba da ci gaba da ci gaba da ci gaba da ci gaba da ci gaba da ci gaba da ci gaba.
Political analysts saye cewa shi zai iya haƙƙoƙi ƙananan Donald Trump na re-election a 2020 president elections.Diplomatic hadin gwiwa tsakanin Japan da South Korea ya haƙĩƙa saboda pandemic.
“South Korea ya gabatar da Japan ta “ambigu da kuma pasif karantina na'urorin” bayan Japan ya gabatar da cewa kowane mutum da aka zo daga South Korea zai zama a cikin karantina na biyu kwanan wata a cikin yanki da aka ƙirƙirƙirar. “
South Korean masana'antu na farko aka polarised a kan sha'awar Tsarin Moon Jae-in a kan daidaitacce.
Manyan Koreans da aka ƙirƙirar ƙirƙirar da ke ba da sha'awar da Moon game da abin da suka ce za su yi amfani da gabatarwa a kan tsarkakewa, ko za su ji dadin shi. Pandemic ya sa kasashe don ƙirƙirar ƙarƙirar ƙarƙirar ƙarƙirar.
Wadannan commentators suna albarkatar da cewa zai iya taimakawa gundumar don ƙirƙirƙirar ƙarƙirar ƙasa.
A Hungary, harkokin harkokin da ya ba da lissafi na farko, Viktor Orbán, don ƙirƙirar ta karkashin karkashin karkashin karkashin karkashin karkashin karkashin karkashin karkashin karkashin karkashin karkashin karkashin karkashin karkashin karkashin karkashin karkashin karkashin karkashin karkashin karkashin karkashin karkashin karkashin karkashin karkashin karkashin karkashin karkashin karkashin karkashin karkashin karkashin karkashin karkashin karkashin karkashin karkashin.
Tsarin coronavirus da aka kwatanta a cikin wasu matsaloli na samarwa, wanda ya wuce a duniya ta amfani da kayan aiki don haɓaka matsaloli, ban sha'awa, da kuma ƙirƙirar ayyukan masana'antu da kayan aiki.
The U.S. Food and Drug Administration ya gabatarwa game da matsala na magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magunguna.
Manyan wuraren da aka kwatanta hanyoyin ciniki da aka ƙaddamar da takardun sha'awar da aka kammala kayayyakin kayayyakin kayayyakin kayayyakin kayayyakin kayayyakin kayayyakin kayayyakin kayayyakin kayayyakin kayayyakin kayayyakin kayayyakin kayayyakin kayayyakin kayayyakin kayayyakin.
Tsarin fasaha masana'antun fasaha ya haƙƙoƙi game da ƙarfi na kayayyakin lantarki.
Tedros Adhanom, Jami'ar Jami'ar WHO, ya sanar da cewa daidai da kayan aiki na masu amfani da masu amfani da kayan aiki na ma'aikata ya ci gaba da ƙaunar.
Wannan bukatun haƙƙoƙin haƙƙoƙin haƙoƙin haƙoƙin haƙoƙin haƙoƙin haƙoƙin haƙoƙin haƙoƙin haƙoƙin haƙoƙin haƙoƙin haƙoƙin haƙoƙin haƙoƙin haƙoƙin haƙoƙin haƙoƙin haƙoƙin haƙoƙin haƙoƙin.
Yana da ƙaddamar da matsaloli na halitta a duniya, tare da WHO ya amsa cewa wannan zai haɗari masu sana'a ma'aikata.
A Australia, pandemic ya samar da wani sabon damar ga daigou abokan ciniki don sayar da Australian kayayyakin zuwa China.
Kayan aiki ya samar da matsaloli na baby formula a wasu masana'antu da aka sauƙi ta Australian gundumar.Dangane da yawa matsaloli na COVID-19 a Northern Italiya da Wuhan yankin, da kuma karkashin high tallace-tallace na kayayyakin kayayyakin, biyu yanayi da aka tsammani daga matsaloli matsaloli.
Takaddun shaida na China da Italiya da hanyoyi da kuma lissafi kasuwanci na kayan kayan kayayyakin da aka yi amfani da su da kyautata, kuma ya canza haɗari na kayan kayan kayan kayan kayan da aka rage a Turai da kuma North America.
Northern Italiya tare da muhimmanci masana'antun masana'antun haƙƙoƙin haƙoƙin haƙoƙin haƙoƙin haƙoƙin haƙoƙin haƙoƙin haƙoƙin haƙoƙin haƙoƙin haƙoƙin haƙoƙin haƙoƙin.
Ƙungiyoyi na kayayyakin da aka kammala kawai lokaci na lokaci, ko a birnin Wuhan, yayin da masana'antu na kasar Sin ya ba da kayayyakin gine-gine don tabbatar da yawancin abokan ciniki.
Halitta yana da samfurori a Italiya don ƙirƙirar kayayyakin kayayyakin don ƙirƙirar kayayyakin don wadannan mahimmanci.
Ƙararrawa a duniya da tattalin arziki da aka haifar a kasar Sin: a karkashin media bayan 16 Maris, tattalin arziki a kasar Sin da aka ci gaba da ƙarfi a cikin biyu na farko na 2020 saboda matsaloli da aka gabatar da kudade don rage virus, kuma tallace-tallace kasuwanci ya rage 20.5%.
Kamar yadda kasar Sin yana da babban tattalin arziki da masana'antun masana'antun masana'antun masana'antun masana'antun masana'antun masana'antun masana'antun masana'antun masana'antun masana'antun masana'antun masana'antun masana'antun.
Agathe Demarais na Economist Intelligence Unit ya ce da cewa kasuwar za su zama mai zafi har zuwa lokacin da wani m bayanan game da mahimmanci.
A watan Janairu 2020, wasu masana'antun shaida cewa kasuwanci tsari na epidemic a kan ci gaba na duniya za a iya ƙara da tsari na 2002-2004 SARS.
Yawancin wani masu kwarewa na Washington University a St. Louis ya gabatar da $ 300+ biliyan a kan duniya supply chain wanda za a iya zama har zuwa shekaru biyu.
"Organization of the Petroleum Exporting Countries (OPEC) ya ce ya "scrambled" bayan ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar. "
Sabuwar kasuwanni na duniya ya ƙara a watan Fabrairu 24, saboda yawan COVID-19 matakan da aka ƙara a waje daga kasar Sin.
Yau 27 Fabrairu, saboda rage rage game da sarrafa coronavirus, daban-daban U.S. stock indexes ciki har da NASDAQ-100, S&P 500 Index, da Dow Jones Industrial Average ya gabatar da ƙarfi daga 2008, tare da Dow ya rage 1,191 mataki, mafi girma a cikin wani rana bayan kudi na 2007-08.
All three indexes da aka fara a cikin makonni da fiye da 10%.
Yau 28 Fabrairu, Scope Ratings GmbH ya ƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙira.
Sabuwar haƙƙoƙin haƙoƙin haƙoƙin haƙoƙin haƙoƙin haƙoƙin haƙoƙin haƙoƙin haƙoƙin haƙoƙin haƙoƙin haƙoƙin haƙoƙin haƙoƙin haƙoƙin haƙoƙin haƙoƙin haƙoƙin haƙoƙin haƙoƙin haƙoƙin haƙoƙin haƙoƙin haƙoƙin haƙoƙin haƙoƙin haƙoƙin.
Manyan mata da wani kasa da kasa da kasa da kasa da kasa da kasa da kasa da kasa da kasa.
Tattalin arziki Mohamed El-Erian ya karanta da aikace-aikace-aikace na banki da kuma kasashe.
Cibiyar banki suna haɗari fiye da suka haɗari a kan kasuwanci crash na 2008.
Tourism ne daya daga cikin mafi girma da aka rarraba a kan tafiya ban, shigar da jama'a, ciki har da tafiya dubawa, da kuma sabis na kasa da kasa da kasa a kan wani tafiya a kowace duniya.
Saboda haka, da yawa kamfanonin jirgin kasa da aka cancelled jiragen sama saboda ƙananan tallace-tallace, ciki har da British Airways, China Eastern Airlines, da Qantas, yayin da British yankin jirgin kasa Flybe ya sa.
Matsa lantarki a cikin masana'antun jirgin kasa ya kasance a kan wani matsa lantarki da suka wuce.
Manyan tashar jiragen kasa da ferry harabar da aka shigar.
Epidemiya aka kwatanta tare da Chunyun, wani manyan tafiya mako da aka haɗu tare da Chinese New Year holiday.
Manyan ayyukan da ke ƙaddamar da yawa da yawa da aka cancelled da kasa da yanki, ciki har da shekara-shekara New Year festivals, tare da kamfanoni da aka rufe da kayayyakin da kuma tourist attractions kamar Hong Kong Disneyland da Shanghai Disneyland.
Manyan Lunar New Year events da kuma tourist attractions da aka shigar da hanyoyi don taimakawa da masana'antu, ciki har da Babu City a Beijing da kuma halitta halitta.
A 24 na 31 masana'antu, gundumar da yankin na kasar Sin, masana'antun sha'awa ya ƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙira.
Wadannan yankin sun hada da 80% na GDP da 90% na fitarwa na kasar.
Hong Kong ya ƙirƙirar matakan jima'i na magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magunguna.
Lissafi zuwa kaya a Turai da Latin America ya rage 40%.
North America da Middle East retailers ya nuna 50-60% rage.
Wannan ya ƙaddamar da 33-43% ajiya a cikin tafiya zuwa mallaka a watan Maris fiye da watan Fabrairu.
Sabuwar mall operator a kowace duniya ya ƙirƙirar ƙirƙirar, kamar ƙirƙirar sanitary, shirye-shirye na thermal scanners don duba jiki na abokin ciniki, da canje-shirye.Dangane da wani Jami'ar Jami'ar Jami'ar for Latin America na Jami'ar shawarar, da pandemici-induced lissafi za a iya saita tsakanin 14 da 22 miliyan mutane a ƙarƙirar masana'antu a Latin America fiye da cewa zai zama a wannan hali ba tare da pandemic.
A watan Janairu da Fabrairu 2020, a lokacin da epidemic a Wuhan, game da 5 miliyan mutane a kasar Sin ya ba da aiki.
Manyan na China na fiye da 300 miliyan ma'aikata ma'aikata suna riga a cikin gida a cikin kasashen waje ko riga a kasar Hubei. A watan Maris 2020, fiye da 10 miliyan Americans ya ra'ayin aiki da aka ba da bukatun gwiwa.
The coronavirus tsari za a iya kammala 47 miliyan wurare a Amurka da kayayyakin aiki za a iya zama 32%, a kan takardun da Federal Reserve Bank of St. Louis.Lockdown a Indiya ya haifar da fiye da miliyan Indiyan ma'aikatar ma'aikata (wannan da aka bayar ta hanyar da yau da kullum farashin).The bincike daga Angus Reid Institute ya samu cewa 44% na Canadian haɗari ya samu wani nau'i na kayyadewa.Hakanan 900,000 ma'aikatar da aka ba da aiki a Spaniya tun da ya fara a cikin lockdown a gundumar Maris 2020.
A karshe watan Maris, 4 miliyan ma'aikata na Faransa ya ba da bukatun kudi na lokaci, kuma 1 miliyan ma'aikata na Birtaniya ya ba da bukatun don karfafawa a cikin tsarin da aka ba da karfafawa. Har ila yau, fiye da miliyan kamfanoni a Jamus da aka ba da ma'aikata a cikin shirye-shirye na short-stage da aka sani da Kurzarbeit.
The German short-time work remuneration scheme da aka samu ta Faransa da kuma Birtaniya.
Tattalin arziki da kuma al'amurran al'amurran al'amurran al'amurran al'amurran al'amurran al'amurran al'amurran al'amurran al'amurran al'amurran al'amurran al'amurran al'amurran al'amurran al'amurran al'amurran al'amurran al'amurran al'amurran.
shirye-shirye na masana'antu da kuma fasaha masana'antun da suka gabatar da ayyuka (mutanen da aka kammala) don samar da lissafi zuwa hadin gwiwa na masana'antun, inganta lissafi na ma'aikata da kuma jama'a, da kuma taimakawa masana'antun a gane.
By Maris 2020, a ko'ina cikin duniya da kuma a daban-daban ƙarfi, museums, library, performing venues, da sauran ilimi jami'o'i zaune a lokaci ba tare da ayyuka, ayyuka da ayyuka da aka cancelled ko cancelled.
Wani sabon da kuma sauƙi da ci gaba da matsa lamba na magani ne cancellation na al'ada, manyan matsa lamba a cikin wasanni, da sauran jama'a matsa lamba, kamar music festivals da al'ada, fasaha conferences, da fashion shows.
The Vatican ya gabatar da cewa Hanyar Week a Roma, wanda ya zama a cikin karshe rana na Halitta na Halitta, suna cancelled.
Manyan dioceses da shawarar da manyan kristiyanci don zama a cikin gida fiye da rufe misali a ranar Almasihu; wasu masana'antu suna ba da sabis a kan basirar, online live streaming ko TV, yayin da wasu suna samar da drive-in albarkatun.
Tare da Roman Catholic Diocese of Rome shigar da gine-gine da kuma St. Peter's Square kammala daga 'yan gine-gine-gine, sauran gine-gine masu jima'i da kuma cancelled sabis da ƙungiyar jama'a a gine-gine, gine-gine, gine-gine, gine-gine da gine-gine.
Ma'aikata na Iran ya gabatar da ƙirƙirar lissafi a cikin yanayi da aka kwatanta da matsaloli da aka sauƙi, yayin da Saudi Arabia ya ba da lissafi na kasashen waje ma'aikata da kuma abokan ciniki zuwa mahimmanci a Mekka da Medina.
Pandemic ya ƙirƙirar mafi muhimmanci ƙirƙirar a duniya sport calendar tun duniya na II World War.
Most major sporting events have either been cancelled or postponed, ciki har da 2019-20 UEFA Champions League, 2019-20 Premier League, UEFA Euro 2020, 2019-20 NBA season, da 2019-20 NHL season.
Ƙararrawa ya haifar da aikace-aikace na 2020 Summer Olympics, wanda aka kafa a farkon Yuli; International Olympic Committee ya gabatar da 24 Maris cewa abubuwan da suka wuce za a 'ya'ya'yan bayan 2020 amma ba sa'an nan karshen 2021."Kasinon da sauran wasanni wurare a duniya da aka shigar da kuma live poker tournaments da aka rufe ko rufe. "
Wannan ya haifar da yawa masu zane-zane a canza online, tare da yawa online wasan kwaikwayo yanar gizo karanta da muhimmanci ƙarfi a cikin kudi na sabon abokin ciniki.The entertainment masana'antu da aka rarraba, tare da daban-daban music groups sauke ko cancelling concert tours.
Manyan manyan cinikayya, kamar da waɗanda a Broadway, sun haƙƙoƙi dukkan ayyuka.
"Ba da yawa masu sana'a da aka bincike hanyoyin da za su ƙirƙirar da kuma ƙirƙirar ayyuka a kan internet kamar yadda wani yanayin da aka ba da al'amuran live, kamar live streaming al'amurran ko samar da "festivals" a kan yanar gizo don masu sana'a yi, sauke da kuma gabatar da ayyuka. "
Online, da yawa Internet meme-taimakon coronavirus suna ƙirƙirƙirar kamar yadda yawa suka yi wa hoto da kuma sha'awar a cikin ƙananan ƙananan.
Tare da ƙaddamar da COVID-19, ƙaddamar da ƙaddamarwa, xenophobia, da raciya da aka ƙaddamar da mutane na kasar Sin da Asia, da kuma ga mutane daga hotspots a Turai, Amurka da sauran kasashen.
Tare da matsaloli na matsaloli, matsaloli, da matsaloli a wasu kasashe, musamman a Turai, Asia, North America, da Asia-Pacific yankin.
Dukkan bayanai daga watan Fabrairu (a lokacin da mafi yawan matakan da aka ƙaddamar da kasar Sin) suna ƙaddamar da ra'ayi na jima'i a cikin daban-daban jima'i na kasar Sin a duniya wanda ya dace jima'i na jima'i ko dace da abin da aka samu a matsayin hukunci.
wasu kasashe a Afrika da kuma ya zo a cikin anti-Chinese sentiment.
Manyan abokan Wuhan da Hubei suna gabatar da jima'i da jima'i.
Yana da taimako ga Chinese, da kuma offline, da kuma ga waɗanda a cikin yanayi na virus.
Bayan ƙaddamar da ƙaddamar da ƙaddamar da sabon hotspot kasashe, mutane daga Italiya, na farko a Turai don samun wani m ƙaddamar da COVID-19, za su iya ƙaddamar da ƙaddamar da xenophobia.Citizens a cikin kasashen ciki har da Malaysia, New Zealand, Singapore, da kuma South Korea na farko ya rubuta lobi don ba da lissafi na kasar Sin don shiga cikin kasashe su a cikin kwarewa don haɓaka jiki.
A Japan, hashtag #ChineseDontComeToJapan ya ci gaba a Twitter.
Tsarin kasar Sin, kamar yadda sauran Asians a Birtaniya da Amurka, suna gabatar da ƙwayar ƙwayoyi na rasista, kazalika, kazalika.
“American president Donald Trump da aka kwatanta domin ya kwatanta da coronavirus a matsayin “Chinese Virus”, wani al'amuran da aka sani da raci da kuma anti-Chinese. ”
Ma'aikatarwa a Ukraine ya haɗu buses da suka haɗu Ukrainian da kasashen waje daga Wuhan zuwa Novi Sanzhary.
dalibai da suka zo daga Northeast India, wanda ya ƙirƙirar ƙasa tare da kasar Sin, da kuma koyarwa a manyan Indiya birane da aka kwatanta sha'awa da sha'awar coronavirus.
The Bharatiya Janata Party na State Unit president a West Bengal Dilip Ghosh ya ce da cewa Kineskin da aka ƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙiri.
"A cikin kasar Sin, xenophobia da rasismi ga non-Chinese abokan ciniki da aka tsammani da pandemic, tare da abokan ciniki da aka alama a matsayin "" abokan ciniki abinci "" da kuma daidaita a cikin "disposal". "
Manyan aikace-aikace-aikace da paywalls sun haɓaka su don wasu ko dukan coronavirus coverage.
Manyan masana ilimi masu zaman kansu ya samar da ilimi makamashi da aka haƙƙoƙi tare da fitarwa.
Wadannan masana'antun sha'awa za su zabi saukar bayanai su sauri a kan preprint servers kamar bioRxiv.
Emerging Infectious Disease - Infectious disease of emerging pathogen, da yawa sabon a cikin tsarkakewa tsari ko shigarwa mode
Globalization da magunguna - Shigarwa na globalization da magunguna
List of epidemics and pandemics - A list of death tolls due to infectious disease (Lista na epidemics da pandemics)
Ma'aikata da zoonoses – Health risks related to trade of exotic wildlife
Laboratory gwaje-gwaje ga respiratory coronavirus disease 2019 (COVID-19) da SARS-CoV-2 yanar gizo yana hada da hanyoyin da ke ƙirƙirar samfurori da kuma waɗanda ke ƙirƙirar ƙirƙirar antibodies da aka ƙirƙirar a matsayin yanayin da jima'i.
Yanzu na viruses a cikin samfurori an tabbatar da RT-PCR, wanda ya nuna RNA na coronavirus.
Wannan gwaji ne na musamman da aka tsara don samun kawai RNA na SARS-CoV-2 virus.
Yana amfani da ya gabatar da matsaloli mai sauƙi ko matsaloli.
Detection na antibodies (serology) za a iya amfani da su don diagnosis da jama'a monitoring.
Antibody gwaje-gwaje ya nuna da yawa mutane da ya kasance da magani, ciki har da waɗanda suka da matsaloli da aka ban sha'awa ko waɗanda suka kasance asymptomatic.
Ƙara matsaloli na magani na magani da matsaloli na magani a cikin mutane za a iya kammala daga matsaloli na wannan gwaji.
Saboda ƙarfi gwaje-gwaje, a watan Maris 2020, duk wani ƙasƙanci ba da takardun shaida game da ƙarfi na virus a cikin mutane.
Tare da 23 Maris, wani ƙasashe ya yi gwaje-gwaje fiye da 3% na mutane, da kuma akwai masu ƙarfi a kan da yawa gwaje-gwaje da aka yi tsakanin ƙasashe.
Wannan ƙirƙirar da za a iya daidaita da ƙananan ƙananan matsaloli, wanda za a iya zama karfi overestimated a wasu kasashe.
Yana amfani da real-time reverse transcription polymerase chain reaction (rRT-PCR) gwajin za a iya yi a kan shuka samfurori da aka samu da daban-daban methods, ciki har da nasopharyngeal swab ko sputum samfurori.
Mataki suna samuwa a cikin wasu hours to 2 kwanaki.
RT-PCR gwaji da aka yi tare da ƙarfin ƙarfin ƙarfin ƙarfin ƙarfin ƙarfin ƙarfin ƙarfin ƙarfin ƙarfin ƙarfin ƙarfin ƙarfin ƙarfin ƙarfin ƙarfin ƙarfin ƙarfin.
Sa'an nan virus za a iya fitarwa a cikin halitta, yayin da ya ci gaba da ci gaba a cikin lamba.
Ga matsa lamba da aka gwaji a cikin makonni na biyu, alternatively samfurin kayan za a iya dace daga ƙaunar ƙaunar ƙaunar ƙaunar ƙaunar ƙaunar ƙaunar ƙaunar ƙaunar ƙaunar ƙaunar ƙaunar ƙaunar ƙaunar ƙaunar ƙaunar.
Wani na farko PCR gwajin da aka ci gaba a Charité a Berlin a watan Janairu 2020 ta amfani da real-time reverse transcription polymerase chain reaction (rRT-PCR), kuma ya gina asali na 250,000 kits don tallace-tallace ta WHO.
Jami'ar Birtaniya ya ci gaba da gwaji har zuwa 23 Janairu 2020.The South Korean kamfanin Kogenebiotech ya ci gaba da ilimi, PCR-based SARS-CoV-2 detection kit (PowerChek Coronavirus) a kan 28 Janairu 2020.
"A cikin kasar Sin, BGI Group ya zama daya daga cikin kamfanoni na farko da aka samu amfani da haɗin amfani daga National Medical Products Administration na kasar Sin don PCR-based SARS-CoV-2 detection kit.A Amurka, Centers for Disease Control and Prevention (CDC) yana gabatar da 2019-Novel Coronavirus (2019-nCoV) Real-Time RT-PCR Diagnostic Panel zuwa masana'antun magani ta hanyar International Reagent Resource. "
Wani daga cikin uku jima'i gwaje-gwaje a cikin fasaha versions na gwaji kits ya ƙirƙirƙirar matsaloli saboda matsaloli, da kuma bugawa na gwaje-gwaje a CDC a Atlanta; wannan ya haifar da karamin fiye da 100 samfurori a kowace rana da aka yi aiki da kyau a kowace watan Fabrairu 2020.
Tsarin 28 Fabrairu 2020, gwaje-gwaje da yin amfani da biyu kayan da aka kafa ba za a tabbatar da cewa za a yi daidaito, kuma shi ba kawai a lokacin da gwaje-gwaje na jihar da kuma yanar gizo suna ba da damar fara gwaje-gwaje.
Test da aka karfafa da Food and Drug Administration a karkashin Emergency Use Authorization. US kasuwanci labs fara gwaje-gwaje a farkon Maris 2020.
Sabon 5 Maris 2020 LabCorp ya gabatar da samfurin COVID-19 na RT-PCR a duniya.
Quest Diagnostics ya yi amfani da COVID-19 gwaje-gwaje a kasa da kasa a kan 9 Maris 2020.
Duk da cewa ba za a gabatar da ƙarfi mai yawa; samfurori da kuma aiki za a yi daidai da bukatun CDC.
A Rasha, gwajin COVID-19 aka ci gaba da kuma samar da State Research Center of Virology da Biotechnology VECTOR.
On 11 Fabrairu 2020, gwajin da aka kayyade ta Federal Service for Surveillance in Healthcare.A 12 Maris 2020, Mayo Clinic ya sanar da cewa ya ci gaba da gwaji don ƙirƙirar COVID-19.A 13 Maris 2020, Roche Diagnostics ya samu FDA karkashin gwaji wanda za a iya yi a cikin 3.5 hours a girma yawan, wanda ya damar wani na'urorin yi game da 4,128 gwaji a cikin lokaci na 24 hours.
On 19 Maris 2020, FDA ya ba da damar amfani da haɗari (EUA) zuwa Abbott Laboratories don gwaji a kan tsarin m2000 na Abbott; FDA ya gabatar da samfurori na Hologic, LabCorp, da Thermo Fisher Scientific.
On 21 Maris 2020, Cepheid kamar yadda aka samu EUA daga FDA don gwaji wanda ya dace game da 45 minti.
FDA ya karfafawa wani gwaji wanda ya yi amfani da isothermal nucleic acid amplification fasaha a kan PCR.
Saboda wannan ba ka bukatar wani tsari na tsari tsari, wannan magani za a iya samar da matsaloli a kowace 5 minti da matsaloli a 13 minti.
Yana da yanzu game da 18,000 na wadannan masana'antu a Amurka da Abbott yana da mataki don ƙirƙirar samar don samar da 50,000 gwaje-gwaje a kowace rana. A gwaji wanda ya yi amfani da wani monoclonal antibody wanda yaushe da nukleocapsid protein (N protein) na sabon coronavirus an ci gaba a Taiwan, tare da mataki cewa za a iya samar da sakamakon a cikin 15 zuwa 20 minti kamar yadda wani sauri influenza gwaji.
" A Maris 2020 Literature review ya ce cewa "Radiographs na chest suna da karami magani a karshe mataki, yayin da CT [computed tomography] bukatun za a iya dauke kowace samfurori."
Tattaunawa a kan CT sun hada da bilateral multilobar ground-glass opacificities tare da ƙarshe, asymmetrical da ƙarshe.
Subpleural dominance, crazy matsa lamba da kuma ƙirƙirar ci gaba da magani.
A bincike da ke daidaita PCR da CT a Wuhan a cikin mataki na halin yanzu pandemic ya nuna cewa CT ne daidai mai m da PCR, ba tare da ƙarshe, tare da yawa na'urorin image da ke daidaita da sauran pneumonia da magani.
" A kan Maris 2020, na American College of Radiology shawarar cewa "" CT ba za a yi amfani da screening ga ko a matsayin farko-line gwaji don magana COVID-19 "". A kan Maris 2020, CDC yana shawarar PCR don farko screening. "
Kamar yadda wani ɓangare na lantarki tsari da lantarki ne samar da antibodies ciki har da IgM da IgG.
Wadannan za a iya amfani da zartar jiki a cikin mutane da fara 7 kwanaki ko da yaushe bayan matsaloli, don kammala immunity, da kuma a jama'a surveillance.Assays za a iya yi a cikin cibiyar masana'antu (CLT) ko da point-of-care gwajin (PoCT).
The high-gaba automated tsarin a da yawa lissafi labs za su iya yi wadannan gwaje-gwaje, amma kammala za su za a yi amfani da yawan samar da kowane tsarin.
Domin CLT, daya samfurin damuwa na tsakiya an amfani da yawa, amma samfurin tsari za a iya amfani da su karkashin ƙwaƙwalwa.
Domin PoCT, daya samfurin damuwa an ƙaddamarwa ta hanyar daidaitacce.
Saboda PCR magani, wani tsari na tsari ba da bukatun kafin gwaje-gwaje.A 26 Maris 2020, FDA ya gabatar da 29 kwarewa wanda ya gabatar da lissafi kamar yadda ake bukata da kuma yanzu za su iya ƙirƙirar gwaje-gwaje na antibodies.
A karshen Maris 2020, Euroimmun Medical Laboratory Diagnostics da Epitope Diagnostics aka samu Turai da takaddun shaida ga gwajin kits, wanda zai iya gane IgG da IgA antibodies ga virus a cikin damu samfurori.
Testing iya aiki ne wasu hundreds samfurin a cikin hours da kuma haka farashin da yawa fiye da m PCR gwaji na viral RNA.
The antibodies za su karkashin 14 kwanaki bayan da aka fara da jima'i. A farkon Afrilu, Birtaniya ya samu ba da wani daga cikin antibody test kits da aka samuwa ne kyau da kullum.
"Hong Kong ya kafa wani shirye-shirye inda matsala matsala za a iya zama a cikin gida, "Accident department za su ba da wani sample tube ga matsala", za su so a cikin shi, za su karanta da kuma samu wani gwaji matsala a lokacin da suka wuce.The British NHS ya gabatar da cewa shi ne ya gabatarwa wani shirye-shirye don gwaji matsala matsala a cikin gida, wanda ya ƙara rage na wani matsala matsa lamba idan su zo a cikin magungunan magungunan ko da ya kamata a rage wani ambulance idan an amfani da.A cikin drive-through gwaji ga COVID-19 ga matsala matsa lamba, wani masana'antu ya yi samfurin ta amfani da matsa lamba. "
A Jamus, National Association of Legislative Health Insurance Physicians ya ce 2 Maris, cewa shi yana da damar kusa 12,000 gwaje-gwaje a kowace rana a kowace rana.
Costs suna karfafa ta Health Insurance a lokacin da gwajin da aka ba da wani magani.
Bisa ga president na Robert Koch Institute, Jamus yana da cikakken iya aiki don 160,000 gwaje-gwaje a kowace rana.
Kamar yadda 19 Maris drive a gwaje-gwaje da aka bayar a cikin wasu manyan birnin.
A kan 26 Maris 2020, da cikakken yawan gwaje-gwaje da aka yi a Jamus, ba za a sani, saboda kawai matsaloli da matsaloli.
" A farko gwaje-gwaje ya nuna cewa a kan rana 12/2020 a kan kalendarwa, a cikakken 483,295 samfurori da aka gwaje-gwaje har zuwa da kuma ciki har da rana 12/2020 da 33,491 samfurori (6,9%) da aka gwaje-gwaje jiki ga SARS-CoV-2.A Isra'ila, masu bincike a Technion da Rambam Hospital ya ci gaba da kuma gwaji wani tsarin don gwaji samfurori daga 64 magani a lokaci, ta hanyar ƙirƙirar samfurori da kuma kawai gwaje-gwaje bayan da ƙirƙirar samfurori ya zama jiki.A Wuhan, wani makehift 2000-sq-meters gwiwa gwaji gwaji labar da aka sani ""Huo-Yan"" (Chinese: 火眼, ko "Fire Eye" a Ingila) aka kafa a 5 Fabrairu 2020 da BGI, wanda zai iya aiki fiye da 10,000 samfurori a rana. "
Tare da gine-gine da BGI-tallace-tallace Wang Jian da ya dace 5 kwanaki, modeling ya nuna matsala a Hubei za su zama 47% mafi girma da kuma dace da farashin da suka wuce da karantina za za su ƙara biyu idan wannan gwajin iya zama a kan layi.
Wuhan Laboratory da aka sauƙi da Huo-Yan labs a Shenzhen, Tianjin, Beijing, kuma Shanghai, a total 12 birane a cikin kasar Sin.
By 4 Maris 2020, da yawan aiki na yau da kullum ya zama 50,000 gwaje-gwaje a kowace rana.Open-source, multiplexed zane-zane da aka ba da Origami Assays cewa za a iya test har zuwa 1122 magani samfurori ga COVID19 ta amfani da kawai 93 zane-zane. Wadannan m zane-zane za a yi aiki a cikin ƙananan gwaje-gwaje ba tare da bukatun na robots liquid handlers.
By watan Maris, matsaloli da yawa na reagent ya zama wani matsaloli don masana'antu gwaje-gwaje a cikin EU da UK da Amurka.
Wannan ya ce wasu makamashi don bincike samfurin zane-zane da ke ƙaddamar da samfurori a 98 ° C (208 ° F) don 5 minti don sauke RNA genomes don ƙarin gwaje-gwaje.A 31 Maris, an gabatar da Emirates ya zama yanzu gwaji mafi yawanci ga Coronavirus per capita fiye da wani sauran kasa, da kuma a kan tafiya don ƙirƙirar tashi na gwaje-gwaje don samun mafi yawan mutane.
" Wannan shi ne ta hanyar ƙirƙirar ƙirƙirar ƙirƙirar ƙirƙirar ƙirƙirar ƙirƙirar ƙirƙirar ƙirƙirar ƙirƙirar ƙirƙirar ƙirƙirar ƙirƙirar ƙirƙirar ƙirƙirar ƙirƙirar ƙirƙirar ƙirƙirar ƙirƙirar ƙirƙirar ƙirƙirar ƙirƙirar ƙirƙirar ƙirƙirar ƙirƙirar ƙirƙirar ƙirƙirar ƙirƙirar ƙirƙirar ƙirƙirar ƙirƙirar ƙirƙirar ƙirƙirar ƙirƙirar ƙirƙirar ƙirƙirar ƙirƙirar ƙirƙirar ƙirƙirar ƙirƙirar ƙirƙirar ƙirƙirar ƙirƙirar ƙirƙirar ƙirƙirar ƙirƙirar ƙirƙirar ƙirƙirar ƙirƙirƙirar ƙirƙirar ƙirƙirar ƙirƙirar ƙirƙirar ƙirƙirar ƙirƙirar ƙirar ƙirƙirƙirar ƙirƙirar ƙirƙirƙirƙirar ƙirƙirar ƙirƙirar ƙirƙirƙirar ƙirar ƙirƙirƙirar ƙirƙirƙirar ƙirar ƙirƙirar ƙirƙirƙirar ƙirƙirƙirƙir. "
Gina a cikin 14 kwanaki, labara yana iya gudanar da ra'ayoyi na RT-PCR a kowace rana da kuma shi ne na farko a duniya na wannan jerin da aka aiki fiye da kasar Sin.
Tsarin gwaje-gwaje daban-daban da ke shirya daban-daban sassa na coronavirus genetic profile da aka ci gaba a kasar Sin, Faransa, Jamus, Hong Kong, Japan, da kuma Amurka.
The World Health Organization ya ƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙiri.
The German samfurin da aka gabatar da 17 Janairu 2020; takardun da aka ci gaba da Amurka Centers for Disease Control ba za a samuwa don 28 Janairu, ƙaddamar da samfurin samfurin a Amurka da Amurka yana da matsala tare da kwarewa na samfurin samfurin a karkashin tsibirin, kuma wadannan kasashe da Australia ba za su iya samar da yawa samfurin don ƙaddamar da tallace-tallace-tallace masu sana'a masana'antu.
Saboda haka, masana'antun shaida sun sayi da fiye da amfani da gwaje-gwaje na South Korea ya taimakawa don rage da sabon coronavirus.
Tsarin gwaje-gwaje, mafi girma a cikin masana'antu cibiyar masana'antu, aka gina a cikin shekaru da yawa da kasar South Korea.
16 Maris, World Health Organization ya haƙƙoƙi don karfafawa bincike shirye-shirye a matsayin mafi kyau hanyar canza da ci gaba da COVID-19 pandemic.A high tallace-tallace ga bincike saboda girma tsari na virus ya haƙƙƙoƙi tsuntsaye na hundreds na thousands na bincike a cikin private U.S. labs, kuma kayan aiki na swabs da sinadaran sinadaran da aka rarraba.
Maris 2020 China ya gabatar da matsaloli da matsaloli a cikin matsaloli kits.
"A Amurka, zane-zane-zane-zane da aka ci gaba da CDC yana da "" fadi;" "Burocratic gaban da aka ba da hanyoyin da aka ba da hanyoyi.Spain samu zane-zane-zane daga kamfanonin kasar Sin Shenzhen Bioeasy Biotechnology Co Ltd, amma ya samu cewa bayanai suna gabatarwa. "
The kamfanin ya ce da cewa gabatarwa na gabatarwa za a iya zama matsakaici na ƙirƙirar samfurori ko amfani da kits daidai.
The Spanish ministry ya ce za su ƙirƙirar kits wanda ya ba da gabatarwa na gabatarwa, kuma za a canza su tare da wani daban-daban gwaje-gwaje kits samar da Shenzhen Bioeasy. 80% na gwaje-gwaje kits da Czech Republic samuwa daga kasar Sin ya ba da gabatarwa. Slovakia ya samuwa 1.2 miliyan gwaje-gwaje kits daga kasar Sin da aka kammala a matsayin gabatarwa.
Ateş Kara na Turkey Health Ministry ya ce ƙungiyar gwaje-gwaje da Turkey samuwa daga kasar Sin yana da "mafi gabatarwa" da kuma ba ya "make su a amfani.""Britaniya ya samuwa 3.5 miliyan gwaje-gwaje kit daga kasar Sin amma a farkon Aprili 2020 ya gabatar da su ba za a yi amfani. "
Testing, da suka wuce da karantina daga waɗanda suka yi test positive da kuma tracing daga waɗanda waɗanda SARS-CoV-2 mutanen da aka hadin gwiwa, ya ƙaddamar da matsaloli.
Tsarin bincike da ke aiki a Italiya birnin Vò, yanki na farko COVID-19 matsaloli a Italiya, ya yi biyu matsaloli na cikakken mutane na game da 3,400 mutane, game da kowane kwanaki.
game da ƙarfin mutane da aka yi test positive ba ya kasance ba tare da matsala, da kuma dukan matsala da aka samu aka karantawa.
Tare da tafiya zuwa komuniya da aka rage, wannan ya canza sabon magunguna a cikakken.
Ƙararrawa da ƙararrawa, ƙararrawa tafiya, gwaje-gwaje, da kwarantena, 2020 coronavirus pandemic a Singapore ya ci gaba da yawa sauƙi fiye da a wasu masana'antu masana'antu, amma ba tare da ƙananan ƙararrawa kamar ƙirƙirar dabbobi da kasuwanci.
Manyan ayyukan da aka cancelled, kuma Singapore ya fara shawarar abokan ciniki don zama a cikin gida a kan 28 Maris, amma dalibai da aka saukewa a lokacin da kammala a 23 Maris.
Manyan sauran ƙasashen da aka gudanar da pandemic tare da agresive contact tracking, inbound travel kudi, gwaje-gwaje, da karantina, amma tare da less aggressive lock-down, kamar Iceland da South Korea.
A bincike na takardun shaida ya samu cewa kasashe da suka yi gwaje-gwaje mafi, da yawan matsaloli, yana da farashin matsaloli na matsaloli, za a yiwuwa saboda wadannan kasashe suna mafi kyau da za su iya gane waɗanda suna kawai m ko ba tare da matsaloli.
WHO yana ƙirƙirar cewa kasashen da ba da gwaji iya aiki da kuma kasashe labars tare da ƙananan kwarewa a kan COVID-19 za su karanta da farko da fiye da kowane kudi na COVID-19 samfurori zuwa daya daga cikin 16 WHO reference labs don karantawa gwaji.
Daga cikin 16 reference labs, 7 ne a Asia, 5 a Turai, 2 a Afrika, 1 a North America da 1 a Australia.
A karkashin tabarau, da rubutu "Positive a matsayin % na gwaje-gwaje" ne daidaita da tsarin gwaje-gwaje na kasar.
Ma'aikatar da ke yi gwaje-gwaje kawai mutane da aka ba a cikin magunguna zai zama mafi kyau a matsayin % na gwaje-gwaje fiye da ƙasa wanda ya yi gwaje-gwaje dukan abokan ciniki, ko ba su nuna magunguna, wasu abubuwa da aka daidaita.
Handwashing (au taywashing), wanda aka sani da tayin halitta, yana da matsaloli na tayi don ƙirƙirar ƙaunar, mafita, microorganisms, ko sauran ban sha'awa.
"Handwashing tare da sabis daidai a wasu "" critical moments"" a cikin rana yana haɓaka ƙaddamar da yawa magani, kamar magani da cholera, da aka ƙirƙirar ta hanyar fecal-oral. "
Ma'aikatan za a iya samun magana da magungunan ƙaunar ƙaunar ƙaunar ƙaunar ƙaunar ƙaunar ƙaunar ƙaunar ƙaunar ƙaunar ƙaunar ƙaunar ƙaunar ƙaunar ƙaunar ƙaunar ƙaunar ƙaunar ƙaunar ƙaunar ƙaunar ƙaunar ƙaunar ƙaunar ƙaunar ƙaunar ƙaunar ƙaunar ƙaunar ƙaunar ƙaunar ƙaunar ƙaunar ƙaunar ƙaunar ƙauna.
Ma'aikatan ciniki a kowace rana a lokacin da ku yi amfani da sabunta sun hada da: kafin da kuma bayan ƙafafa, bayan kammala da ƙafa da abinci ko canza lamba, kafar da abinci, kafar da abinci, kafar da abinci da kuma kafar da abinci ko aiki da roba masana'antu, masana'antu, ko bututu.
Idan ruwa da sabun ba za a yi samuwa, kake iya saukewa tare da ash.The World Health Organization ƙirƙirƙirar ku:
Yanzu, a lokacin da kuma bayan aiki da abinci.
Yanzu da kuma bayan taimakawa ga matsaloli.
Bayan haɓaka shigarwa ko saukewa da mutum wanda ya amfani da toilet.
Bayan haɓaka nasu, coughing ko ajiya.
Bayan haɓaka haihuwa, haihuwar haihuwa, ko haihuwar haihuwar haihuwa.
Medical Hand Hygiene yana kira da hanyoyin halitta da aka kwatanta da hanyoyin halitta.
Tallace-tallace-tallace ma'aikata kafin ƙirƙirar magani ko magani za a iya ƙirƙirar ko ƙirƙirar ƙirƙirar magani.
Ma'aikata mai girma mai amfani da tayi ne don halitta ma'aikata (bacteria, viruses, ko sauran microorganisms da za a iya ƙirƙirar magani) da kuma kayayyakin da za a iya ƙirƙirar magani ko magani.
Wannan shi ne musamman muhimmanci ga mutane da suka aiki a cikin kayayyaki ko aiki a cikin yanki, amma kuma wani muhimmanci ma'aikata ga jama'a.
Ƙungiyoyin ƙungiyar ƙungiyar ƙungiyar ƙungiyar ƙungiyar ƙungiyar ƙungiyar ƙungiyar ƙungiyar ƙungiyar ƙungiyar ƙungiyar ƙungiyar ƙungiyar ƙungiyar ƙungiyar ƙungiyar ƙungiyar ƙungiyar ƙungiyar ƙungiyar ƙungiyar ƙungiyar ƙungiyar ƙungiyar ƙungiyar ƙungiyar ƙungiyar ƙungiyar ƙungiyar ƙungiyar ƙungiyar ƙungiyar ƙungiyar ƙungiyar ƙungiyar ƙungiyar ƙungiyar ƙungiyar ƙungiyar ƙungiyar ƙungiyar ƙungiyar ƙungiyar ƙungiyar ƙungiyar ƙungiyar ƙungiyar ƙungiyar ƙungiyar ƙungiyar ƙungiyar ƙungiyar ƙungiyar ƙungiyar ƙungiyar ƙungiyar ƙungiyar ƙungiyar ƙungiyar ƙungiyar ƙungiyar ƙungiyar ƙungiyar ƙungiyar ƙungiyar ƙungiyar ƙungiyar ƙungiyar ƙungiyar ƙungiyar ƙungiyar ƙungiyar ƙungiyar ƙungiyar ƙungiyar ƙungiyar ƙungiyar ƙungiyar ƙungiyar ƙungiyar ƙungiyar ƙungiyar.
da kuma rage infant mortality rate a cikin gida baƙi.
A bincike na 2013 ya nuna cewa ingantacin tayi na'ura za a iya taimakawa da ƙananan ingancin a cikin ƙwayar ci gaba a cikin abokan cinye shekaru.
A cikin masana'antun ci gaba, yawan zafin jima'i da aka kwatanta da magani da magani za a iya rage ta hanyar ƙirƙirar tsari mai sauƙi, kamar ƙirƙirar ma'aikata da sabun.
Wannan sauƙin aiki za a iya rage matsalolin daga wadannan magani da fiye da 50%.
Takaddun sha'awa da ke taimakawa da tayi za a iya rage episodes na diarrhoea da game da uku, kuma wannan ne daidaita da samar da ruwa mai sauri a low-gaba yanayi.
48% na rage na tsari na tsari za a iya haɓaka tare da tayi tare da sabuntawa.Handwashing tare da sabuntawa ne mafi kyau da kuma mafi kyau yanayi don ƙirƙirar tsari da acute respiratory infections (ARI), kamar yadda na'ura mai aiki da aka yi a cikin gida, koyarwa, da jama'a a duniya.
Pneumonia, wani manyan ARI, yana da ƙaddamar da ƙaddamar da ƙaddamar da ƙaddamar da matsaloli tsakanin mutane da suka wuce da shekaru 5 da suka wuce, wanda ya ƙaddamar da rayuwa na 1.8 miliyan mutane a kowace shekara.
Diarrhea da pneumonia suna daidaita a kan gudu 3.5 miliyan abokan ciniki a shekara.
Sabuwar UNICEF ya ce da cewa ƙirƙirar ruwansa tare da sabis kafin kula da kuma bayan yin amfani da tufafi a cikin al'amurran za a iya haifar da mutane fiye da duk wani na'ura mai ban mamaki ko magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan.
Hand washing an ƙirƙirar tare da sauran hanyoyin halitta a matsayin sassa na ruwa, halitta da halitta (WASH) shirye-shirye.
Hand washing kuma taimakawar daga impetigo wanda aka ƙirƙirar ta hanyar tsari na jiki.
Kyakkyawan ƙaunar ƙaunar ƙaunar ƙaunar ƙaunar ƙaunar ƙaunar ƙaunar ƙaunar ƙaunar ƙaunar ƙaunar ƙaunar ƙaunar ƙaunar ƙaunar ƙaunar ƙaunar ƙaunar ƙaunar.
A 2012 Danish bincike ya nuna cewa ƙarfi tayi za a iya ci gaba da matasa, matsa lamba na daidaitacce da aka sani da hand eczema ko hand dermatitis, wanda shi ne musamman matsa lamba tsakanin ma'aikata ma'aikata.
Ƙararrawa tare da ƙararrawa mai tsanani da aka sani a matsayin daya daga cikin matsaloli na obsessive-compulsive disorder (OCD).
Yawancin lokaci a kowace rana a lokacin da su yi amfani da sabis don rage ƙirƙirar ƙirƙirar ƙirƙirar ƙirƙirar ƙirƙirar ƙirƙirar ƙirƙirar ƙirƙirar ƙirƙirar ƙirƙirar ƙirƙirar ƙirƙirar ƙirƙirar ƙirƙirar ƙirƙirar ƙirƙirar ƙirƙirar ƙirƙirar ƙirƙirar ƙirƙirar ƙirƙirar ƙirƙirar ƙirƙirar ƙirƙirar ƙirƙirar ƙirƙirar ƙirƙirar ƙirƙirar ƙirƙirar ƙirƙirar ƙirƙirar ƙirƙirar ƙirƙirar ƙirƙirar ƙirƙirar ƙirƙiri.
Other occasions when correct handwashing technique should be practised in order to prevent the transmission of disease include before and after treating a cut or wound; bayan shawarar, coughing, or blowing your nose; bayan haɓaka haihuwa abun ciki ko hanyoyin haihuwa; kuma bayan haɓaka abun ciki.
A wasu kasashe, yana da ƙananan ƙarfi na tayi tare da sabun.
A bincike na hoto a 54 kasashe a 2015 ya nuna cewa a karkashin 38.7% na gida da suka yi hoto tare da sabunta.A bincike na 2014 ya nuna cewa Saudi Arabia yana da mafi girma yawan 97%; Amurka kusa da tsakiya tare da 77%; da China tare da mafi ƙarfi yawan 23%.Samar da hanyoyi canji methodologies yanzu akwai don ƙirƙirar shigar da hanyoyi na hoto tare da sabunta a lokacin da matsaloli.Group hoto ga dalibai a lokacin da aka kafa a rana ne daya daga cikin kasashe da ci gaba da za a yi amfani da hanyoyin hoto a hanyoyi.
"The "Essential Health Care Program" da aka gyara ta Department of Education a Filipina ne wani samfurin na aikace-aikace don ci gaba da hankali da ilimi da ilimi. "
Dubawa biyu a shekara, saukewa tare da tayi a yau da kullum tare da sabuntawa, kewaye ƙauna a yau da kullum tare da fluoride, ne a cikin tsakiya na wannan kasa da kasa shirin.
Yana da kyau da aka yi amfani da Indonesia.
Ƙararrawa na microorganisms daga daidaitacce ne mai kyau ta ƙirƙirar sabis ko detergents zuwa ruwa.
Ma'aikata na sabis da na'ura mai aiki ne don rage gwiwa zuwa tsari, da kuma inganta solubility.
Samun ruwa ne mai kyau mai tsari mai tsari saboda fats da protein, wanda ke da kayan organic ƙarfi, ba da sauƙi a cikin ruwa.
Ƙararrawa, amma, an taimakawa ta m ruwa.
Tsarin sabis, saboda yin amfani da hankali, za a iya ƙirƙirar bacteria da aka samu daga fiye da amfani.
A yawancin bincike da ya gabatar da ƙirƙirar ƙirƙirar daga ƙirƙirar ƙirƙirar ƙirƙirar ƙirƙirar ƙirƙirar ƙirƙirar ƙirƙirar ƙirƙirar ƙirƙirar ƙirƙirar ƙirƙirar ƙirƙirar ƙirƙirar ƙirƙirar ƙirƙirar ƙirƙirar ƙirƙirar ƙirƙiri.
" CDC yana ƙirƙirar "Liquid sabis tare da hands-free daidaitacce don ƙirƙirar ne mafi kyau". "
Antibacterial soaps da aka ci gaba da ƙarfi a kan health-conscious jama'a.
Yanzu, akwai duk wani dokokin cewa yin amfani da antiseptics ko disinfectants zabi ga antibiotic-resistant albarkatun a cikin halitta.
Duk da haka, antibacterial soaps hada da yawanci antibacterial kayayyakin kamar triclosan, wanda yana da cikakken lissafi na resistant sassa na jiki.
Saboda haka, har ila yau, har ila yau da kullum, duk da cewa antibacterial soaps ba za su zabi ga antibacterial resistant strains, za su iya ba su da kyau kamar yadda za su zama masana'antu.
Kamar yadda wani surface-actant da kuma skin-protecting kayayyakin, da m formula za a iya ƙunshi asiri (acetic acid, ascorbic acid, lactic acid) a matsayin pH-regulator, antimicrobially active benzoic acid da kuma ƙarin daidaitacce (aloe vera, vitamin, menthol, plant extracts). A cikakken bincike daga Jami'ar Oregon School of Public Health ya nuna cewa tsanani sabis ne har ila yau da kullum-grade anti-bacterial sabis dauke triclosan a canza magani da sauke bacteria daga gwiwa.
Hot ruwa da aka fi dace da hanyoyin, ba za a iya haifar da bacteria.
Bacteria suna ci gaba da mafi sauri a cikin jiki na jiki (37 ° C).
Duk da haka, zafi, soaped ruwa ne mafi kyau fiye da zafi, soaped ruwa a canza asali mafita da kuma bacteria.
Yadda za a yiwuwa, masana'antun bincike ya nuna cewa amfani da ruwa mai zafi ba ya yi amfani da su rage microbial ƙarfi a kan maza.
Hand sanitizer ko Hand antiseptic ne wani non-aikace-aikace na ruwa.
A karshe 1990s da karshe na 21st century, alcohol rubs non-aikace-aikace-aikacen halitta (kowane aka sani da alcohol-aikace-aikacen halitta, antiseptic halitta-aikacen halitta, ko hoto sanitary) ya fara ci gaba da alama.
Mafi ne a kan isopropyl alcohol ko ethanol da aka ƙunshi tare da wani matsa lamba kamar Carbomer (polymer na acrylic acid) a cikin gel, ko wani humectant kamar glycerin a cikin lamba, ko foam don amfani da sauki da kuma rage da matsa lamba na alkohol.
Ƙaddamar da karfe hydrogen-peroxide yana ƙirƙirar ƙarin antimicrobial aiki.Hand sanitizers ciki har da wani karfi na 60 zuwa 95% alcohol ne m germ killer.
Alcohol rub sanitizers mata bacteria, multidrug resistant bacteria (MRSA da VRE), tuberculosis, da kuma wasu viruses (ciki da HIV, herpes, RSV, rhinovirus, vaccinia, influenza, da kuma hepatitis) da fungi.
Alcohol rub sanitizers ciki har da 70% alcohol ya sa 99.97% (3.5 log reduction, sama da 35 decibel reduction) na bacteria a kan ku 30 seconds bayan amfani da kuma 99.99% zuwa 99.999% (4 zuwa 5 log reduction) na bacteria a kan ku 1 min bayan amfani.
Alcohol-based hanyoyin halitta ne fiye da cikakken ineffective ga norovirus (ko Norwalk) type viruses, mafi yawancin matsaloli na lantarki gastroenteritis.Su da yawa hanyoyin antiseptic ko alkohol rub da aka yi amfani da cikakkiya sauƙi ko ƙarfafafa biyu.
Ma'aikatan da kuma ƙasa na dukkansa da tsakanin da kuma ƙasa na dukkansa suna rubuta game da 30 secs har zuwa dace da lantarki, foda ko gel.
Finger tips must be washed well too, rubbing su a biyu ƙasa.The U.S. Center for Disease Control da Prevention yana ba da shawarar tayi a kan tayi sanitary rubs, musamman a lokacin da ƙaunar ne m.
Ƙarin amfani da wadannan kayan aiki ne a kan amfani da sauri da kuma sauri matsa lamba aiki ga micro-organisms; duk da haka, su ba za a yi amfani da wani tsabar kammala, idan ba tare da sabis da ruwa.
Tsarin amfani da na'ura mai tsanani na asali na asali za a iya ƙirƙirƙirar ƙwayar kowa a kowace da kuma / ko ƙirƙirar ƙwayar ƙwayar da aka ƙirƙirar a cikin formula.
Ƙarƙwalwar Alcohol za a iya rage ko rage ta ƙirƙirar glicerine da / ko sauran moli na formula.
A cikin gwaje-gwaje, na'ura mai aiki da karfin ruwa na albarkatun da ke ƙirƙirar karfin ruwa na albarkatun na albarkatun na albarkatun na albarkatun na albarkatun na albarkatun na albarkatun na albarkatun na albarkatun na albarkatun na albarkatun na albarkatun na albarkatun na albarkatun da albarkatun.
Allergic contact dermatitis, contact urticaria syndrome, ko hypersensitivity to alcohol ko additives samuwa a cikin albarkatun hanyoyi rare.
Tallace-tallace-tallace-tallace-tallace-tallace-tallace-tallace-tallace-tallace-tallace-tallace-tallace-tallace-tallace-tallace-tallace-tallace-tallace-tallace-tallace-tallace-tallace-tallace-tallace-tallace-tallace
Duk da kyakkyawance, non-aqueous kayan aiki ba za a kammala ma'aikata na organic kayan, amma kawai za a kammala su.
Saboda wannan, na'ura mai aiki da hankali ba tare da sabis da ruwa a ƙirƙirar ƙirƙirar da yawa magungunan magunguna, kamar yadda magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan.
Alcohol-free hand sanitary ingancin ne mai girma a kan kayayyakin da tsari, da kuma tarihi suna da muhimmanci low-performed alcohol da alcohol rubs.
Kyakkyawan lokaci, tsari da ke amfani da benzalkonium chloride ya nuna daidaito da kuma cumulative antimicrobial aiki bayan amfani, ba tare da al'amurran, wanda ya nuna ya rage a ingancin bayan yin amfani da sauƙi, za a yiwuwa saboda matsakaici yanayin yanayin.
Manyan mutane a cikin mahimmanci na low income ba za su iya ba da sabis da kuma amfani da ƙasa ko ƙasa a gaban.
Zafi ko ƙasa za a iya zama mafi kyau fiye da ruwa kawai, amma za a iya zama mafi kyau fiye da sabun.
Wani matsaloli ne cewa idan ƙarfi ko ashi ne tsare da microorganisms, yana iya ƙirƙirar ƙirƙirar magani ko ƙirƙirar shi.
Kamar yadda sabis, ashe ne kuma wani tsare-tsaren, saboda a haɗari da ruwa, yana samar da wani alkali sanyaya.
WHO ya ƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙira
Tsarin ruwan ruwan ruwan ruwan ruwan ruwan ruwan ruwan ruwan ruwan ruwan ruwan ruwan ruwan ruwan ruwan ruwan ruwan ruwan ruwan ruwan ruwan ruwan ruwan ruwan ruwan ruwan ruwan ruwan ruwan ruwan ruwan ruwan ruwan ruwan ruwan ruwan ruwan ruwan ruwan ruwan ruwan ruwan ruwan ruwan ruwan ruwan ruwan ruwan ruwan ruwan.
Ƙararrawa Ƙararrawa Ƙararrawa Ƙararrawa Ƙararrawa Ƙararrawa Ƙararrawa
Running ruwa ne mai ban sha'awa, saboda matsakaita basins za a iya ƙaddamar, yayin da yawan ruwa na ruwa ba za a yi wani farashin.
Later ma'aikata ta hanyar haɓaka su tare da wani yawan sabis, ciki har da ƙasa na ma'aikata, tsakanin ƙasa, da kuma a karkashin hanyoyin.
Sabon ya haifar da bacteria daga ƙarfi, da bincike yana nuna cewa mutane suna son ƙarfi da hankali a lokacin da sabun da aka amfani da fiye da ruwa kawai.
Scrub a kowace 20 seconds.
Scrubbing ya ƙirƙirar shawara, wanda yana taimakawa ka rufe magungunan daga jiki, kuma scrubbing a tsawon lokaci rufe fiye da magungunan magungunan.
Ƙara kyau a karkashin ruwa.
Sanya a cikin basin za a iya ƙirƙirƙirar ma'aikata.
Sauke tare da sauki rubutu ko sauke da iska.
Ƙungiyoyin da aka fi dace da kuma ƙarfin ruwa mai sauƙi ne mai sauƙi da aka ƙirƙirar. The most commonly missed areas are the thumb, the wrist, the areas between the fingers, and under fingernails.
Artificial na'urorin da kuma chipped na'urorin na'urorin za a iya haɓaka microorganisms.
Daidaitacce lotion da aka sauƙi da yawa don tabbatar da ƙaunar da aka rufe; daidaitacce ƙaunar za a iya ƙirƙirar ƙaunar da za a iya ƙirƙirar shigarwa na shigarwa.
" Bincike daban-daban low-cost za a iya yi amfani da su taimakawa tayi a lokacin da cutar ruwa da / ko sabun ba za a iya samuwa, e.g. duba ruwa daga jerrycan ko gurd tare da kyau hole da kuma / ko amfani da ashe idan ake bukata a cikin masana'antu.A cikin matsaloli da kayayyakin ruwa da aka kammala (tallafi ko masana'antu na masana'antu a masana'antu), akwai water-conserving solutions, kamar ""tippy-taps"" da sauran low-cost options. "
A tippy-tap ne mai sauƙi fasaha da amfani da jiki da aka haɓaka ta roba, da kuma matsa lantarki da aka aiki tare da kowane yawan ruwa a kan ma'aikata da kuma wani bar na soap.
Ƙararrawa mai kyau na ma'aikata ne mai muhimmanci sassa na halitta na ma'aikata, amma akwai wani kwarewa game da mafi kyau nau'i na halitta a cikin masana'antu.
Ƙararrawa da yawa na bincike yana nuna cewa rubutu na karfi ne mafi m fiye da na'ura mai aiki da karfin ruwa da aka samu a cikin yawa wasanni.
A 2008, wani bincike da aka gudanar da Jami'ar Westminster, London, da aka gabatar da masana'antu-tallace-tallace masana'antu na European Tissue Symposium, don haɓaka matsaloli na halitta da aka bayar da kudi na kudi-tallace-tallace-tallace-tallace-tallace-tallace-tallace.
Bayan kammalawa da kuma kammalawa ma'aikata tare da na'ura mai zafi da iska, da yawa na bacteria aka samu a karkashin 194% a kan daidaitacce da kuma a kan ƙasa na 254%.
Drying tare da jet-air dryer ya ƙaddamar da karkashin karkashin yawan bacteria a kan daidaitacce da 42% da kuma a kan ƙasa da 15%.
Bayan kammalawa da kuma kammalawa tare da takarda, yawancin bacteria a karkashin karkashin karkashin 76% a kan takarda da karkashin 77% a kan karkashin. Binciken masana'antun da suka yi bincike su kuma gudanar da gwaje-gwaje don ƙirƙirƙirar idan akwai damar haɓaka tsari na sauran masu amfani da dukiya da kuma yanayi na dukiya saboda kowane irin kammalawa.
The jet-air dryer, wanda fuskantar iska daga na'ura a cikin haske na 180 m / s (650 km / h; 400 mph), yana iya fuskantar micro-organisms daga kansa da na'ura da kuma iya haɓaka wasu masu amfani da baƙi da kuma yanayi na baƙi har zuwa 2 meters.
Ƙararrawa Ƙararrawa Ƙararrawa Ƙararrawa Ƙararrawa Ƙararrawa Ƙararrawa Ƙararrawa Ƙararrawa Ƙararrawa Ƙararrawa Ƙararrawa Ƙararrawa
Takardar takarda ba ya nuna ƙarfi na micro-organisms.A 2005 a cikin binciken da aka yi da TÜV Produkt und Umwelt, daban-daban hanyoyin hanyoyi da aka gyara.
Wadannan canje-canje-canje a kan bacterial sayarwa bayan kammalawa:
Manyan daban-daban masana'antun ruwan ruwan ruwan ruwan ruwan ruwan ruwan ruwan ruwan ruwan ruwan ruwan ruwan ruwan ruwan ruwan ruwan ruwan ruwan.
Hand washing ta amfani da hand sanitary wipes ne wani yanayin a lokacin tafiya a lokacin da ba tare da sabis da ruwa.
Alcohol-based Hand Sanitizer ya kamata a hada da har zuwa 60% na alkol.
Medical hanyoyi aka ban sha'awa da yawa bayan Hungarian daktara Ignaz Semmelweis ya samu da ingancin (a 1846) a cikin ci gaba da magana a cikin magungunan magungunan magungunan.
Kuna da kayan aiki na lantarki da ke samar da feedback don gane ma'aikata don sauke ma'aikata a lõkacin da suka so.
Wani bincike ya samu rage yawan jima'i da amfani da su.
Medical tayar-washing ne a cikin mafi yawancin 15 seconds, yin amfani da yawancin sabis da ruwa ko gel don riga da kuma riga kowane ɓangare na maza.
Ma'aikata ya kamata a rubuta tare da digits interlocking.
Idan akwai tsuntsaye a karkashin na'urar, wani bristle brush za a iya amfani da shi.
Saboda bacteria za a iya zama a cikin ruwa a kan ma'aikata, yana da muhimmanci don kammala da kuma kammala da sauri tare da mai sauki rubutu.
Bayan suƙoƙi, takarda za a yi amfani da ruwa (da kuma buga wani yanki idan ake bukata).
Yadda za a canza re-contamination na ma'aikata daga wadannan surface.
"Tare da tayi-washing a cikin magani setting ne don rufe magani microorganisms ("" germs") da kuma rage su canza. "
The New England Journal of Medicine ya gabatar da cewa matsaloli na hanyoyin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin.
Wani bincike ya nuna cewa dace-gizo da kuma sauran tsari na sauki za a iya rage da yawan tsari na tsari da tsari na tsari na tsari na 66%.The World Health Organization ya gabatar da karatu wanda ya gabatar da ƙaddamar da tsari na tsari da tsari a cikin masana'antu masana'antu.
Tsarin hanyoyi na halitta na hanyoyi ta shirye-shirye za a iya samuwa a kan shafin yanar gizo don jama'a comment.
Shawarar da muhimmanci review da Whitby et al.
Masana'antun kasuwanci za a iya karanta da kuma karanta hankali, idan ake bukata na daidaitacce.
"World Health Organization yana da "Five Moments" ga 'yan mata: "
Bayan ƙaddamar da damu / body fluids
kafin aiki aseptic, kuma
Tsarin antiseptic chemicals zuwa sabis (""medicated" ko "antimicrobial" sabis) ya ƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙiri. "
Wannan matsaloli zai iya dacewa kafin yi aiki ko a cikin yanayi a cikin abin da haihuwa da ban mamaki-tallace-tallace.To 'scrub' 'yan ku'yarwa ga aiki, yana da bukatun da za a iya sauke da kuma sauke ba tare da su ba tare da su tare da ku, wasu chlorhexidine ko iodine rufe, sterile rubutun don riga ma'aikata bayan riga, da kuma wani sterile tsari don rigawa da kuma wani sterile kayan aiki don rigawa a karkashin mata.
Duk wani jewelry ya kamata a ƙara.
Wannan tsari yana da mahimmanci da ƙaunar ƙaunar ƙaunar ƙaunar ƙaunar ƙaunar ƙaunar ƙaunar ƙaunar ƙaunar ƙaunar ƙaunar ƙaunar ƙaunar ƙaunar ƙaunar ƙaunar ƙaunar ƙaunar ƙaunar.
Long scrub times (10 min) ba za a bukatar.
Kada rufe, ruwa a kan abun ciki za a iya haƙĩƙa daga rigawa daga cikin hanyoyin.
Bayan tayi-washing ne kammala, kammala ne tare da wani sterile ƙarfi da kuma wani na'urorin jiki ne donated.
Za a rage ƙaddamar da microbes, shi ne mafi kyau don sauke ku, ko amfani da tayi antiseptic kafin da kuma bayan haƙĩƙa a kan wani magani.
Domin ci gaban staphylococcal sinadaran a cikin magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magunguna.
Saukewa tare da sabun tsaye ya yi a fiye da triple da yawan bacterial magani tsaye zuwa kayayyakin kamar yadda saukewa tare da sabun antibacterial.Yarƙawar saukewa tare da sabun na asali tare da saukewa tare da sabun antibacterial a kan lokaci na 30 seconds kowane ya nuna cewa saukewa tare da ruwan albarkatun ya rage bacterial tsarewa 26% fiye da sabun antibacterial.
But soap and water is more effective than alcohol-based hand rubs for reducing H1N1 influenza A virus and Clostridium difficile spores from hands.Interventions to improve hand hygiene in healthcare settings can involve education for staff on handwashing, ƙirƙirar samfurin na alcohol-based handwashing, da kuma lissafi da kuma tallace-tallace alama ga ma'aikata.
Yana da bukata don ƙarin bincike game da abin da suka yi amfani ne mafi kyau a cikin daban-daban matsaloli.
A cikin masana'antu masana'antu, tayi tare da sabunta suna sani a matsayin kasuwanci da muhimmanci kayan aiki don samun kyau jiki, kuma ko da kyau abinci.
Duk da haka, ba tare da kayayyakin ruwa, sabis ko na'ura mai aiki da kanka a cikin gida, a cikin koyarwa da a cikin yanayin aiki, yana da matsaloli don samun daidaito na'ura mai aiki da kanka.
Saboda haka, a cikin mafi girma na masana'antu Afrika, hanyoyin hanyoyin hanyoyin hanyoyin hanyoyin hanyoyin hanyoyin hanyoyin hanyoyin hanyoyin hanyoyin hanyoyin hanyoyin hanyoyin hanyoyin hanyoyin hanyoyin hanyoyin hanyoyin hanyoyin hanyoyin hanyoyin hanyoyin.
Duk da haka, low hanyoyin hoto da za a iya zama matsaloli na hanyoyin hoto fiye da matsaloli ko ruwa.
Ƙirƙirar da ƙirƙirar ƙirƙirar ƙirƙirar ƙirƙirar ƙirƙirar ƙirƙirar ƙirƙirar ƙirƙirar ƙirƙirar ƙirƙirar ƙirƙirar ƙirƙirar ƙirƙirar ƙirƙirar ƙirƙirar ƙirƙirar ƙirƙirar ƙirƙirar ƙirƙirar ƙirƙirar ƙirƙirar ƙirƙirar ƙirƙirar ƙirƙirar ƙirƙirar ƙirƙirar ƙirƙirar ƙirƙirar ƙirƙirar ƙirƙirar ƙirƙirar ƙirƙirar ƙirƙirar ƙirƙirar ƙirƙirar ƙirƙirar ƙirƙirar ƙirƙirar ƙirƙirar ƙirƙirar.
Domin wannan aiki da kyau, monitoring da assessment ne da ake bukata.
" A tsarin bincike na 70 bincike ya nuna cewa yanar gizo na jama'a da aka yi amfani da ci gaba da hankali a cikin LMICs, yayin da masana'antun masana'antun masana'antun masana'antun masana'antun masana'antun masana'antun a jami'o'i ne "Three Star Approach" da UNICEF wanda ke ƙirƙirar jami'o'i don yin tsanani, mafi kyau mataki don tabbatar da cewa dalibai zauna ma'aikata tare da sabun, tsakanin sauran mahimmanci. "
Kuma a lokacin da yawancin kayayyakin suna samu, dalibai za su iya canza daga daya zuwa karshe uku stars.
Tare-tallace-tallace-tallace-tallace-tallace-tallace-tallace-tallace-tallace-tallace-tallace-tallace-tallace-tallace-tallace-tallace-tallace-tallace-tallace-tallace-tallace-tallace-tallace-tallace-tallace-tallace-tallace-tallace-tallace-tallace-tallace-tallace-tallace-tallace
Global Handwashing Day ne wani manyan misali na kwarewa wanda ya ba da sha'awa don samun daidaitaccen canje-canje.A cikin matsaloli na coronavirus 2019-20, UNICEF ya ƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙiri.
Kyakkyawan bincike da aka kira kudin kudi na kudi na tayi a cikin kasashe da ci gaba a kan DALYs ajiya.
Duk da haka, wani bincike yana nuna cewa inganta tayi tare da sabunta ne daidai da mafi kudi-tallace-tallace da sauran ruwa da sanitary ayyuka.
"The muhimmanci na ƙaunar ƙaunar ƙaunar ƙaunar ƙaunar ƙaunar ƙaunar ƙaunar ƙaunar ƙaunar ƙaunar ƙaunar ƙaunar ƙaunar ƙaunar ƙaunar ƙaunar ƙaunar ƙaunar ƙaunar ƙaunar ƙaunar ƙaunar ƙaunar ƙaunar ƙaunar ƙaunar ƙaunar ƙaunar ƙaunar ƙaunar ƙaunar ƙaunar ƙaunar ƙaunar ƙaunar ƙaunar ƙaunar ƙaunar ƙaunar ƙaunar ƙaunar ƙaunar ƙaunar ƙaunar ƙaunar ƙaunar ƙaunar ƙaunar ƙaunar ƙaunar ƙaunar ƙaunar ƙaunar ƙaunar ƙaunar ƙaunar ƙaunar ƙaunar ƙaunar ƙaunar ƙaunar ƙaunar ƙaunar ƙaunar ƙaunar ƙaunar."
A lokacin da yawa da yawa da suka yiwuwa cewa magungunan da aka haifar da matsaloli da aka sani da miasmas.
A cikin 1980s, matsaloli-tallace-tallace da kuma matsaloli-tallace-tallace-tallace da aka ƙirƙirar Amurka Centers for Disease Control da Prevention don ƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙiri.
Tsarin tsuntsaye na tsarkakewa a 2009 da kuma COVID-19 pandemic a 2020 ya ƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙira.
"Kama, takardun da "make-make-make-make-make-make-make-make-make-make-make-make-make-make-make-make-make-make-make-make-make-make-make-make-make-make-make-make-make-make-make-make-make-make-make-make-make-make-make-make-make-make-make-make-make-make-make-make-make-make-make-make-make-make-make-make-make-make-make-make-make-make-make-make-make-make-make-make-make-make-make-make-make-make-make-make-make-make-make.
"The phrase "washing one's hands of" wani abu, shi ne ya sayar da sha'awar da sha'awar da sha'awar da wannan abu ko samar da sha'awar a cikin shi. "
Yana da asali daga albarkatun Almasihu a Matiyu a lokacin da Pontius Pilate ya sauke kammala daga kwarewa don haƙĩƙa Yesu Kristo, amma ya zama wani albarkatun da amfani da yawa mafi girma a wasu Ingila albarkatun.
A cikin Shakespeare's Macbeth, Lady Macbeth yana fara tsare-tsarensa a cikin kwarewa don taimakawa don sauke wani na'ura mai ban sha'awa, ya nuna sha'awar da sha'awar da suka gabatar da matsaloli da ya haƙĩƙa ma'aikata.
Yawan da aka samu cewa mutane, bayan da suka gane ko dace da hanyoyin ban sha'awar, za su son ƙwayar ƙwayar da sauran, kuma za su ji dadin hanyoyin ruwan ruwan ruwan ruwan.
"Baya da haka, waɗanda suka dace su su sauke kakewa bayan kyakkyawan kyakkyawan yana da matsala a cikin sauran 'raba'yarwa 'tallace-tallace-tallace-tallace-tallace-tallace-tallace-tallace-tallace-tallace-tallace-tallace-tallace-tallace-tallace-tallace-tallace.
Religions ƙirƙirar ƙirƙirar ƙirƙirar ƙirƙirar ƙirƙirar ƙirƙirar ƙirƙirar ƙirƙirar ƙirƙirar ƙirƙirar ƙirƙirar ƙirƙirar ƙirƙirar ƙirƙirar ƙirƙirar ƙirƙirar ƙirƙirar ƙirƙirar ƙirƙirar ƙirƙirar ƙirƙirar ƙirƙirar ƙirƙirar ƙirƙirar ƙirƙirar ƙirƙirar ƙirƙirar ƙirƙirar ƙirƙirar ƙirƙirar ƙirƙirar ƙirƙirar ƙirƙirar ƙirƙirar ƙirƙirar ƙirƙirar ƙirƙirar ƙirƙirar ƙirƙirar ƙirƙirar ƙirƙirar ƙirƙirar ƙirƙirar ƙirƙirar ƙirƙirar ƙirƙirar ƙirƙirƙiri.
Hinduism, Yahudaism da Islam ƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙiri.
Kuma, Hinduism, Buddhism, Sikhism, Yudaism da Islam ba da sha'awar kafin da kuma bayan kowane abinci.
Ƙungiyar Ƙungiyar Ƙungiyar Ƙungiyar Ƙungiyar Ƙungiyar Ƙungiyar Ƙungiyar Ƙungiyar Ƙungiyar Ƙungiyar
Workplace hazard controls for COVID-19 ne aikace-aikace na kasuwanci da kuma halitta da kayan aiki ga hazard controls to prevention of coronavirus disease 2019 (COVID-19).
Ƙararrawa Ƙararrawa Ƙararrawa Ƙararrawa Ƙararrawa Ƙararrawa Ƙararrawa Ƙararrawa Ƙararrawa Ƙararrawa Ƙararrawa Ƙararrawa Ƙararrawa Ƙararrawa Ƙararrawa Ƙararrawa Ƙararrawa Ƙararrawa
Saboda U.S. Occupational Safety and Health Administration (OSHA), wurare da ƙananan matsa lamba na ƙananan matsa lamba yana da matsa lamba tare da jama'a da sauran ma'aikata, domin abin da aka ba da matsa lamba na lamba, ciki har da tayi, ƙirƙirar ma'aikata don zama a cikin gida idan su ne magani, na halitta na halitta, da kuma ci gaba da halitta da kuma halitta na aiki na yanki.
Ƙararrawa na matsaloli na matsaloli ya hada da waɗanda suka bukatar matsaloli na matsaloli ko matsaloli tare da mutane waɗanda ba za su sani ko san da COVID-19, amma za su iya rage saboda ƙaddamar da jama'a ko kasashen waje tafiya.
Wannan ya hada da ma'aikata da suka haɗa tare da jama'a, kamar a cikin koyarwa, aiki yanayi tare da high-tensity, da wasu high-volume retail settings.
Ƙarƙwalwar Ƙarƙwalwar Ƙarƙwalwar Ƙarƙwalwar Ƙarƙwalwar Ƙarƙwalwar Ƙarƙwalwar Ƙarƙwalwar Ƙarƙwalwar Ƙarƙwalwar Ƙarƙwalwar Ƙarƙwalwar Ƙarƙwalwar Ƙarƙwalwar Ƙarƙwalwar Ƙarƙwalwar Ƙarƙwalwar Ƙarƙwalwar Ƙarƙwalwar Ƙarƙwalwar Ƙarƙwalwar Ƙarƙwalwar Ƙarƙwalwar Ƙarƙwalwar Ƙarƙwalwar Ƙarƙwalwar Ƙarƙwalwar Ƙarƙwalwar Ƙarƙwalwar Ƙarƙwalwar Ƙarƙwalwar Ƙarƙwalwar Ƙarƙwalwar Ƙarƙwalwar Ƙarƙwalwarar Ƙarƙwalwarar Ƙarƙwalwarar Ƙarƙwalwarar Ƙarƙwalwarar Ƙarƙwalwarar Ƙarƙwalwararƙwalwarar Ƙarƙwalwarar Ƙarƙwalwarar Ƙarƙwalwarar Ƙarƙwalwarar Ƙarƙwalwararƙwalwarar Ƙarƙwalwarar Ƙar Ƙarƙwalwararƙwalwarar Ƙar Ƙarƙwalwararƙwalwarar Ƙarƙwalwarwarar Ƙar Ƙar Ƙarƙwalwarwarar Ƙar Ƙarƙwalwarar Ƙarƙwalwarar Ƙarƙwalwarwarar Ƙar Ƙar Ƙar.
OSHA ya kira masu sana'a da masu sana'a ma'aikata da aka kwatanta da mutum da aka sani ko san cewa yana da COVID-19 ne a high kwatanta jiki, wanda ya ƙara zuwa high kwatanta jiki idan masu sana'a yi aerosol-generating hanyoyin a kan, ko samu ko hanyoyin samfurori daga, aka sani ko sanannen mutum da COVID-19.
Ƙararrawa Ƙararrawa Ƙararrawa Ƙararrawa Ƙararrawa Ƙararrawa Ƙararrawa Ƙararrawa Ƙararrawa Ƙararrawa Ƙararrawa Ƙararrawa Ƙararrawa Ƙararrawa Ƙararrawa Ƙararrawa Ƙararrawa Ƙararrawa Ƙararrawa Ƙararrawa Ƙararrawa
COVID-19 matsa lamba za a iya da yawa matsa lamba a cikin yanayin aiki.
Ma'aikata za su iya ba tare da aiki saboda za su zama magani, za su bukatar ka taimakawa da sauran, ko daga rage na iya rage.
Shirin kasuwanci za a iya canza, duk a kan abin da kayayyakin da ake bukata, da kuma kayayyakin da aka samu da kayayyakin (tallace-tallace-tallace-tallace-tallace-tallace-tallace).
Yanzu, samfurori na kayayyakin daga yanki da aka rarraba da COVID-19 za a iya rarraba. A tsari na jima'i da jima'i na jima'i za a iya amfani da shirye-shirye na jima'i.
Plans daidaita da mataki da aka kwatanta da daban-daban wurare da ayyuka, ciki har da kayayyakin ƙarfi, mataki da ke daidaita daga gida da jama'a yanayi, da mataki da mataki na kowane ma'aikata kamar ƙauna ko mataki na jiki.
Yana da ƙirƙirar hanyoyin da ake bukata da gaskiya, da kuma zane-zane-zane don yanayin da za a iya kafa a matsayin matsaloli.
Ƙwararrawa da tsari na magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magunguna.
Tare da matsaloli ga matsaloli na matsaloli sun hada da rage matsaloli tsakanin ma'aikata, haɓaka mutane da ke da matsaloli na matsaloli, ci gaba da ayyukan kasuwanci, da kuma rage matsaloli a kan sauran al'amari a cikin kayayyakin sha'awar.
Ƙananan magani na magani a cikin jama'a inda kamfanin yana located ya haɗa da yanayin da aka samu.
The hierarchy of hazard controls ne wani framework da aka amfani da a cikin kasuwanci da kayan aiki don ƙirƙirar hazard controls by effectiveness.
Kamar yadda haɗari na COVID-19 ba za a iya haɓaka, da mafi kyau controls ne injiniya controls, da suka wuce administrative controls, da kuma karshe personal protective equipment.
Engineering kudin hada da ƙirƙirar ma'aikata daga wurare-tallace-tallace ma'aikata ba tare da ƙirƙirar ma'aikata, kuma za a iya zama mafi kudi-tallace-tallace-tallace.
Ƙararrawa Ƙararrawa Ƙararrawa Ƙararrawa Ƙararrawa Ƙararrawa Ƙararrawa Ƙararrawa Ƙararrawa Ƙararrawa Ƙararrawa Ƙararrawa Ƙararrawa Ƙararrawa
Personal Protective Equipment (PPE) yana daidai ba da ingancin fiye da injiniyoyi da kuma horo, amma za a iya taimakawa don taimakawa wasu matsa lamba.
All types of PPE must be selected based on the hazard to the worker, properly fitted as applicable (e.g., respirators), consistently and properly worn, regularly inspected,ined, and replaced, as necessary, and properly removed, cleaned, and stored or disposed of to avoid contamination.
Bisa ga U.S. Occupational Safety and Health Administration (OSHA), wurare na ƙarfi na ƙarfi na ƙarfi na ƙarfi na ƙarfi na ƙarfi na ƙarfi na ƙarfi na ƙarfi na ƙarfi da ƙarfi na ƙarfi da ƙarfi na ƙarfi.
Basic magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magunguna.
Kyakkyawan takaddun shaida da kuma ƙirƙirar masu ban sha'awa ne mai muhimmanci mataki a cikin haɓaka ma'aikata, abokan ciniki, masu ziyarci, da kuma sauran a cikin wurare.
The U.S. Centers for Disease Control da Prevention (CDC) yana ƙara cewa ma'aikatar da suke da matsaloli na acute ƙarfin jiki za su zama a cikin gida kafin za su zama free daga matsaloli, matsaloli na matsaloli, da sauran matsaloli a kowace 24 sa'o'i ba tare da amfani da matsaloli-daidaitacce ko sauran matsaloli-daidaitacce, da kuma cewa matsaloli takardar kebantawa ne m, damar ma'aikata zama a cikin gida don taimakawa ga wani matsaloli, da kuma cewa ma'aikatar da aka sani da wadannan takardar kebantawa.
Bayan OSHA, matsakaici matsakaici na matsakaici sun hada da waɗannan da ke bukatar matsakaici ko matsakaici a cikin ƙananan matsakaici (1,8 m) na mutane da ba za a san ko san COVID-19 matsakaici, amma za a iya rage tare da SARS-CoV-2 saboda ƙaddamar da jama'a a kan kasuwanci yanki, ko saboda mutum ya dace kasa da kasa tafiya zuwa wani yanki tare da ƙaddamar COVID-19.
Wadannan sun hada da ma'aikata da suka haɗu tare da jama'a, kamar a cikin koyarwa, wuraren aiki na high-tensity, da wasu girma-tallace-tallace-tallace-tallace-tallace-tallace-tallace-tallace-tallace-tallace-tallace-tallace-tallace-tallace-tallace-tallace-tallace-tallace-tallace-tallace-tallace-tallace-tallace-tallace-tallace-tallace-tallace-tallace-tallace-tallace-tallace-tallace-tallace-tallace-tallace-tallace-tallace-tallace-tallace-tallace-tallace-tallace-tallace-tallace-tallace-tallace-tallace-tallace-tallace-tallace-tallace-tallace-tallace-tallace-tallace-tallace-tallace-tallace-tallace-tallace-tallace.
Ma'aikata a cikin wannan ƙarfin jiki rare bukatar amfani da respirators.
Idan mutum ya zama magana a kan jirgin sama, da ake bukata don sarrafa ma'aikata da sauran abokan ciniki sun hada da ƙirƙirar magana daga sauran mutane da tsawon 6 feet, ƙirƙirar wani ma'aikata don taimakawa da magana, da kuma ba da maski don magana ko ba da magana don ƙafafafa da ƙafafa tare da ƙafafafa a lokacin da kewaye ko kewaye.
Cabin abokin ciniki za su yi amfani da hankali mai sauƙi a lõkacin da suka zo a kan wani matsa lamba, ko yaushe jiki na jiki, ko damar haɓakawa yanki, da kuma iya amfani da masu ƙarin haɓakawa idan matsa lamba yana da matsa lamba, matsa lamba, ko matsa lamba.
Kyakkyawan da sauran abubuwa da ake amfani da kowane lokaci za a ba a cikin biohazard kayan, da kuma ƙarfi da aka sauke da kuma kammala bayan. Ga kasuwanci jirgin sama, ciki har da jiragen ruwa jiragen ruwa da sauran abokin ciniki jiragen ruwa, haɓaka da hasken rana sun hada da ƙirƙirar tafiya a lokacin magani, da kuma ƙirƙirarwa da kuma ban sha'awa a cikin jirgin kasa magani har yanzu idan mutum yana ci gaba da magani ko wasu magani a lokacin da a karkashin.
Ƙararrawa, Ƙararrawa Ƙararrawa, Ƙararrawa, Ƙararrawa, Ƙararrawa, Ƙararrawa, Ƙararrawa, Ƙararrawa, Ƙararrawa, Ƙararrawa, Ƙararrawa, Ƙararrawa, Ƙararrawa, Ƙararrawa, Ƙararrawa, Ƙararrawa, Ƙararrawa, Ƙararrawa, Ƙararrawa, Ƙararrawa, Ƙararrawa, Ƙararrawa, Ƙararrawa, Ƙararrawa, Ƙararrawa, Ƙararrawa, Ƙararrawa, Ƙararrawa, Ƙararrawa, Ƙararrawa, Ƙararrawa, Ƙararrawa, Ƙararrawa, Ƙararrawa, Ƙararrawa, Ƙararrawa, Ƙararrawa, Ƙararrawa, Ƙararrawa, Ƙararrawa
Kada akwai minimally zuwa moderately jama'a transmision, sosai distancing hadin gwiwa za a iya gyara kamar cancellation yanar gizo, gundumar, da kuma sauran manyan gundumar kamar jiki ko chore lissafi ko abinci a cikin kafetaria, ƙirƙirar yanki tsakanin tabbas, tsanani da kwarewa tsawon lokaci, ƙirƙirar abokan ciniki, da kuma amfani da wani musamman health office yanki domin mutane da mayar da gaskiya-kayan magani.
Kada yana da muhimmanci ƙirƙirar a cikin jama'a, fiye da hadin gwiwa na jima'i, ƙarƙirar ƙirƙirar koyarwa na koyarwa za a iya karanta.Dangane masu aiki na gwiwar ma'aikata da ke aiki na yau da kullum, matsaloli na jima'i da aka sani da low da CDC.
Kasuwanci na hukunci da ke da haɗari tare da mutane da aka gabatar da ko da gyara cewa yana da COVID-19 sun amsa da samfurori da hanyoyin da hankali, ciki har da kyau personal protective equipment.
If close contact occurs during apprehension, ma'aikata ya sauke da sauke da sauki da kuma kayan aiki kafin yin amfani da kayan aiki ta amfani da kayan aiki na gida, da kuma karkashin tsarin aiki don sauke da sauki PPE da kuma don sauke da sauke kayan aiki.
OSHA yana san cewa wasu ma'aikata da masu sana'a ma'aikata suna a high ko very high category of exposure risk.
High-risk aiki sun hada da sabis samar, taimako, gwaji, da kuma magungunan jiragen ruwa ma'aikata da aka kwatanta da sanannun COVID-19 ma'aikata.
Wadannan za su zama mafi girma ƙarfi idan ma'aikata yi aerosol-generating tsari, ko ƙirƙirar ko ƙirƙirar samfurori daga, sanannun ko sanannun COVID-19 ma'aikata.
Aerosol-generating tsari sun hada da intubation, cough induction tsari, bronchoscopies, wasu tsari da kuma bincike, ko invasive samfurori.
High matsa lamba matsa lamba aiki sun hada da ma'aikata da sha'awar jiki na mutane da aka san ko san matsa lamba na COVID-19 a lokacin da su zama; wadannan zama mafi girma matsa lamba lamba idan su yi autopsy.Additional injiniyoyi dubawa ga wadannan matsa lamba sun hada da ƙirƙirar wuri ga matsa lamba da COVID-19 da aka san ko san, ciki har da lokacin da aerosol-generating ayyuka suna yi.
Specialized negative pressure ventilation za a iya dace a wasu magani da kuma mortuary settings.
Samfurori za su yi aiki tare da Biosafety Level 3 tsare-tsare.
The World Health Organization (WHO) yana ƙirƙirƙirar cewa magani da aka sauke a cikin daban-daban yanki a kan dace da su ne kowacin COVID-19 kasuwa.Baya daga sauran PPE, OSHA yana ƙirƙirƙirar ƙirƙirar ga waɗanda suka aiki a cikin 6 feet na magani da aka sani da su, ko san cewa za su zama, da SARS-CoV-2, da kuma waɗanda suka yi aerosol-generating tsari.
A Amurka, NIOSH-tallace N95 filtering facepiece respirators ko mafi kyau za a yi amfani a cikin hadin gwiwar, written respiratory protection shirin wanda ke hada da fit-testing, horo, da magani.
Other types of respirators can provide greater protection and improve worker comfort.The WHO ba shawarar coverals, kamar yadda COVID-19 ne wani magunguna na halitta, kuma ba za a canza ta hanyar jiki.
WHO yana ƙirƙirƙirar kawai maskara ga ma'aikata na checkpoint.
Ga waɗanda suka samu samfurori na halitta daga, haɓaka, ko ƙirƙirar COVID-19 ma'aikata ba tare da wani tsari na aerosol-generating, WHO ta ƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙiri.
Idan aerosol-generating tsari da aka yi, da maski ne mai tsari da N95 ko FFP2 respirator.
Saboda cewa duniya samfurin PPE ne m, WHO yana ba da shawara don rage bukatar ga PPE ta hanyar telemedicine, jiki ƙarfi, kamar yadda za a ba da dukiya, don ba kawai waɗanda suka yi amfani da tsabar kyakkyawan tsabar kyakkyawa don ba a cikin wuri tare da wani COVID-19 magani, yin amfani da kawai PPE da ake bukata don daidai da aiki, ci gaba da amfani da wannan tsabar kyakkyawa ba tare da sauke shi yayin da kewaye masu yawa masu magani da wannan magani, da kewaya da kuma haɓaka tsabar kyakkyawa na PPE, da kewaya da amfani da masks ga mutane da ke ba da magani.
Katherine Maher, CEO na Wikimedia Foundation
TO: Dukkan aiki na Wikimedia Foundation
SUBJECT LINE: [Covid-19] Ƙirƙirar Ƙirƙirar Ƙirƙirar Ƙirƙirar Ƙirƙirar Ƙirƙirar Ƙirƙirar Ƙirƙirar Ƙirƙirar Ƙirƙirar Ƙirƙirar Ƙirƙirar
DATE/TIME: 14 Maris, 2020, 00:24 UTC
LICENSE: CC0: Duk haƙƙoƙin haƙƙoƙin haƙoƙin
Za mu samu a cikin mahimmanci a wannan watan.
COVID-19 epidemic ne abin da ya sauke mu duniya al'umma al'umma da kuma wajibi mu da wani.
Za mu ba da kwarewa ga matsaloli, amma mu san cewa mu mafi kyau yanayin ne a kan irin wannan duniya empathy, kamfanoni, da cibiyoyin gine-gine da aka samu a cikin yammacin wannan shirye-shirye.
The camaraderie da sha'awar da za mu nuna tsakanin duk mu kolega a kan email, tallace-tallace, da chat ne mai ban sha'awar da ban mamaki mutane da muke maye aiki tare da.
Ina za a iya zama mafi kyau da kuma bangarori don sayar da ku a matsayin ma'aikata.
Last week, wani mutum ya ƙirƙirar da ni da shawara ga aiki da mu.
Yana ƙaddamar da abin da yana da muhimmanci don duniya zai iya karanta zuwa Wikipedia a yanzu, da kuma yadda wani karfi alama shi ne don wannan muhimmanci kayayyakin zama online da aka samuwa ga dukkan.
Kayan aiki yana yiwuwa wannan, ko kana dauke da shafin yanar gizo, ko mu ma'aikata da aka bayar, ko mu jama'a mai sarrafawa.
The duniya yana bukatar bayanai da Wikipedia ya samar, yanzu fiye da kadan.
Wannan shi ne a lokacin da ba kawai abin da mu yi, amma yadda mu yi shi, za su yi da muhimmanci matsala a duniya.
Saboda da muhimmanci na wannan ayyuka da al'ada a cikin shi, za mu yi wasu muhimmanci canji-canji a kan yadda za mu aiki tare da mu, a karkashin wannan makonni.
Ƙirƙirar a kan ayyuka da kuma takardar kebantawa
Kamar yadda Robyn ya ce a karshe, c-taimakewa ya gabatar da karshe don tallace-tallace da aikace-aikace na gaba da kwanakin da watanni.
A cikin wannan jima'i, mu daidaita da abin da za mu san shi zai zama mai kyau yanayin ga abin da mu daidaita da kuma mafi kyau hanyoyi don ƙirƙirar shirye-shirye a lokacin da wannan lokaci.
Saboda haka, za mu so su canza stress da kuma taimaka mu misali a tsawon lokaci.
Idan kana bukatar ka saukewa, shi ne a kansa.
Ga dukan ma'aikata, abokan ciniki, da abokan ciniki:
Our yanayin aiki na yau da kullum zai zama game da 4 sa'o'i a rana, ko 20 sa'o'i a makonni kafin karantawa.
Za mu yi shawarar kudi - idan za ka iya aiki da mafi yawan lokaci, aiki za ka iya amfani da ku.
Duk da haka, duniya ne mai ban sha'awa a yanzu, kuma ko kana bukatar ka taimakawa da suka fi so, samun kayayyakin kayayyakin, ko zo zuwa dabbobi, ma'aikata ne mu matsaloli.
Za mu yiwuwa da lokaci.
Idan kana so, ba ka yi aiki.
Wannan ya kamata a fara ba, amma mu ce shi.
Kowace rana ko PTO da ake bukata - kawai ce manajanka da kuma taimakawa tawagar da kalendarwa da takardar kebantawa don tabbatar da kewayon aiki suna ƙunshi.
(Kai ka samu diagnosis positive ga COVID-19, don Allah ba Bryan a cikin T&amp;C Ops sani don haka T&amp;C iya taimakawa tare da taimakawa da kuma tabbatar da cewa yanayin da aka samu da bukatun sha'awa daga management).
Hourly masu zaman kansu za su yi bayar da cikakken.
Za mu ya ce, kuma za mu gamsar da sha'awa mu ga abokan ciniki da masu zaman kansu.
Kowane mutum zai zama bayarwa a kan kowane lokaci da suka yi aiki a lokacin da kowane lokaci.
Wannan ya hada da idan kana so kuma ba za a iya aiki.
Idan kana so ka aiki, mu taimaka ka.
Manyan mutane suna amfani da aiki a matsayin hanyar canalizing sha'awar su tare da duniya kusa da mu.
Yadda za mu yi, za mu iya zama ban mamaki, musamman a lokacin da wannan.
Yanzu, shi ne game da ku.
Our tambayoyi ne cewa ka saita tare da manajanka, don haka mu san abin da za a yiwuwa da kuma za a iya canza da yaushe.
wasu aiki da aka sani da muhimmanci.
Kuna wasu abubuwa da za mu yin.
The SRE, HR Ops, Trust & Safety, da kuma Fundraising tawagar (m.m.
Za mu fara tsari tare da duk departments don duba da mahimmanci a yanzu da kuma za mu tafi da hankali don taimakawa abin da ake bukata don mu misali.
Za mu da yawa da za mu yi, za mu duba a cikin mafi muhimmanci ayyuka.
Sauke yanzu ba zai sauri sauƙi.
Muna ba da aikace-aikace don "dubble-time to catch up" a lokacin da pandemic ya gabatar.
Za ka ba za a koyar da sa'o'i don ƙaddamar da takardar kebantawa wanda yanzu ba ne realist.
Tuntube da cewa yanayin da aka canza, kuma za mu aiki don ƙirƙirar sabon mataki da lokaci inda ake bukata.
Yadda za a yi amfani da APP (Annual Planning)?
Saboda haka, don ƙaddamar da sabon al'amurran aiki da aikace-aikace na yau da kullum, za mu shirya aikace-aikace don ƙirƙirar Aikace-aikace na 2020-2021.
Our aikace-aikace ne ya ce da ƙirƙirar aikace-aikace na 2019-2020 wanda zai ba da ƙarin lokaci don zuba jari don taimakawa ma'aikata don ƙirƙirar matsaloli, kammala, da kuma taimakawa ga ma'aikace-aikacen, yayin da za a taimakawa ga waɗanda suka bukatar ko za su iya aiki a ƙarƙirƙirar lokaci a cikin wasu makonni.
Wannan aikace-aikace na aikace-aikace ya ƙarƙirar ƙarƙirar aiki na aikace-aikace da kuma ƙarƙirar a kowace shirye-shirye.
Za mu ƙirƙirar ƙirƙirar mu da Birtaniya a cikin Birtaniya a cikin makonni da kuma za mu gabatar da ƙirƙirar da ƙirƙirar a kan ƙirƙirar ƙirƙirar.
Thanks to tawagar APP ga tafiya a cikin wannan.
Office status, shigarwa, da kuma shigarwa
Last week, mu karanta cewa daya daga cikin mu SF-based kolega za a iya daidaita da COVID-19 virus.
Duk da ƙarfi mai tsanani, mun shawarar mai tsanani mai tsanani mai tsanani don ƙirƙirar dukan yanki a kan San Francisco office.
Ya yi amfani da yanayin anti-virus na hospital-grade don fitar da kowane yanki, kamar yadda na lobby da lift banks zuwa mu karkashin.
The gine-gine yana amfani da harsuna na duty-of-care ta amfani da kayayyakin da ke taimakawa da kayan aiki na abokan ciniki.
Za mu ji dadin cewa ofishin zai zama da kyau a lokacin da za mu karanta da ku.
Our DC ofishin yana located a cikin WeWork, wanda ya gabatar da COVID-19 protocol tare da mu da kuma dukan DC-based ma'aikata.
Kamar yadda ya wuce rana, mu DC ofishin tafi zuwa wani cikakken remoto setup a karkashin hanyoyin da aka gabatar da San Francisco.
Kamar yadda wasu daga mu New York-based ma'aikatar da san, mu kuma kasance a hadin gwiwa game da leasing wani yanki a Brooklyn.
Wannan tallace-tallace ne a faruwa, amma za a iya ƙara.
wasu masu zaman kansu suna aiki tare da tsawon lokaci na farko.
Our long-term remote colleagues san cewa shi zai iya zama wani adjustment, kuma za su so ka bayar da wasu sabis:
Ƙara tsawon yanayi zuwa mafi girma na daya ko biyu sa'o'i.
Shin da yawa sesiyoyin da ake bukata, duba yadda za a iya rage su a karkashin kwanaki da yawa.
Shawarwar da makonni, da agenda, da kuma sauke reading kayayyakin a karkashin.
Yadda za a yi video, tare da kayayyakin kamar Google Docs da Zoom don taimakawa da samar da yanar gizon.
Yawo wani lead don taimakawa kowane gundumar, wani mutum don kammala chat ga tambayoyi da kuma gudanar da lissafi na speaker, da wani mutum don taimakawa da alama (ko yi aiki tare da alama).
Sauke email to tech support idan kana bukatar m headset.
Yadda za a yi amfani da your wellness refund for snacks.
Sauke #remoties channel a Slack don magana tare da ma'aikata game da aiki da aka gabatarwa
HR Operations tawagar ne a cikin webinar-based ergonomics magani don taimakawa da ci gaba da aiki a kan Foundation.
Yau a cikin wannan makonni, mun ba mu ba da abokan ciniki na jama'a don buga ayyuka masu amfani da Wikimedia, kamar editathons, har zuwa WHO ya gabatar da pandemic.
Za mu san cewa za mu san cewa bukatun mu ga cancellations da sauran kudi za a iya yiwuwa don ƙaddamar da ayyuka da aka gabatar da kudi da kuma cewa ba zai zama hukunci ga ba za a haɗari ko canzari waɗannan mataki.
Wannan makonni na gaba za mu ci gaba da ƙarin ƙirƙirar a kan Wikimania da sauran yankin da kwarewa gundumar gundumar.
Ƙungiyoyi daga ko'ina duniya jama'a yana da matsala a kan ƙarfi, amma sauƙi a kan ƙarfi da kuma damar dace a kan mahimmanci, Wikimedia da sauransu.
Kamar yadda ya wuce, CRT yana aiki don kafa shafin a kan Meta-Wiki don samar da yanki don ƙirƙirƙirar da matsakaici da kuma ƙirƙirar sadarwa da su tare da su.
Ƙungiyar sadarwa game da matsalolin COVID-19
Za mu rubuta a kan kalendarku a ranar Alhamis na gaba, 14:00 UTC/07:00 PT don wani musamman staff meeting.
Za mu yi amfani da wannan lokaci don ƙirƙirar ƙarin updates, ƙirƙirar tambayoyi da kuma ci gaba da lokaci tare da su.
Mu ne a cikin wannan tare da kuma a nan taimaka kamar yadda za mu iya.
Yanzu, za ka iya samun bayanai daga wannan email, da kuma duk wani mahimmanci COVID-19 related bayanai, a kan Office Wiki.
The CRT zai tabbatar da wadannan yanar gizo da kuma dukkan bayanai a cikin wani yanki.
Za mu kuma aiki don ƙirƙirar hadin gwiwa tare da ma'aikata da suka rufe a cikin kasashen da aka rufe da yawa a yanzu.
Shin kana da wani tambayoyi game da tafiya, events, wani babban aiki tsari, ko coverage kwarewa, ko wani abu da za ka iya bukatar taimakawa, don Allah ba ka so ka karanta da kuma aiki tare da CRT.
Za mu taimakawa don taimakawa da taimakawa da liaise kamar yadda ake bukata.
Shin kana da wani kwarewa mai ban sha'awa ko ban sha'awa, don Allah email Bryan Judan - Director of HR International Global Operations.
Duk da haka, duk da haka, ba za a yiwuwa a matsayin ƙirƙirar aiki da kuma wajibi.
Mafi, su ne shawarar da cewa a yanzu, mu aiki da abokan ciniki za mu iya bukatar daidaita a cikin wani hanyar da muku ba a gaban.
Wannan shi ne mataki da za mu san da ake bukata don taimaka mu dauke tare da mu, samar da harkokin mu da taimaka da su bukatar, da kuma duniya da sabis da su canza.
Our shirye-shiryen aiki za su zama a gare mu a lokacin da kowane lokaci zai zama.
Yanzu, yana da lokaci don taimakawa da mata da mata da kuma samar da yanki don muhimmanci aiki da za a zama a cikin kowane makonni da kuma mako watanni.
We need all of you to make that happen, kuma don haka mu bukatar ka dukkanku don taimakawa da ku da haɗinku, don haka za ka iya zama a cikin mafi kyau a lokacin da bukatun yana da bukata.
Yanzu, don Allah - sauke ma'aikata da kuma ba su haƙĩƙa jiki!
Katherine, CRT (Amanda K, Amy V, Bryan J, Doreen D, Gregory V, Jaime V, Joel L, Lynette L, Ryan M, da Tony S), da sauran Leadership Team (Grant I, Heather W, Jaime V, Janeen U, Lisa S, Robyn A, Ryan M, da Toby N).
b'Angiotensin-converting enzyme 2 (ACE2) ne wani enzyme da aka gabatar da yanki (cell membranes) na cellulose, arteries, heart, kidney, da intestines.
ACE2 ya ƙirƙirar aiki na related angiotensin-converting enzyme (ACE) ta ƙirƙirar yawan angiotensin-II da kuma ƙirƙirar Ang(1-7) yin shi wani m maganin maganin maganin maganin maganin maganin magani.
Human version na enzyme da yawa aka kira da hACE2.
Angiotensin-converting enzyme 2 ne zinc wanda ke da metalloenzyme located a kan surface na endothelial da sauran cells.
ACE2 protein yana da wani N-terminal peptidase M2 yankin da C-terminal collectrin renal amino acid transporter yankin.
ACE2 ne a single-pass type I membrane protein, tare da sinadaran enzymatically aiki yanki a kan yanki na cellular yanki a lamba da sauran dokokin.
The extracellular yankin na ACE2 an ƙirƙirar daga transmembrane yankin da wani enzyme da aka sani da sheddase, da kuma da aka samu soluble protein an rufe a cikin damuwa da ya saukar a cikin urine.
ACE2 yana samuwa a cikin mafi yawan jiki: ACE2 yana haɓaka a cikin cell membrane na musamman lamba Type II alveolar cell, enterocytes na m jiki, arterial da venous endothelial cell da arterial m muscle cell a mafi yawan jiki.
ACE2 mRNA ekspression ne kuma samu a cikin cerebral cortex, striatum, hypothalamus, da brainstem.
Primary aiki na ACE2 ne a yi aiki a matsayin counterbalance ga ACE.
ACE ƙirƙirar hormone angiotensin I a cikin vasoconstricting angiotensin II.
ACE2 a kansa ya ƙirƙirar karboxyl-terminal amino acid phenylalanine daga angiotensin II (Asp-Arg-Val-Tyr-Ile-His-Pro-Phe) da kuma hydrolyses shi a cikin vasodilator angiotensin (1-7), (H-Asp-Arg-Val-Tyr-Ile-His-Pro-OH).
ACE2 yana iya ƙirƙirar wasu peptides ciki har da [des-Arg9]-bradykinin, apelin, neurotensin, dynorphin A, da ghrelin.
ACE2 yana ƙirƙirar ƙirƙirar ƙirƙirar ƙirƙirar ƙirƙirar amino acid transporter SLC6A19 da aka ƙirƙirar a cikin magani na Hartnup.
Kamar yadda wani transmembrane protein, ACE2 yana aiki a matsayin babban ƙarfi a cikin cellular ga wasu coronaviruses, ciki har da HCoV-NL63; SARS-CoV (virus wanda ya sa SARS); da SARS-CoV-2 (virus wanda ya sa COVID-19).
Kyakkyawancin, ƙirƙirar ƙirƙirar S1 protein na SARS-CoV da SARS-CoV2 tare da enzymatic yankin na ACE2 a kan surface na cellulose ya sa a endocytosis da translocation na biyu na virus da enzyme a endosomes located a cikin cellulose.
Wannan tsari yana da bukatar priming na S protein ta shirye-shirye serine protease TMPRSS2, wanda inhibition ne a karshe bincike a matsayin m therapeutic.This ya tafi wasu zuwa hypothesize cewa rage yawan ACE2, a cikin cell, za su iya taimakawa a ci gaban lantarki.
Duk da haka, da yawa masana'antun masana'antun masana'antun da kuma masana'antun gwiwar da suka gabatar da yin amfani da ACE inhibitor da ARB therapy.
"A tsarin bincike da meta-analytics da aka buga a kan 11 Yuli 2012, ya samu cewa "" amfani da ACE inhibitors aka haɗu tare da wani muhimmanci 34% rage na jiki na pneumonia karkashin controls.""
"More, "" ra'ayoyi na pneumonia da aka rage a cikin magani da ACE inhibitors wanda aka da mafi girma ra'ayoyi na pneumonia, musamman da waɗanda suna da shigarwa da ƙwayar ƙwayar."
"The amfani da ACE inhibitors aka haƙƙoƙi tare da rage a kan pneumonia-related fatality, ba tare da matsalolin da aka dace fiye da kyakkyawan jiki na pneumonia."
Recombinant Human ACE2 (rhACE2) an san cewa shi ne wani sabon therapy ga acute lung injury, kuma ya nuna ya inganta lantarki hemodynamics da oxygen saturation a matasa da lipopolysaccharide-induced acute respiratory distress syndrome.
The half-life na rhACE2 a cikin mutane ne game da 10 hours da kuma matsaloli na aiki ne 30 minti a kan matsaloli na matsaloli (matsaloli) na 24 hours.
Manyan bayanai sun nuna cewa rhACE2 za a iya zama wani magani magani ga waɗanda suna da intolerance ga classic renin-angiotensin tsarin inhibitors (RAS inhibitors) ko a cikin magani inda circulating angiotensin II ne ƙara.
"b'COVID-19 apps ne mobile software apps da aka tsara don taimakawa contact tracking a gyara da 2019-20 coronavirus pandemic, wanda shi ne tsari na sanin mutane ("contacts") wanda za a iya zama a kan wani matsaloli."
Manyan aikace-aikace da aka ci gaba ko shiryawa, tare da takaddun shaida na kasar a wasu yanki da yanki.
Manyan frameworks don gina contact tracing apps da aka ci gaba.
Tsarin bayanai, musamman game da tsarin da ke daidaita da yanki na masu amfani na app.
Kyakkyawan ƙaunar ƙaunar ƙaunar ƙaunar ƙaunar ƙaunar ƙaunar ƙaunar ƙaunar ƙaunar ƙaunar ƙaunar ƙaunar ƙaunar ƙaunar ƙaunar ƙaunar ƙaunar ƙaunar ƙaunar ƙaunar ƙaunar ƙaunar ƙaunar ƙaunar ƙaunar ƙaunar.
On April 10, 2020, Google da Apple ya gabatar da cewa za su ƙirƙirar aiki don ƙirƙirar takardun shaida na Bluetooth-based apps har zuwa tsarin aiki na Android da iOS.
A kasar Sin, kasar Sin, tare da Alipay, ya ƙirƙirar wani app wanda ya sa abokan ciniki don duba idan su daidaita da mutane da suke da COVID-19.
Yana amfani a fiye da 200 birnin kasar kasar Sin. A Singapore, wani app da aka sani da TraceTogether yana amfani.
"The app da aka ci gaba da cibiyar IT na yanar gizo, da aka rufe a matsayin open source da za a yi a gundumar. North Macedonia ya kafa ""StopKorona!"", wani Bluetooth-based app don rarraba jima'i tare da mutane da aka jima'i da kuma samar da wani sauri yanar gizo ga masana'antu."
Aikace-aikace da aka ci gaba da Ministry of Communications and Technology da Ministry of Health.
Saboda 14 April 2020, app ya zo a karkashin karɓar da Google Play Store da Apple App Store.
"A 12 Afrilu, kamfanoni ya ce da cewa app na contact tracing ne a cikin mataki na ci gaba da ci gaba, kuma za su zama samuwa a cikin makonni. A similar app ne shirya a Ireland, da kuma a Faransa ("StopCovid")."
Bugu Australia da New Zealand suna zuba jari apps da aka yi amfani da Singapore's TraceTogether app da BlueTrace protocol.Russia yana zuba jari wani geofencing app ga dalibai na COVID-19 da aka gyara a Moscow, da aka tsara don tabbatar da cewa su ba su rufe gida.
Ross Anderson, masana'antu injiniya a Jami'ar Cambridge, ya ƙunshi wani yawan masu amfani da kwarewa tare da tsarin app-based, ciki har da gabatarwa tsanani da ƙananan karfi idan yin amfani da app ne karfi don ƙananan yawanci.
"Dangane da matsaloli game da ƙaddamar da 'yan 'coronavirus' apps, Apple ya ƙirƙirar kowane irin shirye-shiryen za su iya ƙirƙirar apps da coronavirus a cikin App Store, ƙirƙirar su don kawai 'yan'uwan 'yan' ko wasu da aka sani."
Google da Amazon suna ƙirƙirar samuwa.
Ma'aikata na privacy ya gabatar da sha'awa game da matsakaici na masana'antu da amfani da coronavirus apps, musamman game da koyarwa cibiyar sadarwa da aka kafa don taimakawa da coronavirus pandemic za a rarraba a lokacin da lantarki da ya gabatarwa.
Amnesty International da kuma fiye da 100 masana'antun sha'awar da ya ba da sha'awar don ƙirƙirar wannan nau'i.
shirye-shirye ya gabatar da mataki na 8 a kan gwiwar gwiwar:
“Shirƙirar za su zama ‘wallace, bukatun da kuma daidaitacce’”;
Ƙararrawa na monitoring da surveillance za su kasance tare da tsarkakewa;
The amfani da bayanai za su zama kammala don COVID-19;
takardar kebantawa da takardar kebantawa na data za a iya haifar da kuma za a iya tabbatar da cewa za a iya haifar da bukatun;
Digital surveillance za a iya samun daidaitawa da maraskiya.
kowane shigarwa na data tare da kasashe ba za a kafa a kan lissafi;
za a iya samun kayan aiki tare da lissafi da hakkin ciniki don haɓaka lissafi;
"Yar da ake bukata a cikin duk 'ya'yan masu amfani', ciki har da masu sana'a masu sana'a masu sana'a da kuma al'amurran. The German Chaos Computer Club (CCC) da Reporters Without Borders (RSF) kuma ya gabatar da checklists."
Tsarin Google / Apple da aka gabatar da shirye-shirye ta hanyar ƙirƙirar ƙirƙirar ƙirƙirar ƙirƙirar ƙirƙirar ƙirƙirar ƙirƙirar ƙirƙirar ƙirƙirar ƙirƙirar ƙirƙirar ƙirƙirar ƙirƙirar ƙirƙirar ƙirƙirar ƙirƙirar ƙirƙirar ƙirƙirar ƙirƙirar.
wasu kasashe da aka amfani da yanar gizo na yanar gizo a kan cibiyar yanar gizo maimakon apps, ƙarfafafa da duk da bukatar ka sauke wani app da kuma damar ka karanta tracking.
A Isra'ila, yanar gizo a kan yanar gizo a kan yanar gizo.
Yanar gizo da cibiyar sadarwa da yana da amfani da takardun yanar gizo yana da mahimmanci na privacy matsaloli.
Duk da haka, ba dukkan tsarin tare da cibiyar sadarwa suna da bukatar ka iya samun damar bayanai a kan cibiyar sadarwa; wasu cibiyar sadarwa tsarin da aka kafa cewa amfani da cibiyar sadarwa kawai don sadarwa (duba a karkashin).
A South Korea, wani tsarin ba tare da app da aka yi amfani da contact tracking.
Kamar yadda ya amfani da wani musamman app, tsarin da aka kammala bayanai tracking daga daban-daban kayayyakin ciki har da mobile na'urorin tracking data da kartani data, da kuma ƙirƙirar wadannan don ƙirƙirar kayayyakin via text messages ga mutane da aka rike.
Bugu da amfani da wannan bayanai don alabar ƙananan masu amfani, kamfanonin da aka ƙirƙirar bayanai a kan jama'a, abin da aka yiwuwa saboda ƙananan canje-canje a kan kamfanoni mai ban sha'awar bayan MERS tsari a wannan kasar.
Wannan bayanai ne samuwa ga jama'a ta hanyar da yawa apps da websites.Länder ciki har da Jamus amfani da biyu tsari da kuma privacy-maimakon tsarin.
A kan 6 Aprili 2020, bayanai ba da faruwa.
Privacy-ma'aikata contact tracing ne mai ban sha'awa, tare da wani muhimmanci matsaloli na bincike da aka zo daga kowace 2013.A kan 7 Afrilu 2020, fiye da ƙoƙwalwar masu kwararru suna aiki a kan privacy-ma'aikata bayani, kamar yadda za a amfani da Bluetooth Low Energy (BLE) don log da masu amfani da yanki zuwa sauran wayoyin wayoyin.
Duk da haka, PEPP-PT ne mai tsari mai tsari wanda ya hada biyu tsari da tsari, kuma ba shi ne wani tsari.Decentralized protocols include Decentralized Privacy-Preserving Proximity Tracking (DP-PPT/DP-3T), Temporary Contact Numbers (TCN, fka Contact Event Numbers, CEN), Privacy Sensitive Protocols da Mechanisms for Mobile Contact Tracking (PACT) da sauransu.
A cikin wadannan protocols, daidaitaccen bayanai ba zauna ba daga na'urorin, kuma duk daidaitaccen da aka yi a cikin na'urorin.
The Privacy Group a MIT Media Lab yana ci gaba da SafePaths, wani yanar gizo don amfani da fasaha-ma'aikata a lokacin zuba jari da kuma amfani da location ko path cross-section data don tunanin ƙaddamar da COVID-19.
"A kan bincike daga whitepaper ""Apps Gone Rogue: Maintaining Personal Privacy in a Epidemic"" ya rufe a watan Maris 2020.A wani m ci gaba ne SafeTrace platform na Enigma MPC, kamfanin ci gaba privacy fasahar da aka asali a MIT Media Lab."
SafeTrace yana amfani da kayan aiki da kayan aiki don taimakawa masu amfani don ƙirƙirar bayanai da yanayi tare da masu amfani da sauran masu amfani da ma'aikata, ba tare da haɗari na bayanai.
TCN Coalition ta duniya ya kafa ta 5 Afrilu 2020 ta cikin makamashi da suka gabatar da abin da aka gabatarwa game da abin da ke daidai ne sama da kuma mafi girma a kan takardun shaida, tare da matsaloli don rage raguwa, da kuma taimakawa da aiki na duniya na tracking da alamar apps, wani muhimmanci matsaloli na samun daidaitacce.
Nuwamba 9, 2020, kamfanonin Singapore ya gabatar da cewa ya gabatar da open-source na BlueTrace protocol da aka amfani da kamfanonin kamfanonin app.
Nuwamba 10, 2020, Google da Apple, kamfanonin da ke ƙirƙirar Android da iOS mobile dandamali, ya gabatar da shirye-shirye na contact tracking, wanda suka ce za su canza privacy, a kan ƙirƙirar Bluetooth Low Energy fasaha da privacy-ma'aikata cryptography.
Har ila yau, za su gabatar da takardun shaida na core fasaha da aka amfani da tsarin.
Bisa ga Apple da Google, tsarin da aka kafa a cikin uku mataki:
shiryawa na kayan aiki don ƙirƙirar ƙirƙirar ƙirƙirar ƙirƙirar don samar da kamfanonin coronavirus tracking apps
Google da Apple yana zuba jari da kwarewa na take-up da dai sauransu ta ƙirƙirƙirar tsarin ta hanyar aiki da tsarin aiki updates, kuma sa'an nan sauke shi daidai da haka a lokacin da lantarki ya gabatarwa.
b'Drug repositioning (kowane aka sani da maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin.
Wannan shi ne daya daga cikin bincike na kimiyya da aka ci gaba a cikin ci gaba don ci gaba da hankali da ingantacin COVID-19.
Sauran bincike hanyoyin hada da ci gaba da COVID-19 vaccine da convalescent plasma transfusion.SARS-CoV-2 yana da game da 66 druggable protein, wanda kowane yana da yawa ligand binding sites.
Ƙararrawa da waɗanda suka ƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙira.
Of the most important SARS-CoV-2 target proteins are papain-like protease, RNA m RNA polymerase, helicase, S protein, da ADP ribophosphatase.
Hussein A A, et al ya gabatar da wasu magungunan kandidate wanda ya sa'an nan daidaita da kuma gyara domin daidaitacce su tare da mafi girma kamar yadda aka karfafawa magungunan magunguna don ci gaba da wani karfi anti-SARS-CoV-2 magungunan a cikin bincike na preclinical da za a zabi a cikin wani bincike bincike zane.
Chloroquine ne wani anti-malarial magani da aka amfani da wasu autoimmune magani.
18 Maris, WHO ya gabatar da cewa chloroquine da hydroxychloroquine da aka kwatanta zai zama a cikin hudu magani da aka bincike a matsayin sassa na jiki na Solidarity.
New York gundumar Andrew Cuomo ya gabatar da cewa New York State gwaje-gwaje na chloroquine da hydroxychloroquine za a fara a kan 24 Maris.A 28 Maris, FDA ya gabatar da amfani da hydroxychloroquine sulfate da chloroquine phosphate a karkashin Emergency Use Authorization (EUA).
Tsarin da aka ba da takaddun shaida ta FDA ta ci gaba da ci gaba da ci gaba da ci gaba da ci gaba da ci gaba da ci gaba da ci gaba da ci gaba da ci gaba da ci gaba da ci gaba da ci gaba.
"The CDC ya ce cewa "" amfani, dosing, ko lokaci na hydroxychloroquine don ƙirƙirar ko ci gaba da SARS-CoV-2 magani "" ba za a kafa."
"Doctors ya ce suka yi amfani da magani a lokacin da 'da ba da wani yanki'."
A Turkey bincike tawagar a Istanbul yana yi wani m bincike game da amfani da chloroquine a gabatar da zinc, vitamin A, vitamin C da vitamin D.
Large bincike ne a cikin Duke University da kuma University of Oxford.
NYU Langone Medical School yana gudanar da bincike a kan lantarki da kuma ingancin da amfani da hydroxychloroquine.
"Chinese ilimi gwaje-gwaje a Wuhan da Shenzhen ya ce ya nuna favipiravir shi ne "samar da ingancin"."
35 dalibai a Shenzhen ya gabatar da matsaloli na matsaloli na 4 kwanaki, yayin da tsawon matsaloli ya kasance 11 kwanaki a cikin 45 dalibai da ba su samu shi.
A cikin binciken da aka yi a Wuhan, a kan 240 magani da pneumonia, yarda da aka samu favipiravir da yarda da umifenovir.
The Italian Pharmaceutical Agency ya haƙƙoƙi mutane da cewa daidaici don taimakawa da magungunan magunguna ne karfi da kuma preliminary.
2 Afrilu, Jamus ya gabatar da cewa zai samuwa magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magunguna.
Kamar yadda South China Morning Post ya ce, Shinzo Abe ya ba da shawarar zuwa gabatarwar Trump game da samfurori. The magani za a iya zama karfi a cikin matsaloli na magani, a lokacin da magani ya ƙara.
Yana iya ba da gaskiya don amfani da mace ko waɗanda suka ci gaba da zane.
"A wani bincike na lopinavir / ritonavir (Kaletra), wani gabatarwar antivirals lopinavir da ritonavir, ya gaban cewa "daidaituwa ba ya zama."
Wadannan magungunan da aka tsara don ƙirƙirar HIV daga ƙirƙirar ta hanyar ƙirƙirar da protease.
Shafin bincike na Jami'ar Colorado sun ci gaba da mayar da magungunan magunguna don samun wani magungunan da za a gaban tare da protease na SARS-CoV-2. Kuna da ra'ayoyi a cikin kamfanonin kimiyya game da ƙirƙirar kayayyakin don ƙirƙirar magungunan da aka tsara don HIV / AIDS.
WHO ya hada lopinavir / ritonavir a cikin kasa da kasa Solidarity gwaji.
Remdesivir aka kafa da kuma ci gaba da Gilead Sciences a matsayin matsaloli ga Ebola virus magani da Marburg virus magani. Gilead Sciences ya sauƙi samu cewa Remdesivir yana da anti-viral aiki in vitro ga yawa filo-, pneumo-, paramyxo-, da kuma corona- viruses.
Wani matsaloli tare da antiviral therapy ne ci gaba da resistance ta hanyar mutations wanda za a iya ƙirƙirar ƙananan magani da ƙaddamarwa.
Wadannan farko pre-trial bincike nuna remdesivir za a iya da high genetic barrier to resistance.There are several clinical trials in progress, ciki har da biyu da aka yi ta Cleveland University Hospitals; daya ga mutane da matsalolin magani da kuma daya ga waɗanda da mafi matsalolin magani.
Yana da uku ci gaba da ilimi gwaje-gwaje na intravenous vitamin C ga mutane da aka shigar da kuma matsala tare da COVID-19; biyu placebo-controlled (China, Canada) da kuma daya ba tare da kontrol (Italy).
New York State ya fara gwaje-gwaje ga antibiotic azithromycin a 24 Maris 2020.
Japan ta National Center for Global Health and Medicine (NCGM) yana shirya wani binciken lissafi don Teijin's Alvesco (ciclesonide), wani inhaled corticosteroid don asthma, don magani na pre-symptomatic dalibai da aka rage da sabon coronavirus.
A form of angiotensin-converting enzyme 2, wani Phase II bincike ne a faruwa tare da 200 maganin da za a yi daidaita daga matsaloli na matsala a Denmark, Jamus, da kuma Austria don tabbatar da ingantacin da matsaloli.
Tsarin bincike daga Montreal Heart Institute a Canada suna yanzu bincike jiki na colchicine a canza jiki da matsa lamba matsa lamba a cikin mata da matsa lamba na matsa lamba na COVID-19.
The bincike, da aka sani da COLCORONA, yana ƙirƙirar 6.000 masu girma da shekaru 40 da kuma mafi girma da suka gabatar da COVID-19 da kuma haifar da matsaloli na matsaloli ba da bukatun.
Bayanai da ke daidaito, kowace da kowace ko ba tare da wani daidaitacce tsari ba za su yiwuwa.
Manyan anticoagulants suna daidaita a Italiya.
Low-molecular-manyar heparin an amfani da yawa don magance magani, wanda ya ba da Italiya Pharmaceuticals Agency don gabatar da hanyoyi game da amfani da shi.
A multicenter bincike a kan 300 maganin bincike amfani da enoxaparin sodium a cikin prophylaxis da kuma therapeutic dosages aka gabatar a Italiya a watan April 14.
Saboda SARS-CoV-2 ne wani viruses, da yawa kimiyya da sha'awar da aka dauka a kan daidaitacce da anti-viruses da aka ci gaba don gabatarwa na zamani kamar MERS, SARS, da West Nile viruses.
Ribavirin: Ribavirin an amsa don gyara COVID-19 bisa ga Chinese 7th edition guidelines
Umifenovir: Umifenovir aka ƙirƙirar don gyara COVID-19 bisa ga Chinese 7th edition zane-zane
wasu magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan:
Tocilizumab (Anti-IL-6 receptor): Shigar da China.
Tambayoyi a Italiya da kuma China. da kuma duba Tocilizumab#COVID-19.
b'A COVID-19 vaccine ne wani hypothetic vaccine ga coronavirus disease 2019 (COVID-19).
Duk da cewa duk wani vaccine da aka kammala gwaje-gwaje, akwai da yawa kwarewa a cikin ci gaba don samar da wannan vaccine.
Yau a watan Fabrairu 2020, World Health Organization (WHO) ya ce cewa ba za a rage wani vaccine ga SARS-CoV-2, wanda ya yi amfani da virus, zai zama samuwa a kowace 18 watanni.
Five vaccine candidates suna a cikin fasaha I ingancin bincike a watan Afrilu.
COVID-19 ya samu a watan Disamba 2019.
Ƙararrawa mai girma a duniya a 2020, wanda ya ƙirƙirar ƙananan kudi da bincike don ci gaba da magunguna.
Manyan masana'antu suna amfani da gaban genomes don ci gaba da m vaccines ga SARS-CoV-2.
Yadda ya ce a watan Aprili, imperatives na CEPI ta zane-zane na magungunan magungunan sun hada da gudun, samar iya aiki, gyare-gyare da kuma duniya damar.
A watan Aprili, masana'antu na CEPI ya gabatar da cewa 10 daban-daban fasaha dandamali suna a cikin bincike da ci gaban a karkashin 2020 don samar da wani karfi magani ga COVID-19.
Main yanar gizo-gizo da aka ci gaba a cikin Fashi I Safety Studies sun hada da:
Nucleic acid (DNA da RNA) (Fase I ci gaba da kuma vaccine kandida: Moderna, mRNA-1273)
viral vector (Fase I developer da vaccine kandida: CanSino Biologics, adenovirus type 5 vector)
Kamar yadda ya gabatar da CEPI masana'antu a watan Afrilu, 115 total vaccine kandida ne a cikin mataki na ci gaba, tare da 78 ya gabatar da a matsayin ayyuka (79, bayan Milken Institute), kuma 37 wasu ya gabatar da, amma tare da ƙananan jama'a bayanai da aka samuwa (mani ne a shirye-shirye ko a shirye-shirye).
A Phase I-II gwaji ya yi preliminary ingancin da immunogenicity gwaji, shi ne mafi yawanci randomized, placebo-controlled, da kuma a da yawa wurare, yayin da ya ƙirƙirar da mafi dace, m doses.
Phase III gwaje-gwaje ke ƙaddamar da yawa masu amfani, ciki har da ƙaddamarwa, da kuma gwaje-gwaje da ingancin na vaccine don ƙirƙirar magani, yayin da kammala ga matsaloli a cikin mafi kyau dosage.
"Out of 79 vaccine candidates in active development (confirmed by early April 2020), 74 suna ba a cikin al'umma (muka a "preclinical" bincike)."
A kan 24 Janairu 2020 a Australia, Jami'ar Queensland ya gabatar da cewa yana binciken damar wani magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magunguna.
A kan 24 Janairu 2020 a Canada, International Vaccine Center (VIDO-InterVac) a Jami'ar Saskatchewan ya sanar da fara aiki a kan wani vaccine, wanda ya fara gwaje-gwaje a cikin mutane a 2021.
Tsarin ci gaba da magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magunguna.
A kan 29 Janairu 2020, Janssen Pharmaceutical Companies, wanda Hanneke Schuitemaker ya wuce, ya gabatar da cewa ya fara aiki a cikin ci gaba da magani.
Janssen yana samar da magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magunguna.
18 Maris 2020, Emergent BioSolutions ya gabatar da kamfanoni tare da Vaxart don ci gaba da magani.
8 Fabrairu 2020, Laboratory OncoGen a Romania ya gabatar da wani makaranta game da zane na ajiya tare da fasaha da aka amfani da ajiya neoantigen ajiya therapy.
Mataki na bincike cibiyoyin karatun 25 Maris ya gabatar da cewa za su ƙirƙirar tsari na vaccine da suka fara bincike.
Yau 27 Fabrairu 2020, wani kamfanin na Generex, NuGenerex Immuno-Oncology, ya gabatar da suka fara shirye-shirye na magungunan don samar da magungunan peptide na Ii-Key ga COVID-19.
"Wai so su samar da wani vaccine kandida cewa za a iya gwaje-gwaje a cikin mutane a cikin '90 kwanaki."
Maris 5, 2020, Washington University a St. Louis ya gabatar da hanyoyi don ci gaba wani vaccine.
Maris 5, 2020, U.S. Army Medical Research and Materiel Command a Fort Detrick da kuma Walter Reed Army Institute of Research a Silver Spring, biyu a West Maryland, ya gabatar da su yi aiki a kan wani magani.
A kan 10 Maris 2020, Emergent Biosolutions ya gabatar da cewa ya gabatar da Novavax Inc.
a cikin ci gaba da samar da wani vaccine.
Kamfanoni da kuma ya gabatar da aikace-aikace na preclinical gwaje-gwaje da fasaha I gwaje-gwaje don watan Yuli 2020.
Maris 12, 2020, Indiya na Health Ministry ya gabatar da su aiki tare da 11 isolat, da kuma har da wani sauri tsari zai dace har zuwa kowace shekara-shekara na shekara-shekara zuwa biyu don samar da wani vaccine.
Maris 12, 2020, Medicago, kamfanin biotechnology a Quebec City, Quebec, ya sanar da ci gaba da wani coronavirus-kayan ƙarfi tare da ƙarin kudi daga Canadian Institutes for Health Research.
Vaccin candidate ne a cikin bincike na lab, tare da bincike a cikin mutane da aka kafa a watan Yuli ko Agusta 2020.
"Kuma wannan makonni, The Guardian ya gabatar da cewa U.S. President Donald Trump ya ba da CureVac "'waya kudi" don samfurin samun wani Covid-19 vaccine", wanda Jamus ta gabatarwa.
Maris 17, 2020, kamfanin Pharmaceutical Amurka Pfizer ya gabatar da shirye-shiryen tare da kamfanin Jamus BioNTech don samar da wani mRNA-based vaccine.
mRNA-based vaccine candidate BNT162, yanzu a cikin pre-clinical gwaje-gwaje tare da gwaje-gwaje da za a fara a watan Aprili 2020.
A Italiya a watan Maris 17, 2020, Takis Biotech, wani Italiya biotech kamfanin ya gabatar da su za su iya samun pre-clinical gwaje-gwaje results a watan Afrilu 2020, kuma wata final vaccine candidate za su iya fara gwaje-gwaje a cikin jiki.
A Faransa a watan Maris 19, 2020, Coalition for Epidemic Preparedness Innovations (CEPI) ya gabatar da $ 4.9 miliyan a cikin COVID-19 vaccine research consortium tare da Institut Pasteur, Themis Bioscience (Vienna, Austria), da kuma Jami'ar Pittsburgh, ƙirƙirar total CEPI a ci gaba na COVID-19 vaccine zuwa $ 29 miliyan.
Other CEPI investment partners for COVID-19 vaccine development are Moderna, Curevac, Inovio, Novavax, Jami'ar Hong Kong, Jami'ar Oxford, da Jami'ar Queensland.
20 Maris 2020, masana'antun magani na Rasha ya sanar da cewa masana'antun masana'antun da aka fara gwaje-gwaje a dabbobi na sassa daban-daban vaccine candidates.
Imperial College London masu bincike ya gabatar da 20 Maris 2020 cewa sun ci gaba da wani auto-amplifying RNA vaccine ga COVID-19.
Vaccin candidate da aka ci gaba a cikin 14 kwanaki bayan da aka samu tsari daga kasar Sin.
A karshe Maris, Canada ya gabatar da $ 275 miliyan a cikin kudi don 96 bincike ayyuka game da magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magunguna.
"A cikin wannan lokaci, Canada ta gabatar da C$ 192 miliyan musamman don ci gaba da vaccine COVID-19, tare da aikace-aikace don kafa wani kasa "vaccine banki" na wasu sabon vaccines da za a iya amfani da idan wani coronavirus matsa lamba ya zama."
"A 2 April 2020, masu bincike a Jami'ar Pittsburgh School of Medicine ya gabatar da bincike na PittCoVacc, wani m COVID-19 vaccine a cikin mako, ya ce cewa "MNA samar da SARS-CoV-2 S1 subunit vaccines ƙirƙirƙirar ƙarfi antigen-specific antibody responses [a cikin mako] wanda aka ban sha'awa da fara 2 makonni bayan immunization."
A Canada a 16 April 2020, University of Waterloo School of Pharmacy ya gabatar da zane na wani DNA-based vaccine kandida kamar wani m nasal spray.
Tsarin amfani da bacteriophages, DNA za a tsara don ƙirƙirar a cikin mutane bacteria don samar da mai ban sha'awa virus-kayan ƙarfi, wanda za a iya ƙirƙirar tsarin immunity don samar da antibodies ga SARS-CoV-2 virus.
Maris 2020, U.S. Government, masana'antun masana'antun masana'antun masana'antun masana'antun masana'antun masana'antun masana'antun masana'antun masana'antun masana'antun masana'antun masana'antun masana'antun masana'antun masana'antun masana'antun masana'antun masana'antun masana'antun masana'antun masana'antun masana'antun masana'antun masana'antun masana'antun masana'antun masana'antun masana'antun masana'antun masana'antun masana'antun masana'antun masana'antun masana'antun masana'antun.
Duk da wasu vaccines yana da matsakaici, wanda aka sani da "non-specific effects".
Saboda haka, za su iya samun kasuwanni fiye da magani da za su canza.
Tambayoyi da aka rarrabawa a Australia ya zo don ƙirƙirar 4,170 ma'aikata.
Yana iya vaccines a ci gaba ba za a iya dace ko dace.
Ma'aikata bincike don ƙirƙirar inganci da amfani da COVID-19-specific haihuwa model, kamar ACE2-transgenic mace, sauran gwaji haihuwa, da kuma non-man primates, sun nuna bukatar biosafety-level 3 daidaitaccen daidaitaccen daidaitaccen daidaitaccen daidaitaccen daidaitaccen daidaitaccen daidaitaccen.
Vaccines ga SARS da MERS suna gwaje-gwaje a cikin haihuwa model.
Tare da 2020, akwai wani magungunan ko magungunan vaccine ga SARS wanda ya nuna shi da shi a cikin mutane.
Bisa ga bincike makamashi da aka buga a cikin 2005 da 2006, da aka samu da ci gaba da sabon magungunan da magungunan don magungunan SARS shi ne wani matsaloli ga gundumar da kuma masana'antun jiki a duniya.
Kamar yadda MERS ya zama m, ya san cewa da aka zama SARS bincike za a iya samar da wani amfani da template don ci gaba da magungunan da magungunan magani ga MERS-CoV magani.
Saboda Maris 2020, akwai daya (DNA-based) MERS vaccine wanda ya gudu phase I lissafi gwaje-gwaje a cikin mutane, da sauran uku a cikin ci gaba, duk da haka suna virus-vectored vaccines, biyu adenoviral-vectored (ChAdOx1-MERS, BVRS-GamVac), da daya MVA-vectored (MVA-MERS-S).
Social media posts da aka ƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙiri.
The patents da aka tsaye da daban-daban social media posts daidaita existing patents for genetic sequences da vaccines ga sauran sassa na coronavirus kamar SARS coronavirus.
b'Coronavirus Disease 2019 (COVID-19) ne wani magani na magani wanda aka haifar da matsaloli na matsaloli na matsaloli 2 coronavirus (SARS-CoV-2).
Jami'ar haƙƙoƙi sun hada da fever, cough, da matsa lamba.
Saboda wasu magani za a iya hada da matsa lamba, muscle pain, diarrhea, throat pain, rage na rufi, da kuma abdominal pain.
The lokaci daga ƙaddamarwa zuwa ƙaddamarwa na ƙaddamarwa yana da yawanci game da wata kwanakin, amma za a iya rufe daga biyu zuwa 14 kwanakin.
Duk da yawancin matakan yana da matakan matakan, wasu yana ci gaba zuwa viral pneumonia da multi-organ failure.
Tare da 17 April 2020, fiye da 2.24 miliyan matsala da aka kwatanta a cikin 210 kasashe da yanki, wanda ya ƙirƙirar fiye da 153,000 mata.
Har ila yau, fiye da 568,000 mutane da aka saukarwa. The virus ne mai ban mamaki tsakanin mutane a lokacin kwarewa, mafi yawanci ta hanyar hanyoyin hanyoyin da aka samar ta hanyar coughing, ajiya, ko tallace-tallace.
Duk da waɗanda suna samarwa a lõkacin da suka haifar da, suka rufe a cikin ƙasa ko a kan ƙasa fiye da ƙarya.
Ma'aikata za su iya samun daidaitacce ta hanyar haɓaka yanki da kuma sa'an nan haɓaka mata, nasu, ko ƙaunarsa.
Virus yana iya haifar a kan yanayi zuwa 72 hours.
Yana da mafi ban sha'awa a cikin farko uku kwanakin bayan da matsala, ba tare da ƙirƙirar za a iya yiwuwa kafin matsala da kuma a karshe matsala na magani.The standard method of diagnosis is by real-time reverse transcription polymerase chain reaction (rRT-PCR) daga wani nasopharyngeal swab.
The amfani da masks ne mai ban sha'awa ga waɗanda suka san da su da viruses da masu zuba jari.
Ƙungiyoyi don amfani da masks ta jama'a suna daban-daban, tare da wasu ma'aikatar da ake bukata da amfani da su, wasu sun shawarar amfani da su, kuma wasu sun ba da amfani da su.
Yanzu, akwai wani vaccine ko musamman antiviral therapy ga COVID-19.
Ƙungiyoyi na Ƙungiyoyi na Ƙungiyoyi na Ƙungiyoyi na Ƙungiyoyi na Ƙungiyoyi na Ƙungiyoyi na Ƙungiyoyi na Ƙungiyoyi na Ƙungiyoyi na Ƙungiyoyi na Ƙungiyoyi na Ƙungiyoyi na Ƙungiyoyi na Ƙungiyoyi na Ƙungiyoyi na Ƙungiyoyi.
Ma'aikata da jima'i na jima'i za a iya zama asymptomatic ko ci gaba da jima'i-jima'i kamar fever, cough, matsa lamba, da matsa lamba.
Emergency dalibai sun hada da matsaloli, matsaloli ko matsaloli na dabbobi, matsaloli, matsaloli, da matsaloli, da kuma matsaloli na fata ko rubuce-rubuce; matsaloli mai sauƙi ne mai ban sha'awa idan wadannan matsaloli suna samuwa.
Ranar da yawa, matsaloli na upper respiratory kamar ajiya, rani ko ƙaunar ƙaunar ƙauna za a iya zama.
Gastrointestinal samfurori kamar magani, ƙirƙirar da rufe da rufe da aka kwatanta a daban-daban farashin.
Wadannan matsala a kasar Sin na farko ya nuna kawai tare da ƙwayar ƙwayar ƙwayar da ƙwayar ƙwayar.
A wasu, magani zai iya ci gaba zuwa pneumonia, multi-organ failure, da kuma jiki.
Yana da aka sani da lokaci na incubation.
Ƙididdiga na COVID-19 yana da yawanci fiye da wata zuwa saduwa, amma za a iya rufe daga biyu zuwa 14 kwanaki.
97.5% na mutane da ke ci gaba da magani za su yi wannan a cikin 11.5 kwanaki bayan jinkiri.Rapporters sun nuna cewa ba da dukkan mutane da aka ci gaba da magani.
Ma'aikatan wadannan asymptomatic ƙirƙirar a cikin ƙirƙirƙirar ba da cikakken san; duk da haka, preliminary nau'i sun nuna cewa za su iya taimaka wa magunguna na magunguna.
Ƙararrawa na mutane da aka ba da matsaloli ba da matsaloli ba ne a yanzu da aka koyarwa, tare da Korea Centers for Disease Control da Prevention (KCDC) ya gabatar da cewa 20% na duk da matsaloli da aka gabatar da matsaloli ba tare da matsaloli.
China ta National Health Commission ya fara ƙirƙirar matsalolin asymptomatic a cikin matsaloli na yau da kullum ta 1 Afrilu; daga 166 matsaloli a wannan rana, 130 (78%) suna asymptomatic a lokacin gwajin.
Duk da sputum da saliva za a iya ƙirƙirar babban viral load.
Ƙararrawa mai girma ya rufe foda foda foda foda foda foda foda foda foda.
A bincike a Singapore ya samu cewa wani cutar cutar zai iya ƙirƙirar cutar zuwa 4,5 meters (15 feet).
Duk da cewa magani ba a cikin iska, National Academy of Sciences ya ce cewa bioaerosol canji zai iya zama m da kuma iska collectors aka kafa a cikin yanki a cikin gida daga cikin gida da mutane yi samfurori positive ga viral RNA.
wasu magani kamar intubation da kardiopulmonary resuscitation (CPR) za a iya ƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙira.
Har ila yau da kullum, za a yiwuwa a cikin matsaloli. The virus ne mafi ban sha'awa a lokacin da mutane suna matsaloli; yayin da ƙirƙirar za a iya yiwuwa kafin matsaloli, matsaloli ne low.
The European Center for Disease Prevention and Control (ECDC) ya ce cewa har yanzu ba za a sani cikakken sauƙi da ci gaba da magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magunguna.
Kyakkyawan, virus aka samu da za a samu a cikin wani rana a kan kartani, a cikin uku kwanakin a kan roba (polypropylene) da karfe (AISI 304) da kuma a cikin hudu hours a kan 99% copper.
Wannan, duk da haka, zauna a kan humidity da kuma zafin jiki.
Sabon da na'ura mai aiki da ake amfani da da dace; sabun kayayyakin rike da mafita ƙarfi na virus, ƙirƙirar shi, kazalika da kuma rufe su daga daidaitacce da sauran yanki.
Saboda wasu tsari, kamar benzalkonium chloride da chlorhexidine gluconate (a tsari disinfectant), suna da karfi.A cikin wani Hong Kong bincike, samfurori na saliva aka samu a kan media na biyu kwanaki bayan fara jiki.
A cikin hudu daga cikin jiki, na farko samfurin ya nuna mafi girma viral load, kuma na sassa ya nuna mafi girma viral load a cikin na biyu rana gwaji.
Tsarin acute respiratory syndrome coronavirus 2 (SARS-CoV-2) ne mai ban mamaki acute respiratory syndrome coronavirus, na farko da aka ƙaddamarwa daga mutane uku tare da pneumonia da aka haƙoƙi da matsaloli na acute respiratory disease a Wuhan.
Dukkan abubuwa na nau'in SARS-CoV-2 ne a cikin coronaviruses da aka kwatanta a cikin halitta.
Daga cikin jiki na mutum, viruses suna gyara ta kasuwanci sabis, wanda ya shigar da hankali.SARS-CoV-2 yana da haɗari tare da asali SARS-CoV.
Lantarki ne organs mafi ƙarfi da COVID-19 saboda magungunan virus ya zo a cikin hoto cell via enzyme angiotensin-converting enzyme 2 (ACE2), wanda shi ne mafi yawa a cikin type II alveolar cell na lantarki.
"The virus yana amfani da wani musamman surface glycoprotein da aka sani da "spike" (peplomer) don ƙirƙirar ACE2 da kuma shiga a cikin harsashi cell."
Acute heart injury aka samu a cikin 12% na sanannen mutane a Wuhan, kasar Sin, kuma yana da yawancin a cikin matsaloli.
Rates na kardiovascular matsaloli ne high, saboda tsarin lantarki matsaloli da tsarin magani matsaloli a lokacin ci gaba da magani, amma acute myocardial matsaloli za a iya daidaita da ACE2 receptors a cikin gundumar.
ACE2 receptors suna high expressed a cikin gine-gine da aka jima'i a cikin gine-gine aiki.
A high incidence of thrombosis (31%) da venous thromboembolism (25%) da aka samu a cikin ICU dalibai da COVID-19 lissafi da za a iya haƙĩƙa da m prognosis.Autopsies na mutane da aka mafarta daga COVID-19 da aka samu diffuse alveolar yarn (DAD), da lymphocyte-containing inflammatory infiltrates a cikin lamba.
Duk da SARS-COV-2 yana da tropism ga ACE2-expressing epithelial cells na matsa lamba, masu matsa lamba da matsa lamba COVID-19 yana da matsa lamba na systemic hyperinflammation.
Yawancin, patogenic GM-CSF-secreting T-cells suna nuna hadin gwiwa tare da rekrutment na inflammatory IL-6-secreting monocytes da matsakaici pulmonary patology a COVID-19 dalibai.
Lymphocytic infiltrates da aka kwatanta a cikin autopsy.
WHO ya gabatar da wasu gwaje-gwaje protocols ga magani.
Tsarin gwaje-gwaje ne real-time reverse transcription polymerase chain reaction (rRT-PCR).
Tsarin gwaji an yi a kan samfurori da aka samu ta nasopharyngeal swab; duk da haka, wani nasal swab ko sputum samfurori za a iya amfani da.
Results suna samuwa a cikin wasu sa'o'i zuwa biyu kwanaki.
Ƙungiyoyin damuwa za a iya amfani da, amma wadannan bukatar biyu damuwa samfurori da aka yi biyu makonni da kuma matsaloli suna da karami mahimmanci.
Tsarin masana'antu na kasar Sin za su iya ƙirƙirar wani sassa na coronavirus da kuma karanta jima'i don ƙirƙirar dukan duniya za su iya ƙirƙirar ƙirƙirar polymerase chain reaction (PCR) gwaje-gwaje don ƙirƙirar jima'i da jima'i.
Tare da 4 Afrilu 2020, gwaji na antibodies (ki za a iya gane mai aiki da magungunan da kowa da kowa da mutum ya kasance magungunan a nan) suna a ci gaba, amma ba za a yi amfani da yawa.
Chinese kwarewa tare da gwaje-gwaje ya nuna daidaici ne kawai 60 zuwa 70%.
The FDA a Amurka ya gabatar da farko tsari-tallace-tallace-tallace a 21 Maris 2020 don amfani a karkashin wannan watan.Diagnostic hadin gwiwar da Zhongnan Hospital na Wuhan Jami'ar ya gabatar da hanyoyi don gane magani a kan lissafin lissafin lissafin lissafi da kuma jiki na jiki.
Bilateral multilobar ground-glass opacities tare da mai girma, asymmetrical da kuma harsuna sabis ne matsaloli a cikin farko jima'i.
Subpleural dominance, crazy matsa lamba (lobular septal matsa lamba tare da variable alveolar matsa lamba), da matsa lamba za a iya buga kamar yadda magani.
Kyakkyawan bayanai suna samuwa game da microscopic lesions da pathophysiology na COVID-19.
Main patological gaban a cikin autopsy ne:
Macroscopy: pleurisy, pericarditis, lung consolidation da lung edema
Tare-tallace-tallace-tallace na jima'i na jima'i na jima'i na jima'i na jima'i:
mild pneumonia: pulmonary edema, pneumocyte hyperplasia, babban atypical pneumocytes, interstitial rage tare da lymphocytic infiltration da multinucleated giant cell formation
Ƙararrawa Ƙararrawa Ƙararrawa Ƙararrawa Ƙararrawa Ƙararrawa Ƙararrawa Ƙararrawa Ƙararrawa
DAD yana da matsaloli na acute respiratory distress syndrome (ARDS) da kuma m hypoxemia.
Cure pneumonia: shirye-shirye na exudates a cikin alveolar cavities da interstitial pulmonary fibrosis
Blood: disseminated intravascular coagulation (DIC); leukoerythroblastic reaction
Takaddun shaida don rage matsaloli na jima'i na jima'i sun hada da riga a cikin gida, ƙarfafafawa da ƙarfafafawa, rufe ma'aikata tare da sabis da ruwa da yawa da kuma a ko'ina 20 sa'o'i, ma'aikata mai kyau na jima'i da kuma ƙarfafafa da mata, ƙauna ko ƙauna tare da ma'aikata.
CDC yana ƙirƙirar ƙarƙirar ƙarƙirar ƙarƙirar ƙarƙirar ƙarƙirar ƙarƙirar ƙarƙirar ƙarƙirar ƙarƙirar ƙarƙirar ƙarƙirar ƙarƙirar ƙarƙirar ƙarƙirar ƙarƙirar ƙarƙirar ƙarƙirar ƙarƙirar ƙarƙirar ƙarƙirar ƙarƙiri.
Yadda za a taimakawa da kyau tayin halitta bayan kake ko ajiya.
The CDC ya ƙirƙirƙirar amfani da ƙarƙirar ƙarƙirar ƙarƙirar ƙarƙirar a cikin jama'a, ƙarƙirar ƙarƙirar ƙirƙirar ta hanyar asymptomatic mutane.Social distancing takardun sha'awar haɓaka haɓaka ƙarƙirar ƙarƙirar ƙarƙirar ƙarƙirar ƙarƙirar ƙarƙirar ƙarƙirar ƙarƙirar ƙarƙirar ƙarƙirar ƙarƙirar ƙarƙirar ƙarƙirar ƙarƙirar ƙarƙirar ƙarƙirar ƙarƙirar.
Distancing hanyoyin ciki har da cewa mutane zauna a kan 6 feet (1,8 m) kauri.
"Hai wani magungunan da aka sani da za a yi amfani da cutar COVID-19. Kamar yadda wani magungunan ba za a yiwuwa kafin 2021 a karshe, wani muhimmanci sassa na gudanar da COVID-19 ne a cikin ci gaba da ci gaba da rage na magungunan, wanda aka sani da "flattening the curve" ."
CDC yana ƙirƙirar da mutane da suka sauke mata tare da sabis da ruwa a kowace 20 seconds, musamman bayan ya zo toaletta ko a lokacin da kake dace, kafin kula da kuma bayan kafa nasu, coughing ko ajiya.
Yana ƙaddamar da yin amfani da na'ura mai aiki da karfin ruwa na karfin ruwa tare da 60% na alkohol, amma kawai a lokacin da sabis da ruwa ba za a iya samuwa. Ga yanayi inda na'ura mai aiki da karfin ruwa na karfin ruwa ba za a iya samuwa, WHO yana samar da biyu samfurori don samfurori.
A cikin wadannan fitarwa, antimicrobial aiki ya yi daga ethanol ko isopropanol.
"Hydrogen peroxide an amfani da taimakawa don taimakawa da bacterial spores a cikin albarkatun; shi ne "" ba mai aiki da kayan aiki don hand antisepsis" ".
Glycerol an ƙara a matsayin humectant.
Ma'aikata suna gudanar da taimakawa, wanda zai iya hada da ruwa therapy, oxygen taimakawa, da kuma taimakawa da sauran matsaloli mai girma.
CDC yana ƙirƙirƙirar da waɗanda suka san cewa su ƙirƙirar magani na jima'i.
Extracorporeal membrane oxygenation (ECMO) an amfani da kwarewa da matsaloli na matsaloli, amma yana da amfani da shi.
Personal halitta da kuma matsaloli da matsaloli suna zuba jari don inganta immunity.
Ƙararrawa Ƙararrawa za a iya yi amfani da waɗanda suke da matsaloli da matsaloli a karshe matsaloli. The WHO da China National Health Commission suna gabatar da hanyoyi don taimakawa ga mutane da aka shigar da COVID-19.
Intensivists da pulmonologists a Amurka suna ƙirƙirar hanyoyin tsari daga daban-daban masana'antu a cikin wani free kayan, IBCC.
Tare da Aprili 2020, ba tare da wani tsari don COVID-19.
Ga matsaloli, wasu masana'antu masu sana'a bauta paracetamol (acetaminophen) fiye da ibuprofen don amfani na farko.
Ƙararrawa za a yi amfani da zane-zane don rage rage virus, musamman a cikin zane-zane-zane a lokacin aiki da za a iya ƙirƙirar aerosols, kamar intubation ko hand ventilation.
Ga masu sana'a ma'aikata ma'aikata ma'aikata da mutane da COVID-19, CDC shawarar da mutum a cikin Airborne Infection Isolation Room (AIIR) fiye da yin amfani da tsare-tallace-tallace, tsare-tallace-tallace-tallace da tsare-tallace-tallace.
Ƙararrawa kayan aiki ne: PPE shiryawa, respirator ko facemask, sunadarai, da kuma magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magunguna.
N95 na'ura mai aiki da karfin ruwa na'ura mai aiki da karfin ruwa na'ura mai aiki da karfin ruwa na'ura mai aiki da karfin ruwa na'ura mai aiki da karfin ruwa na'ura mai aiki da karfin ruwa na'ura mai aiki da karfin ruwa na'ura mai aiki da karfin ruwa na'ura mai aiki da karfin ruwa na'ura mai aiki da karfin ruwa na'ura mai aiki da karfin ruwa.
Yana tsara don haɓaka daga ƙarfi na iska, kamar ƙarfi, amma daidaitacce da wani musamman biological agents ba da hakkinta ga amfani off-label.
Kada masks ba su samuwa, CDC yana ƙirƙirar yin amfani da na'ura mai rufi, ko, a cikin karshe, masks na gida.
Most cases of COVID-19 are not severe enough to require mechanical ventilation or alternatives, amma yawancin matakan ne.
The type of respiratory support for individuals with COVID-19 related respiratory failure is being actively studied for people in hospital, tare da wasu dokokin cewa intubation za a iya canza tare da high flow nasal cannula ko bi-level positive airway pressure.
Ko da kowane daga cikin wannan biyu yana ƙirƙirar sama mai kyau ga mutane da aka kwarewa mai ban sha'awa, ba ya sani.
Wadannan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan.
Manyan masana'antun masana'antun ma'aikata ba da yawa a kowace jiki, wanda kammala iya aiki na masana'antun ma'aikata don ƙirƙirƙirar wani gundumar da yawan COVID-19 matakan da ya fi dace da ake bukata.
Wani bincike a kasar Sin ya nuna 5% ya dace a cikin jiki na jiki, 2.3% ya bukatar mechanical taimako na ventilation, kuma 1.4% ya rãya.
A kasar Sin, fiye da 30% na mutane a cikin magani tare da COVID-19 suna karshe a ICU.
Mechanical ventilation yana zama karfi a matsayin acute respiratory distress syndrome (ARDS) yana ci gaba a COVID-19 da oxygenation yana zama karfi.
Ventilators iya aiki da matsa lamba tsarin da high PEEP ne da ake bukata don ƙarfi oxygen samar da kuma rage rage na ventilator-tallace-tallace lamba da pneumothorax.
High PEEP za a iya ba su samuwa a kan manyan ventilators.
Jirgin bincike a cikin matsaloli na iya fara a watan Janairu 2020, kuma wasu magungunan antiviral suna a cikin gwaje-gwaje.
Remdesivir yana zama mafi kyau.
Duk da cewa sabon magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan.
Antiviral magani za a iya gwaje-gwaje a cikin mutane tare da matsaloli.
The WHO ta ƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙira
Yana ba tare da binciken lissafi da ake bukata cewa shi ne mai ban sha'awa da kuma mai kyau ga magani.
A watan Fabrairu 2020, China ya kafa wani mobile app don taimakawa da magungunan magani.
Ma'aikatan da aka ba da namu da ID number.
The app yana iya ƙara 'tallace-tallace' ta amfani da bayanai na zane-zane da kuma haka wani m jiki na jima'i.
Kowane masu amfani zai iya kuma duba status na uku masu amfani.
Wannan app ba kawai ba ya gabatar da kwarantina, kuma ya ƙirƙirƙirar mata. Big data analytics a kan cellphone data, facial recognition technology, mobile phone tracking da kuma artificial intelligence suna amfani da su zo matsaloli da mutane da suka wuce a South Korea, Taiwan da Singapore.
Maris 2020, Isra'ila ta gabatar da shirye-shirye na lantarki ya sa da lantarki na lantarki na lantarki na mutane da aka rufe da coronavirus.
Takaddun shaida aka daidaita don ƙirƙirar kwarantena da kuma haɓaka waɗanda za su zo a cikin haɗari tare da ra'ayoyi.
Har ila yau, a watan Maris, 2020, Deutsche Telekom ya ƙirƙirar bayanai na yanar gizo tare da shirye-shirye na Jami'ar Jami'ar Jami'ar Jami'ar, Robert Koch Institute, don bincike da kuma haɓaka fitarwa na virus.
Rasha ta ƙirƙirar fasaha na Rasha ta ƙirƙirar karantina.
Italiya Regional Health Commissioner Giulio Gallera ya ce ya ce ta sayi daga mobile operator cewa "40% na mutane suna karfafawa a kowace lokaci."
Jamus ta ƙirƙirar 48-hour Weekend Hackathon tare da fiye da 42,000 masu amfani.
Kersti Kaljulaid, shugaban Estoniya, ya ba da shawarar duniya don zane-zane da zane-zane don ƙirƙirar coronavirus.
Ma'aikata za su iya matsaloli matsaloli daga karantina, tafiya rage, matsaloli na matsaloli, ko matsaloli na jiki, ko matsaloli na jikin jiki.
BBC ya ce Rory O'Connor ya ce, "Accreased social isolation, loneliness, health anxiety, stress da kuma tattalin arziki ne mai kyau tsuntsaye don haɓaka mutane na jiki da kyau."
Wannan magani za a iya yi da matsaloli tare da wasu matsaloli ko ba tare da wani matsaloli, kamar sauran matsaloli na ƙarfin jiki, kamar tsarkakewa.
Kyakkyawan matsaloli zaune a cikin wata biyu, yayin da waɗannan tare da matsakaici ko matsakaici matsaloli za su iya daidaita uku zuwa shekaru saduwa.
Rasuwar mata za a iya zama a mafi girma rage na matsaloli da COVID-19 a kan bayanai daga sauran matsaloli viruses, kamar SARS da MERS, amma bayanai ga COVID-19 ba. A wasu mutane, COVID-19 za a iya haifar da ƙwayar ƙwayar ƙwayar ƙwayar.
A cikin waɗanda aka fi daidaita mafi, COVID-19 za a iya sauri zuwa acute respiratory distress syndrome (ARDS) wanda ke ƙirƙirar haihuwa, septic shock ko multi-organ failure.
Ƙararrawa da COVID-19 sun hada da sepsis, abnormal daidaitacce da kuma haɗari a gundumar, ƙwayar da ƙwayar.
COVID-19 anabolic abnormalities, musamman da ƙarfi na prothrombin lokaci, suna rubuta a cikin 6% na waɗanda aka samu a gundumar tare da COVID-19, yayin da abnormal ranka aiki suna nuna a cikin 4% na wannan jiki.
Yawancin 20-30% na mutane da aka samu tare da COVID-19 nuna ƙarfin jiki enzymes (transaminases).
Saboda wannan binciken, daidaici lokaci tsakanin matsaloli da matsaloli ya kasance fiye da kowane kwanaki, tare da fiye da fiye da fiye da fiye da fiye da fiye da jiki.
Duk da haka, magani da aka canza zuwa ICU yana da m lokaci na 7 kwanakin tsakanin jiki da kuma jiki.
A cikin bincike na kwarewa na kwarewa, tsawon lokaci daga rarraba samfurori zuwa jima'i ne 14 kwanaki, tare da cikakken rarraba na sassa zuwa 41 kwanaki.
A bincike na National Health Commission (NHC) na kasar Sin, ma'aikata yana da matsaloli na 2.8% yayin da ma'aikata yana da matsaloli na 1.7%.
Histopathological bincike na post-mortem lamba samfurori nuna diffuse alveolar da cellular fibromyxoid exudates a biyu lamba.
Viral cytopathic canje-canje da aka kammala a cikin pneumocytes.
Ƙananan ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar.
A cikin 11.8% na matsaloli da aka gabatar da National Health Commission na kasar Sin, matsaloli na halitta aka karanta da matsaloli na troponin ko matsaloli na halitta.
Bisa ga watan Maris bayanai daga Amurka, 89% na waɗanda aka shigarwa suna da matsaloli.Hawar da kayayyakin jima'i da sosio-tattalin arziki na yankin za a iya haƙĩƙa matsaloli.
Takaddun shaida na matsaloli daga matsaloli vary due to those regional differences, but also because of methodological difficulties.
The undercounting na matsaloli za a iya ƙirƙirƙirar matsaloli.
Duk da haka, cewa matsaloli ne matsaloli na matsaloli da aka dauka a cikin gabatarwa, za a iya san cewa matsaloli na yanzu ne alama.
Smokers suna 1.4 fiye da za a yiwuwa da matsaloli na COVID-19 da kuma game da 2.4 fiye da za a bukatar matsalolin jiki ko zama fatan fiye da non-smokers.
The Hong Kong Hospital Authority ya samu a cikin 20% zuwa 30% a cikin iya aiki na lamba a cikin wasu mutane da aka rarraba daga magani, da kuma lamba scans ya nuna ƙarfin jiki.
Wannan zai iya ƙirƙirar post-intensive care syndrome bayan rabuwa.
Daga Maris 2020, shi ne ba ya sani idan matsaloli na zamani ya samar da karfi da tsawon lokaci a cikin mutane da ke samu daga magani.
Immunity da aka kira kamar yadda za a yiwuwa, bisa ga matsaloli na sauran coronaviruses, amma matsaloli a cikin abin da rage daga COVID-19 da aka dacewa da matsaloli ga coronavirus a karshe lokaci da aka kwatanta.
Wadannan matsaloli suna kira shi ne matsaloli na daidaitacce na jima'i, fiye da re-infection.
The virus an san cewa shi ne na al'umma da kuma yana da al'umma, ta hanyar tsarkakewa lantarki.
Yanzu asali ne ba, amma a watan Disamba 2019, ƙirƙirar jima'i na jima'i ya zama fiye da cikakkiya na jima'i zuwa jima'i.
A bincike na farko 41 matsaloli na confirmed COVID-19, da aka buga a watan Janairu 2020 a cikin The Lancet, ya nuna da farko lokaci na farawa na matsaloli ne 1 Disamba 2019.
Shafin shafi na WHO ya gabatar da farko na matsaloli a 8 Disamba 2019.
Manyan matsalolin da aka yi amfani da yawancin matsalolin.
Wadannan talakawan zauna da yankin da tsawon lokaci da ke daidaita da yawan gwaje-gwaje, ingancin tsabar kudi tsarin, matsaloli yanayin, lokaci daga farko tsibirin da kuma yawan jiki kayan ciki har da umurni, jini da jiki.
A karkashin 2019, WHO ya sa ICD-10 tsare-tsaren code U07.1 ga matsala daga SARS-CoV-2 tsare-tsare-tsare da kuma U07.2 ga matsala daga COVID-19 tsare-tsare-tsare-tsare-tsare-tsare-tsare-tsare.
Bisa ga takardar kebantawa na Johns Hopkins University, duniya matsaloli-tallace-tallace ratio ne 6.9% (153,822/2,240,191) a kan April 17, 2020.
Sauran ƙarfi sun hada da matsalolin matsalolin matsalolin (CFR), wanda ya nuna ƙarfi na matsalolin matsalolin da aka magana daga matsalolin, da matsalolin matsalolin matsalolin matsalolin (IFR), wanda ya nuna ƙarfi na matsalolin matsalolin da aka magana da matsalolin.
Wadannan takardun shaida ba zauna lokaci da kuma tafiya da yawancin yawancin daga jima'i zuwa kwarewa.
Duk da ba da dukan mutane da aka rage da antibodies, ƙaddamar da antibodies za a iya samar da bayanai game da yawa mutane da aka rage.
A epicenter na tsarkakewa a Italiya, Castiglione d'Adda, wani m kasashe na 4.600, 80 (1.7%) ya zama mata.
A Gangelt, magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magunguna.
Bugu da haka, tsarin jima'i na Jamus ba da ƙarfi.
A Netherlands, game da 3% za a iya da antibodies, kamar yadda ya dace daga damu donors.
69 (0.004% na jama'a) da aka gabatar da ya zama fatan daga COVID-19.
Tsarin pandemic da matsaloli da matsaloli ne daban-daban ga mata da mata.
Ma'aikata ne mafi girma a cikin ma'aikata a cikin binciken da aka yi a kasar Sin da Italiya.
Ƙararrawa mafi girma ga mutane ne a cikin 50s, tare da matsaloli tsakanin mutum da jima'i hanya a 90s.
A kasar Sin, daidaitaccen daidaitaccen daidaitaccen daidaitaccen daidaitaccen daidaitaccen ne 2.8%.
Ma'aikatar daidai da wannan jima'i-daban ba za a sani, amma jima'i da jima'i da kuma jima'i za a iya zama wani sababu.
Ƙararrawa na jima'i, ƙararrawa na jima'i a cikin jima'i da jima'i da jima'i da suke ci gaba da matsaloli kamar hipertensiya a cikin matsaloli fiye da jima'i na jima'i za su iya taimaka wa ƙararrawa a cikin jima'i.
A Turai, 57% na mutane da aka rage daga COVID-19 suna maza da 72% daga waɗanda suka rãba daga COVID-19 suna maza.
Tare da Aprili 2020, U.S. gundumar ba ya zo bayanai game da jima'i na COVID-19.
Jirgin bincike ya nuna cewa magungunan magani kamar Ebola, HIV, influenza da SARS suna haifar da mata da mata a daban-daban.
A mafi yawan masu sana'a ma'aikata, musamman ma'aikata, ne mata, kuma suna da mafi yawancin da aka rarraba da virus.
The World Health Organization ya gabatar da 11 Fabrairu 2020 cewa takardun jiki zai zama "COVID-19".
WHO ya ce Tedros Adhanom Ghebreyesus ya ce da cewa CO yana da alama ga corona, VI don magani, D don magani, da kuma 19 don lokacin da magani ya zama farko: 31 Disamba 2019.
Sunan da aka zabi don kawar da alama a cikin wani musamman yanki (m.g. China), al'amari na al'amari, ko al'amari na mutane, a karkashin kasa da kasa da kasa da al'amari don al'amari da ake bukata don ƙirƙirƙirƙirƙirƙirƙiri.
"WHO yana amfani da "COVID-19 virus" da "COVID-19 virus" a cikin jama'a."
"Ba tare da magani da magani suna dauke da 'coronavirus'."
"A lokacin da aka farawa na farko a Wuhan, kasar Sin, virus da magani aka dauke da 'coronavirus' da 'Wuhan coronavirus'."
A watan Janairu 2020, WHO ya gabatar da 2019-nCov da 2019-nCoV acute respiratory disease a matsayin sunan magani ga viruses da magani a karkashin hanyoyi na 2015 don amfani da wurare a cikin magani da maganin viruses.
Shafin sunan COVID-19 da SARS-CoV-2 aka gabatar da 11 Fabrairu 2020.
Saboda ƙarfi na ƙarfi a cikin kayayyakin tsari, wasu masana'antu na dijital suna buga kayayyakin magani, kamar ƙarfi na nasal da na'ura mai rufi.
A cikin wani misali, a lokacin da wani Italiyan magani ya ba da yaushe wani ventilator valve, kuma masana'antu ba za a iya samar da a cikin lokacin da ake bukata, wani yanki start-up ya reverse-engineered da aka buga da 100 valves da ake bukata a kowace rana.
Bayan farkon farko na COVID-19, takardun sha'awar, takardun sha'awar da takardun sha'awar game da asali, ƙarfi, ƙarfin sha'awar, matsaloli da sauran matsaloli na jikin sha'awar da aka sauri online.
Ƙaddamar da mutane suna iya ƙirƙirar virus zuwa wasu haihuwa.
The bincike ba ya samu nau'i na virus replication a cikin mata, ducks, da chickens.
Duk wani magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magunguna.
International bincike a kan vaccines da magungunan magani a COVID-19 ne da aka yi ta hanyar gundumar, kamfanoni da kuma masana'antun masana'antu.
"A watan Maris, World Health Organization ya fara "SOLIDARITY Testimony" don inganta matsaloli da yanayin antivirals mai dace da ingancin."
Duk da haka, ba za a iya samun wani vaccine, amma daban-daban masana'antu suna ci gaba da wani vaccine candidate.
Tsarin aiki a kan SARS-CoV yana amfani da saboda SARS-CoV da SARS-CoV-2 duk da suka amfani da ACE2 receptor don shiga al'umma.
Tare da uku zane-zane na zane-zane.
Na farko, masu bincike suna da hankali don samar da dukan magungunan virus.
Tsarin amfani da wannan virus, ko da aka haifar da ko haihuwa, yana da hankali don ƙirƙirar tsari na jikin jiki a kan wani sabon jikin COVID-19.
A biyu tsari, subunit vaccines, yana da shirya don samar da wani vaccine wanda ya ƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙirƙira.
A kan SARS-CoV-2, wannan bincike ya ƙunshi a kan S-spike protein wanda taimaka virus ya sa ACE2 enzyme receptor.
Tare da takaddun shaida ne na nucleic acid vaccines (DNA ko RNA vaccines, wani sabon fasaha don samar da shaida).
Ƙananan magani daga kowane na wadannan takaddun shaida za su zama gwaje-gwaje ga ingancin da ingancin.A 16 Maris 2020, na farko na gwaji na magani ya fara tare da hudu masu zaman kansu a Seattle.
The vaccine yana ƙunshi mai ban sha'awa genetics code da aka saita daga viruses wanda ke ƙunshi magani. Antibody dependent enhancement da aka gabatar da cewa wani mahimmanci don ci gaba da magani ga SARS-COV-2, amma wannan ne mai ban sha'awa.
Yana da fiye da 300 active clinical trials a karkashin Aprili 2020.
Sabuwar gwaje-gwaje da aka kammala shigarwa don malaria, ciki har da hudu bincike game da hydroxychloroquine ko chloroquine.
Ƙananan bincike na kasar Sin sun hada da nau'in antivirals, tare da nuni na fashi III na remdesivir a cikin wasu kasashe da za a rabo a karkashin Aprili.
Tsarin COVID-19 da magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magunguna.
Kuna haifar da bukatun ingancin na remdesivir, a kan Maris 2020.
Clinical ingancin da aka kwatanta a cikin maganin da aka yi amfani da remdesivir.
Phase III ilimi gwaje-gwaje da aka yi a Amurka, China da Italiya. Chloroquine, wanda aka yi amfani da malaria, an bincike a kasar Sin a watan Fabrairu 2020, tare da mahimmanci.
Duk da haka, akwai tambayoyi ga peer review na bincike.
Korean da kuma Chinese Health Authorities shawarar amfani da chloroquine.
Duk da haka, Wuhan Institute of Virology, yayin da ya ƙirƙirƙirar wani yawan rana na gram, ya nuna cewa biyu da wannan yawan ne mai ban sha'awa da kuma za a iya zama maza.
A 28 Maris 2020, FDA ya ba da damar amfani da tsare-tsaren hydroxychloroquine da chloroquine a kan takardar shaida na magungunan magungunan magungunan COVID-19. The Chinese 7th edition hanyoyin da aka hada da interferon, ribavirin ko umifenovir don amfani da COVID-19.
preliminary data sun nuna cewa high doses na ribavirin suna da ake bukata don haɓaka SARS-CoV-2 in vitro.
Nitazoxanide da aka ƙirƙirar don ƙarin binciken in vivo bayan ya nuna low-concentrated inhibition na SARS-CoV-2. A binciken da ya nuna cewa farko mataki protein priming da transmembrane protease serine 2 (TMPRSS2) yana da muhimmanci domin shiga SARS-CoV-2 ta hanyar yanayin tare da ACE2 receptor.
The bincike na chloroquine da hydroxychloroquine tare da ko ba tare da azithromycin yana da muhimmanci kammala cewa sun haƙĩƙa da jama'a na magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magungunan magunguna.
Cytokine Storm za a iya zama matsaloli a karshe matsaloli na m COVID-19.
Yana da alama cewa hydroxychloroquine za a iya da anti-cytokine storm properties.Tocilizumab da aka ƙunshi a cikin matsalolin da National Health Commission na kasar Sin bayan wani m binciken da aka kammala.
Yana dauka a cikin mataki na 2 non-randomized gwaji a kasa a Italiya bayan ya nuna mataki a cikin mutane da mataki magani.
Ƙungiyar tare da ferritin damuwa na serum don ƙara cytokine tsuntsaye, shi ne don haɓaka wadannan ci gaba, wanda aka sani da za a zama matsala a cikin wasu matsala mutane.
The interleukin-6 receptor antagonist aka karfafawa ta FDA bisa ga retrospective case studies don magani na steroid refractory cytokine release syndrome induced by a different cause, CAR T cell therapy, a 2017.
Tare da yau, akwai ba tare da wani randomized, controlled evidence cewa tocilizumab ne mai kyau magani ga CRS.
Ƙirƙirƙirar da ƙirƙirar ƙirƙirar ƙirƙirar ƙirƙirar ƙirƙirar ƙirƙirar ƙirƙirar ƙirƙirar ƙirƙirar ƙirƙirar ƙirƙirar ƙirƙirar ƙirƙirar ƙirƙirar ƙirƙirar ƙirƙirar ƙirƙirar ƙirƙirar ƙirƙirar ƙirƙirar ƙirƙirar ƙirƙirar ƙirƙirar ƙirƙirar ƙirƙirar ƙirƙirar ƙirƙirar ƙirƙirar ƙirƙirar ƙirƙirar ƙirƙirar ƙirƙirar ƙirƙirar ƙirƙirar ƙirƙirar ƙiri.
Wannan takaddun shaida a cikin SARS tare da matsaloli.
Viral neutralization ne daidaici aiki mechanism ta hanyar cewa passive antibody therapy za a iya canza haɗari da SARS-CoV-2.
Duk da haka, wasu mechanisms, kamar tsari tsari cytotoxicity da kuma / ko phagocytosis, za a iya.
Other forms of passive antibody therapy, don haka, ta amfani da manufactured monoclonal antibodies, ne a ci gaba.
Production na convalescent serum, wanda ya hada da ruwa portion na damuwa daga magani da kuma yana ƙunshi antibodies musamman ga wannan virus, za a iya ƙara don sauri rarraba.
Coronavirus magani, wani jerin magani
Li Wenliang, wani dabbobi a Wuhan Central Hospital, wanda ya sauƙi dauka a kan COVID-19 bayan ya ci gaba da ci gaban da virus.
